Sentence,class,file
http://dx.doi.org/10.1007/s11430-009-0079-y .,Non-OADS,/arxiv_data1/oa_pdf/ee/2e/main.PMC4992103.pdf
http://dx.doi.org/10.1007/s00374-012-0707-0 .,Non-OADS,/arxiv_data1/oa_pdf/ee/2e/main.PMC4992103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/18/main.PMC4992104.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.08.009 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/87/18/main.PMC4992104.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 229 e230,Non-OADS,/arxiv_data1/oa_pdf/87/18/main.PMC4992104.pdf
"Interestingly, this phenomenon could be reproduced with certainty without changing mutation ratesat all.Received: 27 May 2016 Revised: 27 July 2016 Accepted: 5 August 2016 Heliyon 2 (2016) e00141 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
"In short, it has been Article No~e00141 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
The Article No~e00141 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
"Then, the total value of FSof total Article No~e00141 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
"A simple genetic manipulation, by which the rate of the lagging-strand-biased-mutagenesis is increased, can bring about the acceleration of Article No~e00141 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
Article No~e00141 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00141 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/9d/main.PMC4992105.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 99 e100 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.07.006 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b7/61/main.PMC4992106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/61/main.PMC4992106.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/ce/main.PMC4992107.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.02.001 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/55/ce/main.PMC4992107.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 213 e216,Non-OADS,/arxiv_data1/oa_pdf/55/ce/main.PMC4992107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4992108.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 649 –653 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.005 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4992108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4992108.pdf
Available: http://www.who.int .,Non-OADS,/arxiv_data1/oa_pdf/7b/35/main.PMC4992108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/27/main.PMC4992109.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 577 –583 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.005 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/43/27/main.PMC4992109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/27/main.PMC4992109.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/main.PMC4992110.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 137 e141 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.006 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/main.PMC4992110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/main.PMC4992110.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/e2/main.PMC4992111.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 131 e136 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.003 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1a/e2/main.PMC4992111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/e2/main.PMC4992111.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4992112.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 142 e145 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.005 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4992112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/main.PMC4992112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/bf/main.PMC4992113.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 628 –633 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.08.002 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/95/bf/main.PMC4992113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/bf/main.PMC4992113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/9f/main.PMC4992114.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 634 –641 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.08.004 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/17/9f/main.PMC4992114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/9f/main.PMC4992114.pdf
http://dx.doi.org/10.1155/2014/640754 640754.,Non-OADS,/arxiv_data1/oa_pdf/17/9f/main.PMC4992114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ad/main.PMC4992115.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 584 –591 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.015 1319-562X ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/6c/ad/main.PMC4992115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ad/main.PMC4992115.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4992116.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 117 e122 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4992116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/main.PMC4992116.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/03/main.PMC4992117.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 152 e154 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.005 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/35/03/main.PMC4992117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/03/main.PMC4992117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/36/main.PMC4992118.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 614 –620 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.07.005 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/36/main.PMC4992118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/36/main.PMC4992118.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/35/main.PMC4992119.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 112 e116 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.04.007 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/main.PMC4992119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/35/main.PMC4992119.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 97 e98 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.07.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c0/c4/main.PMC4992120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/c4/main.PMC4992120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ee/main.PMC4992121.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 607 –613 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.07.001 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ee/main.PMC4992121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ee/main.PMC4992121.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 146 e151 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.06.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.joco.2016.06.001 .,OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
Available from: http://www.icoph.org/downloads/icocurricres.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
Available from: https://www.acgme.,Non-OADS,/arxiv_data1/oa_pdf/fc/0c/main.PMC4992122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/main.PMC4992123.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 592 –597 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.019 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/main.PMC4992123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/main.PMC4992123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/9f/main.PMC4992124.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.11.017 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/4d/9f/main.PMC4992124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 231 e234,Non-OADS,/arxiv_data1/oa_pdf/4d/9f/main.PMC4992124.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 123 e130 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
http://dx.doi.org/10.1371/ journal.pone.0114012 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
2016;2016:4608979. http://dx.doi.org/10.1155/ 2016/4608979 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
2013;2013:587826. http://dx.doi.org/10.1155/2013/587826 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
2015;74:5. http://dx.doi.org/ 10.4102/aveh.v74i1.13 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
2012;2012:581695. http://dx.doi.org/10.1155/ 2012/581695 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f8/main.PMC4992125.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/main.PMC4992129.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.11.022 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/main.PMC4992129.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 247 e248,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/main.PMC4992129.pdf
http://dx.doi.org/10.3340/ jkns.2007.41.4.272 .,OADS,/arxiv_data1/oa_pdf/e6/9b/main.PMC4992129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.009 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 221 e224,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://www.eeri.org/lfe/pdf/kashmir_eeri_2nd_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://www.kevinmd.com/blog/2010/01/haiti-earthquake-damage-hospitals- health-care-infrastructure.html Accessed 12.12.15.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://www.who.int/hac/crises/hti/appeal/revised_un_appeal/en/ Accessed 12.12.15.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://ascelibrary.org/doi/abs/10.1061/41168% 28399%2945 .,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
http://unesdoc.unesco.org/images/0022/002290/ 229059E.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b8/64/main.PMC4992130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.06.001 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 193 e198,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
2013;4:109. http://dx.doi.org/10.3389/ ﬁmmu.2013.00109 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.3760/cma.j.issn.2095- 4352.2015.02.001 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
2015;5:5. http://dx.doi.org/10.7603/s40681-015-0005-x .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1517/14712598.2013.,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1021/jf505531w .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1097/shk.0b013e3181 62c190 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1007/s00268-014-2922-3 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
2013;98:1 e7.http://dx.doi.org/10.1016/j.ecoenv.2013.09.039 .,OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/ 10.1016/j.ijfoodmicro.2011.12.035 .,OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1098/rsif.2010.0294 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.2106/JBJS.K.01672 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.3855/jidc.4482 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
2013;17:5 e11.http://dx.doi.org/10.4103/0972-124X.107466 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
2015;830:29 e46.http://dx.doi.org/10.1007/ 978-3-319-11038-7_2 .19.,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/ 10.1371/journal.pone.0124001 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
http://dx.doi.org/10.1002/pros.22983 .,Non-OADS,/arxiv_data1/oa_pdf/88/4c/main.PMC4992131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/main.PMC4992132.pdf
1Those patients contribute evenly to this paper.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.012 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/main.PMC4992132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 199 e205,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/main.PMC4992132.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/main.PMC4992133.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.016 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/main.PMC4992133.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 239 e243,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/main.PMC4992133.pdf
http://dx.doi.org/10.1097/ SCS.0b013e318190327a .,Non-OADS,/arxiv_data1/oa_pdf/e5/ed/main.PMC4992133.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/9f/main.PMC4992134.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.07.012 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/cc/9f/main.PMC4992134.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 206 e208,Non-OADS,/arxiv_data1/oa_pdf/cc/9f/main.PMC4992134.pdf
http://dx.doi.org/10.4103/0019- 5413.118208 .,Non-OADS,/arxiv_data1/oa_pdf/cc/9f/main.PMC4992134.pdf
http://dx.doi.org/10.1111/j.1756-185X.2010.01477.x .,Non-OADS,/arxiv_data1/oa_pdf/cc/9f/main.PMC4992134.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/fd/main.PMC4992135.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.014 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/05/fd/main.PMC4992135.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 225 e228,Non-OADS,/arxiv_data1/oa_pdf/05/fd/main.PMC4992135.pdf
Available from: http://www.unhabitat.org/grhs/2013 .,Non-OADS,/arxiv_data1/oa_pdf/05/fd/main.PMC4992135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/4f/main.PMC4992136.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.11.021 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/08/4f/main.PMC4992136.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 209 e212,Non-OADS,/arxiv_data1/oa_pdf/08/4f/main.PMC4992136.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/92/main.PMC4992137.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.11.018 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/61/92/main.PMC4992137.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 244 e246,Non-OADS,/arxiv_data1/oa_pdf/61/92/main.PMC4992137.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/4d/ijp-26-03-3723.PMC4992150.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/f6/ijp-26-03-1711.PMC4992152.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/af/ijp-26-03-6177.PMC4992153.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.06.007 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 187 e192,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1038/nbt.2958 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/ j.actbio.2013.12.005 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1126/ sciadv.1600056 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1089/ten.TEB.2014.0168 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1021/ acsami.5b10697 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1002/adma.201501099 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1002/ adma.201004625 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
"http://dx.doi.org/10.1039/c4lc00030g .14.Cha C, Soman P, Zhu W, et al.",OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2015;25:24 e34.http://dx.doi.org/10.1016/ j.actbio.2015.07.030 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1002/adma.201405076 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2015;132:42458. http://dx.doi.org/10.1002/ app.42458 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/ j.actbio.2014.09.033 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1002/ anie.201511767 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/ j.biomaterials.2013.09.078 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/j.actbio.2015.07.034 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1126/sciadv.1501381 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1038/nbt.3413 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/j.eurpolymj.2015.07.034 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1021/ acs.biomac.5b00188 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/ j.carbpol.2014.07.059 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2015;119:93 e99.http://dx.doi.org/10.1016/ j.compscitech.2015.10.002 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2015;71:48 e57.http://dx.doi.org/10.1016/ j.biomaterials.2015.08.028 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/j.biomaterials.2015.10.003 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/ j.biomaterials.2008.12.009 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/ 10.1016/j.biomaterials.2014.04.091 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2014;3:36 e41.http://dx.doi.org/10.1016/j.coche.2013.10.006 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1016/j.biomaterials.2014.12.031 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1038/nmat3357 .,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1002/adma.201305506 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2016;59:53 e60.http://dx.doi.org/10.1016/j.msec.2015.09.104 .41.,OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
2015;7:045012. http://dx.doi.org/10.1088/1758-5090/7/4/045012 .,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
http://dx.doi.org/10.1007/s11706-013-0211-y .H.-B.,Non-OADS,/arxiv_data1/oa_pdf/ea/52/main.PMC4992174.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/9b/main.PMC4992175.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.06.006 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/93/9b/main.PMC4992175.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 235 e238,Non-OADS,/arxiv_data1/oa_pdf/93/9b/main.PMC4992175.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/38/ijp-26-03-5979.PMC4992177.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/33/ijp-26-03-5808.PMC4992178.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © CJ Tann et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/4c/pr201677a.PMC4992358.pdf
Available  from: http://www.WHO.int/TB/publications/  MDRFactSheet2012.pdf  [2012].,Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
Available from: http://www.WHO.int/TB/challenges/ MDR/factsheet_MDR_progress_march 2011.pdf [2011].,Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"Reference Available from: http://www.emro.who.int/ tuberculosis/epidemiological-situation/epidemiological-situation.html [6] He GX, Zhao YL, Jiang GL, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1186/1471-2334-8-166] [PMID: 19077223] [7] Sahebi L, Ansarin K, Farajnia S, Monfaredan A, Sabour S. Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.",Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
[http://dx.doi.org/10.1080/00325481.2015.1069168] [PMID: 26174471] [8] Farmer P. The major infectious diseases in the world-to treat or not to treat?,Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1056/NEJM200107193450310] [PMID: 11463018] [9] Yew WW, Leung CC.",Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.3855/jidc.1259] [PMID: 21795819] [14] Velayati AA, Farnia P, Masjedi MR, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1183/09031936.00081909] [PMID: 19880622] [15] Wright A, Zignol M, Van Deun A, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)60331-7] [PMID: 19375159] [16] Weis SE, Slocum PC, Blais FX, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1056/NEJM199404283301702] [PMID: 8139628] [17] Bahrmand AR, Velayati AA, Bakayev VV.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1016/j.ijid.2008.11.027] [PMID: 18838283] [19] Mirsaeidi MS, Tabarsi P, Farnia P, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1086/507542] [PMID: 16941364] [22] Ramazanzadeh R, Farnia P, Amirmozafari N, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1159/000095971] [PMID: 17008783] [23] Massi MN, Wahyuni S, Halik H, et al.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
[http://dx.doi.org/10.5588/ijtld.09.0730] [PMID: 21396208],Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"[http://dx.doi.org/10.1016/j.ijid.2008.03.012] [PMID: 18514008] [25] Trakada G, Tsiamita M, Spiropoulos K. Drug-resistance of Mycobacterium tuberculosis  in Patras, Greece.",OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
[http://dx.doi.org/10.1056/NEJM200104263441706] [PMID: 11320389] © Sahebi et al.,Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/bf/TORMJ-10-29.PMC4992749.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/dkw174.PMC4992851.pdf
http://apps.who.int/iris/bitstream/10665/ 112485/1/9789241507028_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/0c/dkw174.PMC4992851.pdf
The  twenty ‘formerly BAC’ with invasive features cases tumor-normal pairs’ bam files were retrieved to validate clon-ality analysis via http://cghub.ucsc.edu [10/06/2016 accessed].,OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"Exome Variant Server NHLBI GO Exome Sequencing Project (ESP) Seattle, W A (URL: http://evs.gs.washington.edu/EVS/) [22/12/14 accessed].",OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"National Research Institute (NCI) and National Human Genome Research Institute (NHGRI), The Cancer Genome Atlas (TCGA) URL; http://tcga-data.nci.nih.gov/tcga/ [03/03/2015 accessed].",OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"Wellcome Trust Sanger Institute, COSMIC Catalogue of somatic mutations in cancer http://cancer.sanger.ac.uk/cosmic/signatures  [31/03/2015 accessed].",Non-OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Vinayanuwattikun, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/87/e4/srep31628.PMC4992872.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/e4/nms-05-02-35594.PMC4992994.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/38/nms-05-02-34297.PMC4992995.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/f4/nms-05-02-31919.PMC4993009.pdf
Available from: http://rave.ohiolink.edu/etdc/view?acc_num= mco1115224218 .,Non-OADS,/arxiv_data1/oa_pdf/71/f4/nms-05-02-31919.PMC4993009.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/90/nms-05-02-25852.PMC4993029.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/91/nms-05-02-28949.PMC4993030.pdf
Available from: https://stti.confex.com/stti/bcclinical38/ techprogram/paper_26041.htm .,Non-OADS,/arxiv_data1/oa_pdf/23/91/nms-05-02-28949.PMC4993030.pdf
Available from: http://www.oralhealthplatform.,Non-OADS,/arxiv_data1/oa_pdf/13/7f/DRJ-13-342.PMC4993063.pdf
Available from: http://www.qsa.gov.,Non-OADS,/arxiv_data1/oa_pdf/13/7f/DRJ-13-342.PMC4993063.pdf
Available  from: http://www.education.gov.qa.,Non-OADS,/arxiv_data1/oa_pdf/13/7f/DRJ-13-342.PMC4993063.pdf
Available from: http://www.nidcr.nih.,Non-OADS,/arxiv_data1/oa_pdf/13/7f/DRJ-13-342.PMC4993063.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/d8/nms-05-02-29952.PMC4993069.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/4f/nms-05-02-30777.PMC4993070.pdf
Available from: http://www.cdsco.nic.,Non-OADS,/arxiv_data1/oa_pdf/31/91/AJTS-10-122.PMC4993080.pdf
Available from:  http://www.naco.gov.in/upload/Final%20Publications/Blood%20 Safety/Standards%20for%20Blood%20Banks%20and%20Blood%20 Transfusion%20Services.,Non-OADS,/arxiv_data1/oa_pdf/31/91/AJTS-10-122.PMC4993080.pdf
Available from: http://www.shotuk.org/ wp‑content/uploads/SHOT‑ANNUL‑REPowpsANNRT_ FinalWebVersionBookmarked_2012_06_22.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/7a/AJTS-10-127.PMC4993081.pdf
"S.K.Silverman Department ofChemist ry,University ofIllinois atUrbana -Champaign 600South Mathews Avenue, Urbana ,IL61801 (USA) Twitter:@sksilverma n E-mail :sks@illinoi s.edu Homepag e:http://www .scs.illinoi s.edu/silverm an/ Supportin ginforma tionandtheORCID identifica tionnumber(s) for theauthor(s) ofthisarticle canbefound under http://dx.do i.org/10.1002/a nie.2016043 64.",Non-OADS,/arxiv_data1/oa_pdf/f6/87/ANIE-55-10052.PMC4993102.pdf
"These 2 consor- tia have complementary strengths and address 2 critical areasidentified by the NCI as priorities for PDAC research, namely, (1) Understanding the biological relationship between PDAC and diabetes mellitus (DM) and (2) Evaluating longitudinal screeningprotocols for biomarkers for early detection of PDAC (http://deainfo.nci.nih.gov/advisory/ctac/workgroup/pc/PDACframework.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
"The current NCI-National Institute for Diabetes and Digestive and Kidney Diseases consortium to study chronic pancreatitis, diabetes, and pancreatic cancer (http://cscpdpc.mdanderson.org/) is an ideal op- portunity to assemble such a cohort and collect prospective samples from a cohort at high risk for sporadic PDAC.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
Available at:http://statecancerprofiles.cancer.gov/cgi-bin/deathrates.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
Available at: http://statecancerprofiles.cancer.gov/recenttrend/index.php?,Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
"Available at: http://trendingmed.com/research-advances-pancreatic-cancer/.Accessed March 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
Available: http://statecancerprofiles.cancer.gov/ historicaltrend/index.php?,Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
Available: http://seer.cancer.gov/archive/ csr/1975_2011/browse_csr.php?sectionSEL=6&pageSEL=sect_06_table.12.html.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
"Available at: https://www.genome.gov/27555167/2013-news-feature-the-benefits-of-looking-across-many-cancer-genomes/.Accessed November 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/mpa-45-1073.PMC4993121.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/nms-05-02-32708.PMC4993125.pdf
Available from:  http://www.sportsci.org/jour/03/ wghtrials.htm.,Non-OADS,/arxiv_data1/oa_pdf/e5/a2/JBS-33-1201810.PMC4993136.pdf
Available from:  http://stronglifts.com/5x5/14.,Non-OADS,/arxiv_data1/oa_pdf/bd/fe/JBS-33-1201912.PMC4993141.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2016 |  112  | e54142 | Page 1 of 16Video Article Electrophysiological Method for Recording Intracellular Voltage Responses of Drosophila  Photoreceptors and Interneurons to Light Stimuli In Vivo Mikko Juusola1,2, An Dau2, Lei Zheng1, Diana Rien1,2 1National Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University 2Department of Biomedical Science, The University of Sheffield Correspondence to: Mikko Juusola at m.juusola@sheffield.ac.uk URL: http://www.jove.com/video/54142 DOI: doi:10.3791/54142 Keywords: Neuroscience, Issue 112, Sharp microelectrode, current-clamp, electrophysiology, signaling performance, neural response, insect vision, signal-to-noise ratio, neuroethology, naturalistic light stimulation Date Published: 6/19/2016 Citation: Juusola, M., Dau, A., Zheng, L., Rien, D. Electrophysiological Method for Recording Intracellular Voltage Responses of Drosophila Photoreceptors and Interneurons to Light Stimuli In Vivo.",Non-OADS,/arxiv_data1/oa_pdf/e4/da/jove-112-54142.PMC4993232.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54142/ Introduction The fruit fly ( Drosophila melanogaster ) compound eye is a great model system to investigate the functional organization of photoreceptor and interneuron arrays for neural image sampling and processing, and for animal vision.",Non-OADS,/arxiv_data1/oa_pdf/e4/da/jove-112-54142.PMC4993232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/3f/emss-69489.PMC4993235.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2016 |  112  | e54189 | Page 1 of 7Video Article Experimental Protocol for Biodiesel Production with Isolation of Alkenones as Coproducts from Commercial Isochrysis  Algal Biomass Gregory W. O'Neil1, John R. Williams1, Julia Wilson-Peltier1, Gerhard Knothe2, Christopher M. Reddy3 1Department of Chemistry, Western Washington University 2Agricultural Research Service, United States Department of Agriculture 3Department of Marine Chemistry and Geochemistry, Woods Hole Oceanographic Institution Correspondence to: Gregory W. O'Neil at oneilg@chem.wwu.edu URL: http://www.jove.com/video/54189 DOI: doi:10.3791/54189 Keywords: Environmental Sciences, Issue 112, Algal biofuels, biodiesel, fatty esters, lipids, coproducts, alkenones, Isochrysis Date Published: 6/24/2016 Citation: O'Neil, G.W., Williams, J.R., Wilson-Peltier, J., Knothe, G., Reddy, C.M.",Non-OADS,/arxiv_data1/oa_pdf/00/54/jove-112-54189.PMC4993248.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54189/ Introduction There has recently been a great resurgence of interest in biofuels from algae, particularly for the production of liquid fuels such as biodiesel1 and other biomass-derived oils.2 Proposed benefits include the avoidance of certain food vs. fuel controversies3 and reportedly higher productivities and CO 2 mitigation capabilities than traditional agricultural crops.4 This follows the nearly 20 year United States Department of Energy's Aquatic Species Program (ASP) started in 1978 for the purpose of investigating transportation fuel from algae.",Non-OADS,/arxiv_data1/oa_pdf/00/54/jove-112-54189.PMC4993248.pdf
http://www.eia.gov/dnav/pet/hist/LeafHandler.ashx?,Non-OADS,/arxiv_data1/oa_pdf/00/54/jove-112-54189.PMC4993248.pdf
"D. Fishman, R. Majumdar, J. Morello, R. Pate, J. Yang), United States Department of Energy, http://www1.eere.energy.gov/bioenergy/pdfs/algal_biofuels_roadmap.pdf (accessed August 24, 2015) (2010).",OADS,/arxiv_data1/oa_pdf/00/54/jove-112-54189.PMC4993248.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2016 |  112  | e54045 | Page 1 of 6Video Article Measurement of Carbon Dioxide Production from Radiolabeled Substrates in Drosophila melanogaster Michelle L. Bland1 1Department of Pharmacology, University of Virginia Correspondence to: Michelle L. Bland at mlb2eg@virginia.edu URL: http://www.jove.com/video/54045 DOI: doi:10.3791/54045 Keywords: Cellular Biology, Issue 112, Drosophila , metabolism, respiration, glucose, fatty acid, oxidation Date Published: 6/27/2016 Citation: Bland, M.L.",Non-OADS,/arxiv_data1/oa_pdf/3f/37/jove-112-54045.PMC4993251.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54045/ Introduction Work in the model organism Drosophila melanogaster  has contributed greatly to the understanding of genetic principles, developmental processes, growth, aging, behavior, immunity and human disease1,2.",Non-OADS,/arxiv_data1/oa_pdf/3f/37/jove-112-54045.PMC4993251.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 205–209Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 205 OrIg Inal researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S109531 Treatment of superficial basal cell carcinoma with  ingenol mebutate gel, 0.05% Miriam s Bettencourt1,2 1advanced Dermatology and  Cosmetic surgery, henderson,   2Department of Dermatology,   University of nevada,   las Vegas,  nV, UsaBackground: Basal cell carcinoma (BCC) is the most common cancer in Caucasians.",Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
"4 Although NMSC generally occurs in people over 50 years of age, significant Correspondence: Miriam s Bettencourt advanced Dermatology and Cosmetic surgery, 1701 n green Valley Pkwy suite 7B, henderson, nV 89074, UsaTel +1 702 257 7546Fax +1 702 870 4824email drmiriam@cox.netJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: Original ResearchY ear: 2016V olume: 9Running head verso: BettencourtRunning head recto: Ingenol mebutate gel for superficial basal cell carcinomaDOI: http://dx.doi.org/10.2147/CCID.S109531",Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 209 Ingenol mebutate gel for superficial basal cell carcinoma with fluorouracil14 or imiquimod,15 which are administered for  several weeks.",Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/33/ccid-9-205.PMC4993252.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care 2016:8 135–140HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 135 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S110337Seroprevalence of human immunodeficiency virus  among voluntary counseling and testing clients  at the University of Gondar T eaching Hospital,  Northwest Ethiopia Y ohannes Sinku1,2  Takele Gezahegn1  Yalewayiker Gashaw1  Meseret Workineh1  T ekalign Deressa1 1School of Biomedical and Laboratory  Sciences, College of Medicine and  Health Sciences, University of Gondar,  2Diagnostic Laboratory Case  T eam, University of Gondar T eaching Hospital, Gondar, EthiopiaBackground: The epidemiology of human immunodeficiency virus (HIV) infection in Ethiopia  varies with regions, study population, and time.",Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
"6 According to this report, annual new HIV infections and Correspondence: Tekalign Deressa School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 91 173 8270Email tekalign09@gmail.comJournal name: HIV/AIDS - Research and Palliative Care Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Sinku et alRunning head recto: Seroprevalence of human immunodeficiency virusDOI: http://dx.doi.org/10.2147/HIV .S110337",Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs360/en/.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
"HIV/AIDS - Research and Palliative Care 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 140 Sinku et al  17.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/hiv-8-135.PMC4993253.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/7d/copd-11-1881.PMC4993254.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1881–1894International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1881OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10452 9 What is the impact of different spirometric  criteria on the prevalence of spirometrically  defined COPD and its comorbidities?",Non-OADS,/arxiv_data1/oa_pdf/4d/7d/copd-11-1881.PMC4993254.pdf
"Keywords:  chronic obstructive pulmonary disease, spirometry, prevalence, comorbidity,  biomarkers Background According to current recommendations, a clinical diagnosis of COPD is primarily  based on the detection of airflow obstruction in spirometric measures.1,2 However,  the spirometric criteria defining airflow obstruction in COPD are still subject to lively  debate.3,4 The Global Initiative for Chronic Obstructive Lung Disease recommends the use  of a fixed ratio (FR) of 0.7 for postbronchodilator forced expiratory volume in 1 second  (FEV1)/forced vital capacity (FVC) to confirm the diagnosis.1 This approach has been  criticized as arbitrary and argued to particularly overestimate prevalences in advanced  age.5 Alternatively, the use of the fifth percentile of the predicted value (lower limit of Correspondence: Stefan Karrasch Institute of Epidemiology I, Helmholtz  Zentrum München, German Research  Center for environmental health  (GmbH), Ingolstädter Landstraße 1,  D-85764 Neuherberg, Germany Tel +49 89 3187 4578 Fax +49 89 3187 3380 email stefan.karrasch@helmholtz- muenchen.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Karrasch et al Running head recto: Impact of spirometric criteria on the prevalence of COPD  DOI: http://dx.doi.org/10.2147/COPD.S104529",Non-OADS,/arxiv_data1/oa_pdf/4d/7d/copd-11-1881.PMC4993254.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4d/7d/copd-11-1881.PMC4993254.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/7d/copd-11-1881.PMC4993254.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1123–1128Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1123OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10360 5 Chest pain after percutaneous coronary  intervention in patients with stable angina Chao-Chien Chang1–3 Yueh-Chung Chen4,5 eng-Thiam Ong1 Wei-Cheng Chen1 Chia-hsiu Chang1 Kuan-Jen Chen1 Cheng-Wen Chiang1 1Division of Cardiology, Department  of Internal Medicine, Cathay  general hospital, Taipei, Taiwan,   rOC; 2graduate Institute of Medical  sciences, Taipei Medical University,   Taipei, Taiwan, rOC; 3Department  of Pharmacology, Taipei Medical  University, Taipei, Taiwan, rOC;   4Division of Cardiology, Department  of Internal Medicine, Taipei City  hospital ren-Ai branch, Taipai, Taiwan,   rOC; 5graduate Institute of Medical  sciences, national Defense Medical  Center, Taipei, Taiwan, rOCBackground:  Percutaneous coronary intervention (PCI) has been widely used to treat acute  coronary syndrome but is only recommended as an additional treatment to medical therapy and  risk modification in patients with refractory or progressing angina.",Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
"Keywords:  coronary angiography, percutaneous coronary interventions, chest pain, complica - tions, interventional cardiology, cardiac troponin I Introduction Percutaneous coronary intervention (PCI) has been widely used to treat obstructive  coronary artery disease, including unstable angina, recurrent angina after coronary  artery bypass grafting (CABG), and acute myocardial infarction (MI), contributing  to the reduction of clinical symptoms and mortality rate.1–3 A total of 92,589 PCIs  were performed from January to December 2013, which represented a rate of 1,444  PCI per million population in the UK.4 Although PCI is only recommended as an  additional treatment to medical therapy and risk modification in patients with refractory  or progressing angina because of the controversial reports about its benefit on stable  angina,5–7 the numbers of elective PCI conducted in patients with stable angina still  account for approximately 30%–40% of total PCI procedures in patients with coronary  artery diseases.8,9 This procedure is becoming more prevalent with the advent of reliable  noninvasive coronary imaging.Correspondence: Cheng-Wen Chiang Division of Cardiology, Department  of Internal Medicine, Cathay general  hospital, 280, section 4, ren-Ai road,  Taipei 106, Taiwan, rOC Tel +886 2 708 2121 ext 3116 Fax +886 2 932 4969 email cgh05761@cgh.org.t w Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chang et al Running head recto: Post-PCI chest pain in patients with stable angina DOI: http://dx.doi.org/10.2147/CIA.S103605",Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
Available from: https://www.ucl.,Non-OADS,/arxiv_data1/oa_pdf/27/7f/cia-11-1123.PMC4993255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 305–312Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 305 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S105933 Interrater reliability of a national acute myocardial  infarction register Ragna Elise Støre  Govatsmark1,2 Sylvi Sneeggen2 Hanne Karlsaune2 Stig Arild Slørdahl2 Kaare Harald Bønaa1–3 1Department of Public Health  and General Practice, Norwegian  University of Science and T echnology,   2Department of Medical Quality  Registries, 3Clinic for Heart Disease,   St. Olav’s University Hospital,  Trondheim, NorwayBackground: Disease-specific registers may be used for measuring and improving healthcare  and patient outcomes, and for disease surveillance and research, provided they contain valid  and reliable data.",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"1,2 However, there are challenges in obtaining valid and reliable data, and stud- ies have raised questions about the reliability of data extracted from medical records.9–12 Correspondence: Ragna Elise Støre  GovatsmarkDepartment of Public Health and General Practice, Norwegian University of Science and Technology, Post-box 8905, 7401 Trondheim, NorwayTel +47 45 03 0308Email ragna.e.govatsmark@ntnu.noJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Govatsmark et alRunning head recto: Interrater reliability of a national AMI registerDOI: http://dx.doi.org/10.2147/CLEP .S105933",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Available from: http://www.ucr.uu.se/swedeheart/index.php/start-riks-hia [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Available from: https://www.ucl.ac.uk/nicor/about [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Available from: http://www.amis-plus.ch/; [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Available from: https://lovdata.no/dokument/SF/forskrift/2011-12-16-1250 [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"The Norwegian Myocardial Infarction Register Available from:  http://www.hjerteinfarktregisteret.no/no/Helsepersonell/Bukerman-ual/123918/ [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"Available from: http://www.hjerteinfarktregisteret.no/no/Rap-porter/123785/ [updated May 5, 2016].",Non-OADS,/arxiv_data1/oa_pdf/59/64/clep-8-305.PMC4993256.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2623–2629Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2623Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11099 7 novel glyoxalase- i inhibitors possessing a  “zinc-binding feature” as potential anticancer agents Qosay a al-Balas1 Mohammad a hassan1 nizar a al-shar’i1 nizar M Mhaidat2 ammar M almaaytah3 Fatima M al-Mahasneh1 israa h isawi1 1Department of Medicinal chemistry  and Pharmacognosy, 2Department of  clinical Pharmacy, 3Department of  Pharmaceutical Technology, Faculty  of Pharmacy, Jordan University of  science and T echnology, irbid, JordanBackground:  The glyoxalase system including two thiol-dependent enzymes, glyoxalase I  (Glo-I) and glyoxalase II, plays an important role in a ubiquitous metabolic pathway involved  in cellular detoxification of cytotoxic 2-oxoaldehydes.",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
"Box 3030, irbid 22110, Jordan  Tel +962 7 7633 7216 Fax +962 2 720 1075 email qabalas@just.edu.j o Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Al-Balas et al Running head recto: Glo-I inhibitors possessing a “zinc-binding feature” DOI: http://dx.doi.org/10.2147/DDDT.S110997",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
Available from: http://www.cancer.gov /.,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
Available from: http://www.who.int/ topics/global_burden_of_disease/en /.,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/1f/dddt-10-2623.PMC4993257.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3979–3991International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3979OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11025 1 styrene maleic acid-encapsulated paclitaxel  micelles: antitumor activity and toxicity studies  following oral administration in a murine  orthotopic colon cancer model Neha N Parayath1 hayley Nehoff1 samuel e Norton2 andrew J highton2 sebastien Taurin1,3 roslyn a Kemp2 Khaled greish1,4 1Department of Pharmacology  and T oxicology, 2Department of  Microbiology and Immunology,   University of Otago, Dunedin,   New Zealand; 3Department of  Obstetrics and gynecology, University  of Utah, salt lake city, UT, Usa;   4Princess al-Jawhara centre for  Molecular Medicine, arabian gulf  University, Manama, Kingdom  of BahrainAbstract:  Oral administration of paclitaxel (PTX), a broad spectrum anticancer agent, is  challenged by its low uptake due to its poor bioavailability, efflux through P-glycoprotein,  and gastrointestinal toxicity.",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"However,  PTX (microtubule stabilizing agent) might be an effective anticancer agent in the subset  of colorectal cancers lacking chromosomal instability and APC mutations.4 Furthermore,  studies have shown that PTX inhibits cell migration and VEGF-induced neovasculariza - tion and has an antiproliferative effect toward activated endothelial cells.4correspondence: Khaled greish Princess al-Jawhara centre for Molecular  Medicine, arabian gulf University,  Building 61, King abdul aziz avenue,  Block 328, Manama 3 479 9140,  Kingdom of Bahrain Tel +973 1723 7393 Fax +973 1724 6022 email khaledfg@agu.edu.b h Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Parayath et al Running head recto: SMA paclitaxel micelles for oral delivery DOI: http://dx.doi.org/10.2147/IJN.S110251",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"Available from: http://www.ahc.umn.edu/rar.refvalues.htm l. Accessed  October 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"Available from:  http://livertox.nih.gov/Severity.htm l. Accessed October 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/30/ijn-11-3979.PMC4993259.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/d1/dddt-10-2611.PMC4993261.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2611–2622Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2611Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8482 0construction of p66shc gene interfering lentivirus  vectors and its effects on alveolar epithelial cells  apoptosis induced by hyperoxia chan Zhang Wen-Bin Dong shuai Zhao Qing-Ping li lan Kang Xiao-Ping lei lin guo Xue-song Zhai Department of n ewborn Medicine,   affiliated hospital of luzhou Medical  college, luzhou, sichuan, People’s  republic of chinaBackground:  The aim of this study is to observe the inhibitive effects of p66Shc gene interfering  lentivirus vectors on the expression of p66Shc, and to explore its effects on alveolar epithelial  cells apoptosis induced by hyperoxia.",Non-OADS,/arxiv_data1/oa_pdf/87/d1/dddt-10-2611.PMC4993261.pdf
"In  the course of treatment, the respiratory disorder required long-time, high-concentration  and/or high-pressure oxygen inhalation, often resulting in pulmonary oxidative stress  injury in the survivors and causing pulmonary failure in neonatal period and impaired  lung development in infant period.correspondence: Wen-Bin Dong Department of newborn Medicine,  Affiliated Hospital of Luzhou Medical  college, luzhou 646000, sichuan,  People’s republic of china Tel +86 135 1838 9718 Fax +86 121 6408 5785 email dongwenbin2000@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: p66Shc interfering vector effects alveolar epithelial cells apoptosis DOI: http://dx.doi.org/10.2147/DDDT.S84820",Non-OADS,/arxiv_data1/oa_pdf/87/d1/dddt-10-2611.PMC4993261.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/87/d1/dddt-10-2611.PMC4993261.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/d1/dddt-10-2611.PMC4993261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 175–181Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 175 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S100816 Central centrifugal cicatricial alopecia: challenges  and solutions Ingrid Herskovitz Mariya Miteva Department of Dermatology and  Cutaneous Surgery, University of Miami L Miller School of Medicine,  Miami, FL, USAAbstract:  Central centrifugal cicatricial alopecia (CCCA) is the most common scarring alope- cia among African American women.",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
"Scarring alopecia of the central scalp was described as “hot comb alopecia” initially in 1968 in 51 African American women who practiced hair straightening with a hot comb and petrolatum Correspondence: Ingrid Herskovitz University of Miami L Miller School of Medicine, 1600 North West, Tenth Avenue, RSMB, Room 2023A, Miami, FL 33136, USAEmail iherskovitz@med.miami.eduJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Herskovitz and MitevaRunning head recto: Central centrifugal cicatricial alopeciaDOI: http://dx.doi.org/10.2147/CCID.S100816",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 181 Central centrifugal cicatricial alopecia 47.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/ccid-9-175.PMC4993262.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/25/copd-11-1949.PMC4993263.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1949–1956International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1949HyPO tHesIsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S11163 4 Manual evaluation of the diaphragm muscle Bruno Bordoni1–3 F Marelli2,3 B Morabito2–4 B sacconi5 1Department of Cardiology,   Foundation Don Carlo Gnocchi  IRCC s, Institute of Hospitalization  and Care with scientific Address,   Milan, 2CResO, school of Osteopathic  Centre for Research and studies,   Castellanza, 3CResO, school of  Osteopathic Centre for Research  and studies, Falconara Marittima,   4Foundation Polyclinic University  A Gemelli, University Cattolica  del sacro Cuore, 5Radiological,   Oncological and Anatomopathological  sciences, sapienza University of Rome,   Rome, ItalyAbstract:  The respiratory diaphragm is the most important muscle for breathing.",Non-OADS,/arxiv_data1/oa_pdf/84/25/copd-11-1949.PMC4993263.pdf
"The diaphragm muscle is the main breathing muscle, influencing  with its contractions the respiratory activity.1 The diaphragm collaborates to various  processes such as expectoration, vomiting, swallowing, urination, and defecation.1  It facilitates the venous and lymphatic return and helps the viscera above and below  the diaphragm to work properly.1 Diaphragm’s activity is fundamental in the mainte - nance of posture and body position changes and influences the pain perception, usually  decreased during the inspiratory apnoea.1,2 Diaphragmatic movements also change the  body pressure, as it facilitates the venous and lymphatic return.2 This pressure modula - tion influences the blood redistribution, which could be probably correlated with the  response of baroreceptors and the reduction of pain perception, although there are not  scientific studies supporting this hypothesis yet.2 The most important stimulus for the respiratory acts is provided by chemorecep - tors, whose task is to maintain the biochemical balance of the body.2 Breathing is also  influenced by internal and external conditions, with other ways of neural stimulation  beyond the chemoreceptorial stimulation.2 The diaphragmatic activity is not only  controlled by metabolic mechanism but also by emotional states such as sadness, fear,  anxiety, and anger.2 Breathing stimulates mechanoreceptors of the diaphragm and the  visceroceptors of viscera (moving during the respiratory acts), constituting the mecha - nism of interoception.2 Interoception is the awareness of the body condition obtained  from information coming directly from the body itself.2 Diaphragmatic movements  also stimulate the skin and the mediastinum; this complex of afferent information Correspondence: Bruno Bordoni Department of Cardiology, Foundation  Don Carlo Gnocchi IRCCs, Institute  of Hospitalization and Care with  Scientific Address, S Maria Nascente,  Via Capecelatro 66, Milan 20100, Italy tel +39 2 34 9630 0617 email bordonibruno@hotmail.co m Journal name: International Journal of COPD Article Designation: Hypothesis Y ear: 2016 Volume: 11 Running head verso: Bordoni et al Running head recto: Manual evaluation of the diaphragm muscle DOI: http://dx.doi.org/10.2147/COPD.S111634",Non-OADS,/arxiv_data1/oa_pdf/84/25/copd-11-1949.PMC4993263.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/84/25/copd-11-1949.PMC4993263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/25/copd-11-1949.PMC4993263.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 251–260Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 251 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S106133 T eneligliptin in management of type 2  diabetes mellitus Surendra Kumar Sharma1  A Panneerselvam2  KP Singh3  Girish Parmar4  Pradeep Gadge5  Onkar C Swami6 1Diabetes, Thyroid and Endocrine  Centre, Galaxy Speciality Centre,   Jaipur, 2Aruna Diabetes Centre,   Chennai, 3Fortis Hospital, Sector  62, Phase VIII, Mohali, 4Kokilaben  Dhirubhai Ambani Hospital, Andheri (W), Mumbai,  5Dr Gadge’s Diabetes  Care Centre, Mumbai, 6Unichem  Laboratories Ltd, Jogeshwari (W),  Mumbai, IndiaAbstract: Teneligliptin is a recently developed oral dipeptidyl peptidase 4 inhibitor indicated  for the management of type 2 diabetes mellitus (T2DM) in adults along with diet and exercise.",Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
"3 Additionally, patient education and support are important aspects.3 This Correspondence: Onkar C Swami   Unichem Laboratories Ltd, Unichem  Bhavan, Prabhat Estate, SV Road, Jogeshwari (W), Mumbai 400102, India   Email onkar.swami@unichemlabs.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Sharma et alRunning head recto: Teneligliptin in type 2 diabetes mellitusDOI: http://dx.doi.org/10.2147/DMSO.S106133",Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 260 Sharma et al  24.,Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
Available from: http://www.quintiles.com/~ /media/library/experts/ the-current-regulatory-landscape-for-cardiac-and-cardiovascular- safety-assessments-part-i.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/3c/dmso-9-251.PMC4993264.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/19/ijn-11-4011.PMC4993266.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4011–4024International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4011OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10940 6 guanidinylated bioresponsive poly(amido amine)s  designed for intranuclear gene delivery Jiankun Yu1 Jinmin Zhang1 haonan Xing1 Zhen Yang1 cuifang cai1 conglu Zhang1 Xiaoyun Zhao1 Minjie Wei2 li Yang1 Pingtian Ding1 1school of Pharmacy, shenyang  Pharmaceutical University, 2school of  Pharmacy, china Medical University,   shenyang, People’s republic of chinaAbstract:  Guanidinylated poly(amido amine)s with multiple disulfide linkages (Gua-SS-PAAs)  were designed and constructed as nonviral gene carriers.",Non-OADS,/arxiv_data1/oa_pdf/4d/19/ijn-11-4011.PMC4993266.pdf
"At the same time, nonviral carriers  can be obtained through chemical synthesis with controllable quality, although they  normally possess lower transfection efficiency compared to viral carriers.3 Nonviral carriers are mainly defined as various polymers that can connect to or  complex with exogenous genes, deliver them to cytoplasm, and release the exogenous  gene fragments through the reactions in cell membranes or organelles mediated by the  complexes.4 Currently, the two most popular nonviral gene delivery systems have been  widely used in laboratory and clinical studies: 1) using electroporation to transfect  cells,5–7 and 2) cationic polymers, such as cationic liposomes and polyethylenimines  (PEIs).8 Poly(amido amine)s (PAAs) with multiple disulfide linkages (SS-PAAs) are  the most promising alternatives for liposomes and PEIs.9 The multi-amino structure correspondence: li Yang; Pingtian Ding school of Pharmacy, shenyang  Pharmaceutical University, 103 Wenhua  road, shenhe, shenyang 110016,  People’s republic of china Tel +86 24 2398 6349;   +86 24 2398 6305 email ylsnowle@126.co m;  267204521@qq.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yu et al Running head recto: Bioresponsive PAAs for intranuclear gene delivery DOI: http://dx.doi.org/10.2147/IJN.S109406",Non-OADS,/arxiv_data1/oa_pdf/4d/19/ijn-11-4011.PMC4993266.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4d/19/ijn-11-4011.PMC4993266.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/ijn-11-4011.PMC4993266.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/ab/ijn-11-3927.PMC4993267.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3927–3937International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3927OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10725 0 Dual delivery of active antibactericidal agents and  bone morphogenetic protein at sustainable high  concentrations using biodegradable sheath-core- structured drug-eluting nanofibers Yung-hen hsu1,2 chang-T un lin2 Yi-hsun Yu1,2 Ying-chao chou1,2 shih-Jung liu1,2 err-cheng chan3 1Department of Orthopedic  surgery, chang gung Memorial  hospital, 2Department of Mechanical  engineering, 3Department of Medical  Biotechnology and laboratory  science, school of Medical T echnology,   chang gung University, Tao-Yuan,   TaiwanAbstract:  In this study, we developed biodegradable sheath-core-structured drug-eluting  nanofibers for sustainable delivery of antibiotics (vancomycin and ceftazidime) and recombinant  human bone morphogenetic protein (rhBMP-2) via electrospinning.",Non-OADS,/arxiv_data1/oa_pdf/fe/ab/ijn-11-3927.PMC4993267.pdf
"Such  systems with sustained local antibiotic release are superior to parenteral administration  because they deliver bactericidal concentrations of antibiotics directly to the target  site while avoiding systemic toxicity.3 Nevertheless, the potential risk of irritating correspondence: shih-Jung liu Biomaterials lab, Department of  Mechanical engineering, chang gung  University, 259, Wen-hwa 1st road,  Kwei-shan, Tao-Yuan 333, Taiwan Tel +886 3 211 8166 Fax +886 3 211 8558 email shihjung@mail.cgu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hsu et al Running head recto: Biodegradable sheath-core antibiotic/BMP-eluting nanofibers DOI: http://dx.doi.org/10.2147/IJN.S107250",Non-OADS,/arxiv_data1/oa_pdf/fe/ab/ijn-11-3927.PMC4993267.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/ab/ijn-11-3927.PMC4993267.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/ab/ijn-11-3927.PMC4993267.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/d9/ijn-11-3969.PMC4993268.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3969–3978International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3969OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9655 8 synthesis, characterization, and performance  evaluation of multilayered photoanodes by  introducing mesoporous carbon and TiO2 for  humic acid adsorption soraya hosseini1 hossein Jahangirian2 Thomas J Webster2 salman Masoudi soltani3 Mohamed Kheireddine  aroua1 1Department of chemical engineering,   University of Malaya, Kuala lumpur,   Malaysia; 2Department of chemical  engineering, Northeastern University,   Boston, M a, Usa; 3Department  of chemical engineering, Imperial  college london, south Kensington  campus, london, UKAbstract:  Nanostructured photoanodes were prepared via a novel combination of titanium  dioxide (TiO2) nanoparticles and mesoporous carbon (C).",Non-OADS,/arxiv_data1/oa_pdf/a0/d9/ijn-11-3969.PMC4993268.pdf
"Titanium dioxide (TiO2) is one of the most efficient photocatalysts due to its chemical  stability, nontoxicity, low cost, safety to humans and the environment, strong oxidizing  abilities, super hydrophilicity, long durability, and transparency to visible light.2–4 Due  to the two distinct types of photochemical reactions on a TiO2 surface, many studies on  its photocatalytic activity have been conducted on various types of surface-modified correspondence: soraya hosseini Department of chemical engineering,  University of Malaya, Wilayah Persekutuan,  50603 Kuala lumpur, Malaysia email soraya20h@gmail.co m  hossein Jahangirian Department of chemical engineering,   313 snell engineering center,  Northeastern University, 360 huntington  avenue, Boston, Ma 02115, Usa email kamran.jahangirian@gmail.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hosseini et al Running head recto: Synthesis, characterization, and performance of multilayered photoanodes DOI: http://dx.doi.org/10.2147/IJN.S96558",Non-OADS,/arxiv_data1/oa_pdf/a0/d9/ijn-11-3969.PMC4993268.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a0/d9/ijn-11-3969.PMC4993268.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/d9/ijn-11-3969.PMC4993268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1107–1109Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1107Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S11374 8 Higher vitamin D levels may be associated with  higher levels of sunlight exposure and higher  intake of vitamin D by diet Sevilay Muratli Fatih tufan Gulistan Bahat Mehmet Akif Karan Department of Geriatrics, Istanbul  Faculty of Medicine, Istanbul  University, Istanbul, turkeyDear editor We read the article by Al-Eisa et al1 entitled “Correlation between vitamin D levels  and muscle fatigue risk factors based on physical activity in healthy older adults,”  regarding an important subject – the association among vitamin D deficiency, physical  activity, and muscle fatigue; the findings of this study indicate that increased physical  activity is associated with higher vitamin D levels and less fatigue.",Non-OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
"2016;11:513–522.Correspondence: Fatih tufan Department of Geriatrics, Istanbul  Faculty of Medicine, Istanbul University,  PB 34093, turgutOzal Street, Sehremini,  Fatih, Istanbul, turkey tel +90 212 414 1500 Fax +90 212 414 2022 email drfatiht@istanbul.edu.t r Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Muratli et al Running head recto: Higher vitamin D levels with sunlight exposure and diet DOI: http://dx.doi.org/10.2147/CIA.S113748",Non-OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
"Available from: http://www.ccpe-cfpc.com/en/pdf_files/drug_lists/ normal_values.pd f. Accessed July 19, 2016.",OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f9/bb/cia-11-1107.PMC4993269.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2631–2641Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2631CliniC al Trial repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11218 1 Pharmacokinetic profile of defibrotide in patients  with renal impairment paola T occhetti1 elena T udone2 Jean-Francois Marier3 Thomas C Marbury4 Katie Zomorodi5 Mark eller6 1Gentium, 2Clinical operations,   Gentium, Villa Guardia, Como, italy;   3reporting and analysis Services,   pharsight, a Certara Company,   Montreal, Quebec, Canada; 4orlando  Clinical research Center, orlando, Fl,   5early Development and Clinical  pharmacology, Jazz pharmaceuticals,   6early Drug Development, Jazz  pharmaceuticals, p alo alto, C a, USaAbstract:  Hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome (VOD/ SOS), is an unpredictable, potentially life-threatening complication of hematopoietic stem cell  transplant conditioning.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Keywords:  dialysis, end-stage renal disease, hepatic veno-occlusive disease, sinusoidal  obstruction syndrome Introduction Hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome (VOD/ SOS), is a potentially fatal complication of the conditioning regimen for hematopoietic  stem cell transplantation (HSCT).1,2 Clinical characteristics include hepatomegaly  and/or right upper quadrant pain, ascites, otherwise unexplained weight gain, and  jaundice.1–3 Diagnosis is clinical and generally made according to a set of pre - defined signs/symptoms: the Baltimore criteria (presence, within 21 days of HSCT,  of bilirubin $2 mg/dL plus two or more of the following: hepatomegaly, ascites,  weight gain $5%)4 or the modified Seattle criteria (presence, within 20 days of  HSCT, of two or more of the following: bilirubin .2 mg/dL, hepatomegaly or right Correspondence: paola Tocchetti Biologa nutrizionista, Via F Marchesoli 3,  22100 Como, italy Tel +39 347 431 6587 email  paola.tocchetti@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Tocchetti et al Running head recto: Pharmacokinetic profile of defibrotide in renal impairment DOI: http://dx.doi.org/10.2147/DDDT.S112181",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Available  from: http://ebmtonline.forumservice.net/media/11/tex/content_alt/ EBMT_Handbook2012_CHAP11.pd f. Accessed January 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
Available from: http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Available from:  http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory - Information /Guidances/UCM204959.pd f. Accessed March 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Available from: http://www.emea.europa.eu/ pdfs/human/ewp/022502en.pd f. Accessed February 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Available from: http://www.fda.gov/downloads/Drugs/ Guidances /ucm070107.pd f. Accessed April 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2011/08/WC500109686.pd f.  Accessed May 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/0d/dddt-10-2631.PMC4993270.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/ed/cia-11-1117.PMC4993272.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1117–1121Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1117OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10786 8 Plasma homocysteine level is a risk factor for  osteoporotic fractures in elderly patients Yuefeng Zhu1 Jie shen2 Qun Cheng3 Y ongqian Fan1 Weilong lin1 1Department of Orthopedics,   2Department of Pharmacy,   3Department of Osteoporosis,   huadong hospital, Fudan University,   shanghai, People’s republic of ChinaObjective:  To study the relationship of plasma homocysteine (Hcy), bone turnover biomarkers  (BTB), and bone mineral density (BMD) with osteoporotic fracture (OPF) in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/a8/ed/cia-11-1117.PMC4993272.pdf
"Osteoporosis is a whole- body bone disease characterized by decreased bone strength and increase in the risk  of fracture caused by low bone mass and bone microstructural damage.1 A serious  consequence of osteoporosis is the occurrence of osteoporotic fracture (OPF), that  is, a fracture induced by minor trauma or a daily routine activity.1 OPF is a serious  threat to the health of elderly population, as it can reduce their quality of life and  significantly increase the morbidity and mortality.2 For example, the mortality will  increase to 12%–35% 1 year after hip fracture.3Correspondence: Yuefeng Zhu Department of Orthopedics, huadong  hospital, Fudan University, no 211,  West Yanan road, shanghai 200040,  People’s republic of China Tel +86 21 6248 3180 ext 71501 email zhuyuefenghd@vip.163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhu et al Running head recto: Osteoporotic fractures in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S107868",Non-OADS,/arxiv_data1/oa_pdf/a8/ed/cia-11-1117.PMC4993272.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a8/ed/cia-11-1117.PMC4993272.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a8/ed/cia-11-1117.PMC4993272.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 249–257Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  249 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S110428Acute left-sided colonic diverticulitis: clinical  expressions, therapeutic insights, and role of  computed tomography Patrick Ambrosetti Department of Surgery, Clinique  Générale Beaulieu, Geneva,  SwitzerlandAbstract: The diagnostic approach of patients with suspected acute diverticulitis remains  debated.",Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
"5 If management of acute diverticulitis has undergone meaningful changes over the  past decade, the majority of evidence is currently of poor quality.6 The aim of this  study is to focus on other issues that are also still debated: the place of computed tomography (CT) scan, the role of laparoscopic lavage for colonic perforation, and the surgical indications for patients with chronic symptoms.Correspondence: Patrick Ambrosetti Department of Surgery, Clinique Générale Beaulieu, Ch Beau-Soleil, 1205 Geneva, Switzerland Tel +41 22 830 0520   Fax +41 22 830 2343   Email p_ambrosetti@bluewin.chJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: AmbrosettiRunning head recto: Left-sided colonic diverticulitisDOI: http://dx.doi.org/10.2147/CEG.S110428",Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 257 Left-sided colonic diverticulitis  75.,Non-OADS,/arxiv_data1/oa_pdf/0c/44/ceg-9-249.PMC4993273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/f7/dddt-10-2599.PMC4993275.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2599–2609Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2599Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11287 3 Efficacy and safety of fixed-dose combination  therapy with olmesartan medoxomil and  rosuvastatin in Korean patients with mild to  moderate hypertension and dyslipidemia: an  8-week, multicenter, randomized, double- blind, factorial-design study (OLSTA-D RCT:  Olmesartan rosuvasT atin from Daewoong) Jin-Sun Park,1,* Joon-Han Shin,1,* Taek- Jong hong,2 Hong-Seog Seo,3 Wan-Joo  shim,4 Sang-Hong Baek,5 Jin-Ok Jeong,6  Y oungkeun Ahn,7 Woong-Chol Kang,8  Y oung-Hak Kim,9 Sang-Hyun Kim,10  Min-Su Hyon,11 Dong-Hoon Choi,12  Chang-Wook Nam,13 Tae-Ho Park,14  Sang-Chol Lee,15 Hyo-Soo Kim16 1Department of cardiology, ajou University school  of Medicine, suwon, 2Division of Cardiology, Pusan  National University Hospital, Busan, 3Division  of cardiology, Korea University guro hospital,  Korea University college of Medicine, 4Division  of cardiology, Korea University anam hospital,  5cardiovascular Division, catholic University of  Korea, seoul st Mary’s hospital, seoul, 6Division  of cardiology, chungnam national University  hospital, Daejeon, 7Division of cardiology, chonnam  national University hospital, gwangju, 8Division of  cardiology, gachon University gil hospital, incheon,  9Division of cardiology, asan Medical center,  college of Medicine, University of Ulsan, 10Division  of cardiology, seoul Metropolitan government  Seoul National University Boramae Medical Center,  11Division of cardiology, soonchunhyang University  hospital, 12Division of cardiology, Yonsei University  severance hospital, seoul, 13Department of internal  Medicine, Keimyung University Dongsan Medical  center, Daegu, 14Division of Cardiology, Dong-A  University Hospital, Busan, 15cardiovascular imaging  Center, Samsung Medical Center, Sungkyunkwan  University school of Medicine, 16Department of  internal Medicine, cardiovascular center, seoul  national University hospital, seoul, Korea *These authors contributed equally to this workAbstract:  The pill burden of patients with hypertension and dyslipidemia can result in poor medi - cation compliance.",Non-OADS,/arxiv_data1/oa_pdf/46/f7/dddt-10-2599.PMC4993275.pdf
"Keywords:  fixed-dose combination therapy, olmesartan medoxomil, rosuvastatin, hypertension,  dyslipidemia Introduction The coexistence of hypertension and dyslipidemia, which are central to the pathogenesis  of coronary heart disease, has been reported to be prevalent.1–4 The risk of coronary Correspondence: Hyo-Soo Kim Department of internal Medicine, cardiovascular  center, seoul national University hospital,  101 Daehak-ro, Jongro-gu, Seoul, 110-744, Korea Tel +82 2 2072 2226 Fax +82 2 766 8904 email hyosoo@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Park et al Running head recto: Efficacy and safety of fixed-dose combination DOI: http://dx.doi.org/10.2147/DDDT.S112873",Non-OADS,/arxiv_data1/oa_pdf/46/f7/dddt-10-2599.PMC4993275.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/46/f7/dddt-10-2599.PMC4993275.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/f7/dddt-10-2599.PMC4993275.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1903–1909International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1903OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11042 9 Comparison of the COPD Population screener  and International Primary Care airway group  questionnaires in a general Japanese population:  the hisayama study go Tsukuya1,* Takuya samukawa1,* Koichiro Matsumoto2 satoru Fukuyama2 T omohiro Kumamoto1 akifumi Uchida1 Chihaya Koriyama3 T oshiharu ninomiya4 hiromasa Inoue1 1Department of Pulmonary Medicine,   graduate school of Medical  and Dental sciences, Kagoshima  University, Kagoshima, 2reasearch  Institute for Diseases of the  Chest, graduate school of Medical  sciences, Kyushu University, Fukuoka,   3Department of epidemiology and  Preventive Medicine, graduate school  of Medical and Dental sciences,   Kagoshima University, Kagoshima,   4Department of epidemiology and  Public health, graduate school of  Medical sciences, Kyushu University,   Fukuoka, Japan *These authors contributed equally  to this workBackground:  The incidence of chronic obstructive pulmonary disease (COPD) is increasing  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
"Its prevalence is increasing worldwide,  and it is expected to be the third largest global cause of mortality by the year 2030.1  In Japan, a large epidemiological study (the Nippon COPD Epidemiological Study) Correspondence: hiromasa Inoue Department of Pulmonary Medicine,  graduate school of Medical and  Dental sciences, Kagoshima University,  8-35-1 sakuragaoka, Kagoshima  890-8520, Japan Tel +81 99 275 6476 Fax +81 99 275 6482 email inoue-pulm@umin.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tsukuya et al Running head recto: Validation of COPD screening questionnaires DOI: http://dx.doi.org/10.2147/COPD.S110429",Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
Available from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/a3/b3/copd-11-1903.PMC4993276.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/62/ijn-11-3993.PMC4993277.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3993–4009International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3993OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10435 0 egF and curcumin co-encapsulated nanoparticle/ hydrogel system as potent skin regeneration agent Xiaoling li1 Xianlong Ye2 Jianying Qi2 rangrang Fan1 Xiang gao1  Yunzhou Wu2 liangxue Zhou1 aiping T ong1 gang guo1 1state Key laboratory of Biotherapy  and cancer center, Department of  Neurosurgery, West china hospital,   sichuan University and collaborative  Innovation center for Biotherapy,   chengdu, People’s republic of china;   2college of life science, Northeast  agriculture University, harbin,   People’s republic of china Abstract:  Wound healing is a complex multifactorial process that relies on coordinated signaling  molecules to succeed.",Non-OADS,/arxiv_data1/oa_pdf/c3/62/ijn-11-3993.PMC4993277.pdf
"Few growth factors, except PDGF-BB, have successfully completed clinical trials.11  To overcome the low stability in vivo and undesirable effects at high systemic levels,  growth factors need to be applied in a sustained and localized fashion, so as to achieve correspondence: gang guo state Key laboratory of Biotherapy  and cancer center, Department of  Neurosurgery, West china hospital,  sichuan University and collaborative  Innovation center for Biotherapy, No  17, Block 3, southern renmin road,  chengdu, sichuan 610041, People’s  republic of china Tel +86 28 8516 4063 Fax +86 28 8516 4060 email guogang@scu.edu.c n Yunzhou Wu college of life science, Northeast  agriculture University, No 59 Wood  street, Xiangfang District, harbin,  heilongjiang 150030, People’s republic  of china email wuyunzhou@neau.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: EGF-Cur-NP/H system as skin regeneration agent DOI: http://dx.doi.org/10.2147/IJN.S104350",Non-OADS,/arxiv_data1/oa_pdf/c3/62/ijn-11-3993.PMC4993277.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical ﬁeld.",Non-OADS,/arxiv_data1/oa_pdf/c3/62/ijn-11-3993.PMC4993277.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/62/ijn-11-3993.PMC4993277.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1911–1920International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1911OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10390 8 Current asthma contributes as much as smoking  to chronic bronchitis in middle age: a prospective  population-based study shyamali C Dharmage,1  Jennifer l Perret,1,2   John a Burgess,1  Caroline J lodge,1   David P Johns,3   Paul s Thomas,4 graham  g giles,1,5 John l hopper,1,6  Michael J abramson,7,8  e haydn Walters,3,9   Melanie C Matheson1 1allergy and lung health Unit, Center  for epidemiology and Biostatistics,  The University of Melbourne,  2Institute for Breathing and sleep  (IBas), Melbourne, VIC, 3“Breathe  Well” Center of research excellence  for Chronic respiratory Disease  and lung ageing, school of Medicine,  University of Tasmania, hobart, T as,  4Inflammation and Infection research,  Faculty of Medicine, University of new  south Wales, sydney, nsW, 5Cancer  epidemiology Center, Cancer Council  Victoria, Melbourne, VIC, australia;  6Department of Public health, seoul  national University, seoul, south  Korea; 7allergy, Immunology and  respiratory Medicine, The alfred  hospital, Melbourne, 8school of Public  health and Preventive Medicine,  Monash University, Melbourne, VIC,  9school of Medicine, University of  Tasmania, hobart, T as, australiaBackground and objective:  Personal smoking is widely regarded to be the primary cause of  chronic bronchitis (CB) in adults, but with limited knowledge of contributions by other factors,  including current asthma.",Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
"Bronchial mucus hypersecretion  is the classically accepted cardinal feature, which usually manifests as a productive  cough on most days during at least three consecutive months for 2 or more successive  years.1,2 Nonobstructive or simple chronic bronchitis (NCB) contrasts with “chronic  obstructive bronchitis”, which is included within the definition of chronic obstructive  pulmonary disease (COPD).3 Clinicians and researchers have generally focused on Correspondence: shyamali C Dharmage Center for epidemiology and Biostatistics,  Melbourne school of Population and  global health, level 3, 207 Bouverie  st, The University of Melbourne,  Melbourne, VIC 3010, australia Tel +61 3 8344 0737 Fax +61 3 9349 5815 email s.dharmage@unimelb.edu.a u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Dharmage et al Running head recto: Adult CB and its associations DOI: http://dx.doi.org/10.2147/COPD.S103908",Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
Available from: http://www.nhlbi.,Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/20/copd-11-1911.PMC4993278.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/a7/ijn-11-3951.PMC4993279.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3951–3967International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3951OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10795 2 anti-epha10 antibody-conjugated ph-sensitive  liposomes for specific intracellular delivery  of sirNa Xinlong Zang1 huaiwei Ding2 Xiufeng Zhao3 Xiaowei li1 Zhouqi Du1 haiyang hu1 Mingxi Qiao1 Dawei chen1 Yuihui Deng1 Xiuli Zhao1 1Department of Pharmaceutics,   school of Pharmacy, 2Department of  Pharmaceutical chemistry, school of  Pharmaceutical engineering, shenyang  Pharmaceutical University, shenyang,   People’s republic of china; 3hongqi  hospital affiliated to Mudanjiang  Medical University, Mudanjiang,   People’s republic of chinaAbstract:  Therapeutic delivery of small interfering RNA (siRNA) is a major challenge that  limits its potential clinical application.",Non-OADS,/arxiv_data1/oa_pdf/97/a7/ijn-11-3951.PMC4993279.pdf
"Maximum therapeutic efficacy of siRNA can be obtained  if the siRNAs are delivered to the site of action.6,7 However, a variety of physiologi - cal, cellular, and immunological barriers hinder siRNA molecules from reaching their  target site.8 Physiological barriers are composed of endothelial barrier, degradation correspondence: Yuihui Deng;  Xiuli Zhao school of Pharmacy, shenyang  Pharmaceutical University, No 103,  Wenhua road, shenyang 110016,  People’s republic of china Tel +86 24 2398 6316; +86 24 2398 6308 email dds-666@163.co m;  raura3687yd@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zang et al Running head recto: Anti-EphA10 antibody-conjugated pH-sensitive liposomes for siRNA delivery DOI: http://dx.doi.org/10.2147/IJN.S107952",Non-OADS,/arxiv_data1/oa_pdf/97/a7/ijn-11-3951.PMC4993279.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/97/a7/ijn-11-3951.PMC4993279.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/a7/ijn-11-3951.PMC4993279.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/5c/dddt-10-2643.PMC4993280.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2643–2649Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2643Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11203 9 novel curcumin-loaded human serum albumin  nanoparticles surface functionalized with folate:  characterization and in vitro/vivo evaluation Zhiwang song1,* Y onglin lu1,* Xia Zhang1,* haiping Wang2 Junyi han3 chunyan Dong1 1Breast cancer center, 2Department  of Pharmacy, 3Department of  gastrointestinal surgery, shanghai  east hospital, T ongji University,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  Folate-conjugated, curcumin-loaded human serum albumin nanoparticles  (F-CM-HSANPs) were obtained by the chemical conjugation of folate to the surface of the  curcumin (CM)-loaded human serum albumin nanoparticles (NPs).",Non-OADS,/arxiv_data1/oa_pdf/f2/5c/dddt-10-2643.PMC4993280.pdf
"However, the clinical application of CM has been highly restricted due to its  low bioavailability, low serum concentration and tissue distribution, and its quick  metabolization, which results from its low aqueous solubility (11 ng/mL at pH 5.0)  and short half-life.5–7 In order to solve these problems, researchers have tried different  drug formulations to encapsulate CM, such as nanosuspensions, polymeric micelles, correspondence: chunyan Dong Breast cancer center, shanghai east  hospital, Tongji University, shanghai  200120, People’s republic of china email chunyan_dong@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Song et al Running head recto: CM-loaded, folate-conjugated HSANPs DOI: http://dx.doi.org/10.2147/DDDT.S112039",Non-OADS,/arxiv_data1/oa_pdf/f2/5c/dddt-10-2643.PMC4993280.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f2/5c/dddt-10-2643.PMC4993280.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/5c/dddt-10-2643.PMC4993280.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2016:8 95–104Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  95 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S86746Advanced soft-tissue sarcoma and treatment  options: critical appraisal of trabectedin Ingrid M E Desar1 Anastasia Constantinidou2 Suzanne E J Kaal1 Robin L Jones2 Winette T A van der  Graaf1,2 1Department of Medical Oncology,   Radboud University Medical Center,   Nijmegen, the Netherlands; 2The  Institute of Cancer Research and the Royal Marsden NHS Foundation Trust,  London, UKAbstract:  Soft-tissue sarcomas (STS) are a heterogeneous group of rare solid tumors of mes- enchymal origin.",Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
"The use of chemotherapy or targeted therapy has mostly been Correspondence: Winette T A van  der GraafThe Institute of Cancer Research, 15 Cotswold Road, Sutton, London SM2 5NG, UKEmail Winette.vanderGraaf@icr.ac.ukJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Desar et alRunning head recto: Trabectedin in advanced soft-tissue sarcomaDOI: http://dx.doi.org/10.2147/CMAR.S86746",Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
"Cancer Management and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 104 Desar et al  51.,Non-OADS,/arxiv_data1/oa_pdf/99/aa/cmar-8-095.PMC4993282.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/be/ijn-11-4025.PMC4993285.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e6/be/ijn-11-4025.PMC4993285.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4025–4036International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4025OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5580 7Fusion between fluid liposomes and intact   bacteria: study of driving parameters   and in vitro bactericidal efficacy Zhao Wang1,2* Yufan Ma1,3,4* hayssam Khalil1 rutao Wang1–3 Tingli lu1 Wen Zhao1 Yang Zhang3 Jamin chen1,2 Tao chen1–3 1Key laboratory for space Bioscience  and Biotechnology, school of life  sciences, Northwestern Polytechnical  University, Xi’an, shaanxi,  2shaanxi  liposome research center, Xi’an,   shaanxi,  3Xi’an libang Pharmaceuticals  co, ltd, Xi’an, 4school of Medicine,   Xi’an Jiaotong University, Xi’an,   People’s republic of china *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/e6/be/ijn-11-4025.PMC4993285.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e6/be/ijn-11-4025.PMC4993285.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/be/ijn-11-4025.PMC4993285.pdf
"The reiterative use of the shortinternal TR template underlie s telomerase repeat addition CONTACT Julian J.-L. Chen JLChen@asu.edu School of Molecular Sciences, Arizona State University, Tempe, AZ, USA Published with license by Taylor & Francis Group, LLC © Joshua D. Podlevsky and Julian J.-L. Chen This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
"8, 720 –732 http://dx.doi.org/10.1080/15476286.2016.1205768",Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell 1985; 43:405-13; PMID:3907856; http://dx.doi.org/10.1016/0092-8674(85)90170-9 2.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2008; 36:D339-43; PMID:18073191;http://dx.doi.org/10.1093/nar/gkm700 4. de Lange T. A loopy view of telomere evolution.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Front Genet 2015; 6:321; PMID:26539211; http://dx.doi.org/10.3389/fgene.2015.00321 5.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat New Biol 1972; 239:197-201; PMID:4507727; http://dx.doi.org/10.1038/239197a0 6.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Theor Biol 1973; 41:181-90; PMID:4754905; http://dx.doi.org/10.1016/0022-5193(73)90198-7 7.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1995; 269:1533-4; PMID:7545310; http://dx.doi.org/10.1126/science.7545310 8.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2005; 18:131-8; PMID:15808515; http://dx.doi.org/10.1016/j.molcel.2005.02.035 10.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Biol Chem 2000; 275:19719-22; PMID:10787419; http://dx.doi.org/10.1074/jbc.M002843200 11.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
"Exp Cell Res 1965; 37:614-36; PMID:14315085; http://dx.doi.org/ 10.1016/0014-4827(65)90211-9 12. d ’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP.",OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/nature02118 13.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1990; 247:546-52; PMID:1689074;http://dx.doi.org/10.1126/science.1689074 14.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell 2000; 100:57- 70; PMID:10647931; http://dx.do i.org/10.1016/S0092-8674(00)81683-9 15.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mutagenesis 2002; 17:539-50; PMID:12435851; http://dx.doi.org/10.1093/mutage/17.6.539 16.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Chromosoma 1997; 106:63-9; PMID:9215555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genetica 1997; 100:73-84; PMID:9440260; http://dx.doi.org/ 10.1023/A:1018352706024 18.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Chromosoma 2016; 125:65-73; PMID:26162505; http://dx.doi.org/ 10.1007/s00412-015-0528-7 19.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 1993; 13:1583-9;PMID:8441399; http://dx.doi.org/10.1128/MCB.13.3.1583 21.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
"Roth CW, Kobeski F, Walter MF, Biessmann H. Chromosome end elongation by recombination in the mosquito Anopheles gambiae.Mol Cell Biol 1997; 17:5176-83; PMID:9271395; http://dx.doi.org/ 10.1128/MCB.17.9.5176 22.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Chro-mosoma 2000; 109:372-80; PMID:11072792; http://dx.doi.org/ 10.1007/s004120000094 23. de Lange T. How telomeres solve the end-protection problem.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Sci- ence 2009; 326:948-52; PMID:19965504; http://dx.doi.org/10.1126/science.1170633 24.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Trends Cancer 2015; 1:145-56; PMID:26645051; http://dx.doi.org/10.1016/j.trecan.2015.07.007 25.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
FEMS Microbiol Lett 2011; 319:1-10; PMID:21320158; http://dx.doi.org/10.1111/j.1574-6968.2011.02242.x 26.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Microbiol 2007; 63:1710-8;PMID:17367390; http://dx.doi.org/10.1111/j.1365-2958.2007.05616.x 27.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
BiosciBiotechnol Biochem 2008; 72:2973-80; PMID:18997415; http://dx.doi.org/10.1271/bbb.80454 28.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
MolMicrobiol 1998; 28:905-16; PMID:9663678; http://dx.doi.org/ 10.1046/j.1365-2958.1998.00856.x 29.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1997; 276:561-7; PMID:9110970; http://dx.doi.org/ 10.1126/science.276.5312.561 3 0 .,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1997; 277:955-9; PMID:9252327; http://dx.doi.org/10.1126/science.277.5328.955 31.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genome Res 2003; 13:1975-83; PMID:12952870; http://dx.doi.org/10.1101/gr.1392003 32.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2005; 33:4536-43; PMID:16091631; http://dx.doi.org/10.1093/nar/gki769 33.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Parasitol Res 2006; 98:447-54; PMID:16416120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1997; 277:911-2; PMID:9281073; http://dx.doi.org/10.1126/ science.277.5328.911 35.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Proc Natl Acad Sci USA 2007; 104:9352-7; PMID:17483479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mutat Res 2012; 730:3-11; PMID:22093366; http://dx.doi.org/10.1016/j.mrfmmm.2011.11.002 37.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2014; 42:10605-17; PMID:25143533; http://dx.doi.org/10.1093/nar/gku753 38.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Identi ﬁcation of RNA binding motifs in the R2 retrotransposon-encoded reverse transcriptase.Nucleic Acids Res 2014; 42:8405-15; PMID:24957604; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.Nature 1989; 337:331-7; PMID:2463488; http://dx.doi.org/10.1038/ 337331a0 40.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2013; 41:450-62; PMID:23093598; http://dx.doi.org/10.1093/nar/gks980 42.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Rev Neurosci 2014;15:497-506; PMID:25005482; http://dx.doi.org/10.1038/nrn3730 44.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
JMol Biol 1978; 120:33-53; PMID:642006; http://dx.doi.org/10.1016/ 0022-2836(78)90294-2 45.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell 1988; 53:127-36; PMID:3349525;http://dx.doi.org/10.1016/0092-8674(88)90494-1 46.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2016; 22:204-15; PMID:26598712; http://dx.doi.org/10.1261/rna.053280.115RNA BIOLOGY 729,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1995; 269:1236-41; PMID:7544491;http://dx.doi.org/10.1126/science.7544491 49.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 1991; 11:4572- 80; PMID:1875940; http://dx.doi.org/10.1128/MCB.11.9.4572 50.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
EMBO J 2003; 22:304-14; PMID:12514136; http://dx.doi.org/10.1093/emboj/cdg024 51.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Curr Biol 2004; 14:1148-58; PMID:1524 2611; http://dx.doi.org/10.1016/j.cub.2004.05.054 53.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 1995; 269:396-400; PMID:7618104; http://dx.doi.org/10.1126/science.7618104 54.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2010; 39:307-14; PMID:20670897; http://dx.doi.org/10.1016/j.molcel.2010.06.020 57.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 1995; 9:2227-39;PMID:7557377; http://dx.doi.org/10.1101/gad.9.18.2227 58.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2002; 16:415-20; PMID:11850404;http://dx.doi.org/10.1101/gad.962602 59.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Biol Chem 2013; 288:22141-9; PMID:23760279; http://dx.doi.org/10.1074/jbc.M113.452425 60.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nature Struct Mol Biol 2015; 22:883-8; http://dx.doi.org/ 10.1038/nsmb.3101 61.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2016; http://dx.doi.org/10.1093/nar/gkw605 62.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 2000; 288:863- 7; PMID:10797010; http://dx.doi.org/10.1126/science.288.5467.863 63.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2003; 9:1323-32;PMID:14561882; http://dx.doi.org/10.1261/rna.5570803 64.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Biol Chem 2008; 283:24224-33; PMID:18574244; http://dx.doi.org/10.1074/jbc.M802043200 65.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Structure 2013;21:1870-8; PMID:24055314; http://dx.doi.org/10.1016/j.str.2013.08.013 66.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 1998;26:532-6; PMID:9421511; http://dx.doi.org/10.1093/nar/26.2.532 67.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol2004; 24:3720-33; PMID:15082768; http://dx.doi.org/10.1128/ MCB.24.9.3720-3733.2004 68.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2000; 6:361-71; PMID:10983983; http://dx.doi.org/10.1016/S1097-2765(00)00036-8 69.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Struct Mol Biol 2011; 18:1371-5; http://dx.doi.org/10.1038/nsmb.2174 70.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
EMBO J 2012; 31:150-61; PMID:21989387; http://dx.doi.org/10.1038/emboj.2011.363 71.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cold Spring Harb Perspect Biol 2011; 3:1-9; http://dx.doi.org/ 10.1101/cshperspect.a003558 72.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2012; 18:1747-59; PMID:22875809; http://dx.doi.org/10.1261/ rna.034629.112 73.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2003; 17:1779- 88; PMID:12832393; http://dx.doi.org/10.1101/gad.1099403 74.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2003; 23:6849-56; PMID:12972604; http://dx.doi.org/10.1128/ MCB.23.19.6849-6856.2003 76.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 1998; 26:787-95; PMID:9443971; http://dx.doi.org/10.1093/nar/26.3.787 77.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2001; 21:990-1000; PMID:11158287; http://dx.doi.org/10.1128/MCB.21.4.990-1000.2001 79.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2005; 17:671-82; PMID:15749017; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Struct Mol Biol 2008; 15:634-40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2007; 27:2130-43; PMID:17210648; http://dx.doi.org/10.1128/MCB.01826-06 83.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2002; 30:592-7; PMID:11788723; http://dx.doi.org/10.1093/nar/30.2.592 86.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2007; 35:6280-9; PMID:17855392; http://dx.doi.org/10.1093/nar/gkm713 87.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2003; 23:5606-13; PMID:12897134; http://dx.doi.org/ 10.1128/MCB.23.16.5606-5613.2003 88.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 1995; 23:1091-7; PMID:7739888; http://dx.doi.org/10.1093/nar/23.7.1091 89.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
PloS One 2013; 8:e58661; PMID:23555591; http://dx.doi.org/10.1371/journal.pone.0058661 90.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nature Struct Mol Biol 2014; 21:507-12; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Struct Mol Biol 2005; 12:1072-7; http://dx.doi.org/10.1038/nsmb1019 92.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2013; 19:852-60; PMID:23584428; http://dx.doi.org/10.1261/rna.039131.113 93.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nature 2007; 446:458-61; PMID:17322903; http://dx.doi.org/10.1038/nature05600 94.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2014; 42:3395-408; PMID:24335084;http://dx.doi.org/10.1093/nar/gkt1276 96.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Biol Chem 2008; 283:2049-59; PMID:18039659; http://dx.doi.org/10.1074/jbc.M708032200 97.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell Res 2013; 23:537-51; PMID:23478302; http://dx.doi.org/10.1038/cr.2013.35 98.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
The putative Leishmania telomerase RNA (LeishTER) under-goes trans-splicing and contains a conserved template sequence.PloS One 2014; 9:e112061; PMID:25391020; http://dx.doi.org/ 10.1371/journal.pone.0112061 99.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
FEBS Lett 2013; 587:1399-404; PMID:23523918; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Struct Mol Biol 2008; 15:26-33; http://dx.doi.org/10.1038/nsmb1343 101.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 1999; 19:567-76; PMID:9858580; http://dx.doi.org/10.1128/MCB.19.1.567 102.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
J Cell Biol 2004; 164:647-52; http://dx.doi.org/10.1083/jcb.200310138 103.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2010; 30:2775-86; PMID:20351177; http://dx.doi.org/10.1128/MCB.00151-10 104.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
NucleicAcids Res 1993; 21:2149-55; PMID:8502556; http://dx.doi.org/ 10.1093/nar/21.9.2149 105.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Exp Cell Res 1999; 252:165-74; PMID:10502409; http://dx.doi.org/10.1006/excr.1999.4607 106.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2000; 20:9028-40; PMID:11074001; http://dx.doi.org/10.1128/MCB.20.23.9028-9040.2000 107.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2001; 29:3784-95; PMID:11557810; http://dx.doi.org/10.1093/nar/29.18.3784 108.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Struct Mol Biol 2005; 12:1101-7; http://dx.doi.org/ 10.1038/nsmb1036 109.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic AcidsRes 2007; 35:1452-64; PMID:17284456; http://dx.doi.org/10.1093/nar/gkl1172 111.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2007; 27:869-81; PMID:17889661; http://dx.doi.org/10.1016/j.molcel.2007.07.017 112.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2011; 39:9390-404; PMID:21846770; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell Rep 2015; 13:2244-57; PMID:26628368; http://dx.doi.org/10.1016/j.celrep.2015.11.003 114.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell Rep 2015; 13:2232-43; PMID:26628367; http://dx.doi.org/10.1016/j.celrep.2015.10.075 115.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
"Tang W, Kannan R, Blanchette M, Baumann P. Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes.Nature 2012; 484:260-4; PMID:22446625; http://dx.doi.org/10.1038/nature10924 116.",OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Saccharomyces cere- visiae telomerase is an Sm small nuclear ribonucleoprotein particle.Nature 1999; 401:177-80; PMID:10490028; http://dx.doi.org/10.1038/43694 117.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nucleic Acids Res 2012;40:5625-36; http://dx.doi.org/10.1093/nar/gks200 118.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Commun 2015; 6:6105; PMID:25598218; http://dx.doi.org/10.1038/ncomms7105 119.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nature 2008; 456:910-4; PMID:19052544; http://dx.doi.org/10.1038/nature07584 121.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2009; 15:546-59; PMID:19223441; http://dx.doi.org/10.1261/rna.1194009 122.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2002; 16:2800-12; PMID:12414733; http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Curr Biol 2003; 13:575-80; PMID:12676088; http://dx.doi.org/10.1016/ S0960-9822(03)00169-6 125.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Curr Biol 2000; 10:809-12; PMID:10898986; http://dx.doi.org/10.1016/S0960-9822(00)00562-5 126.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2003; 17:2384-95; PMID:12975323; http://dx.doi.org/10.1101/ gad.1125903 127.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
DNA Repair 2005; 4:1215-26; PMID:15 979949; http://dx.doi.org/10.1016/j.dnarep.2005.04.021 128.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2008; 28:1875-82; PMID:18195041; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell 2016; 165:1171-81; PMID:27156450; http://dx.doi.org/10.1016/j.cell.2016.04.018 130.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2004; 18:1107-18;PMID:15131081; http://dx.doi.org/10.1101/gad.1201704 131.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell 2009; 36:609-19;PMID:19941821; http://dx.doi.org/10.1016/j.molcel.2009.09.041 132.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
EMBOJ 2000; 19:6230-9; PMID:11080168; http://dx.doi.org/10.1093/ emboj/19.22.6230 133.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Biochemistry 2003; 42:5736-47; PMID:12741831; http://dx.doi.org/10.1021/ bi034121y 134.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
RNA 2006; 12:1475-85; PMID:16809815; http://dx.doi.org/10.1261/rna.112306 135.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Cell Biol 2007; 27:2074-83;PMID:17220281; http://dx.do i.org/10.1128/MCB.02105-06136.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Science 2015; 350:aab4070; PMID:26472759; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Eukaryot Cell 2010; 9:1159-70; PMID:20581293; http://dx.doi.org/10.1128/EC.00113-10 138.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Plant Cell 2015; 27:954-68; PMID:25873387; http://dx.doi.org/10.1105/tpc.114.135954 139.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Genet Genomics 2014; 289:1045-60; PMID:25092473; http://dx.doi.org/10.1007/s00438-014-0889-2 140.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Trends Genet 2014; 30:439-52; PMID:25218058; http://dx.doi.org/10.1016/j.tig.2014.08.004 141.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Fractionation mutagenesis and similar consequences ofmechanisms removing dispensable or less-expressed DNA in plants.Curr Opin Plant Biol 2012; 15:131-9; PMID:22341793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Proc Natl Acad Sci USA 2011; 108:73-8; PMID:21164032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Front Genet 2012; 3:188; PMID:23015808; http://dx.doi.org/10.3389/fgene.2012.00188 145.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Genes Dev 2012; 26:2512-23; PMID:23109676; http://dx.doi.org/10.1101/gad.202960.112 146.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Cell 1991; 67:343-53; PMID:1840508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Microbiol Mol Biol Rev 2014; 78:278-303; PMID:24847023; http://dx.doi.org/10.1128/MMBR.00049-13 148.,Non-OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Nat Genet 2003;33:123-4; PMID:12524543; http://dx.doi.org/10.1038/ng1074 149.,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
Mol Phylogenet Evol 2014; 81:71-85; PMID:25152275; http://dx.doi.org/10.1016/j.ympev.2014.08.012732 J. D. PODLEVSKY AND J. J.-L. CHEN,OADS,/arxiv_data1/oa_pdf/e8/64/krnb-13-08-1205768.PMC4993307.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2016 |  112  | e54139 | Page 1 of 13Video Article Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study Jens O. Watzlawik1,2,3, Robert J. Kahoud1,3,5, Bharath Wootla1,2,3, Meghan M. Painter1,2,3, Arthur E. Warrington1,2,3, William A. Carey3,4, Moses Rodriguez1,2,3 1Department of Neurology, Mayo Clinic 2Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic 3Center for Regenerative Medicine, Neuroregeneration, Mayo Clinic 4Division of Neonatal Medicine, Mayo Clinic 5Department of Pediatric and Adolescent Medicine, Mayo Clinic Correspondence to: Jens O. Watzlawik at watzlawik.jens@mayo.edu , Moses Rodriguez at rodriguez.moses@mayo.edu URL: http://www.jove.com/video/54139 DOI: doi:10.3791/54139 Keywords: Immunology, Issue 112, Neurological disease, regeneration, antigen, IgM antibody, polysialic acid (PSA), neural cell adhesion molecule (NCAM), multiple sclerosis (MS), immunotherapy Date Published: 6/29/2016 Citation: Watzlawik, J.O., Kahoud, R.J., Wootla, B., Painter, M.M., Warrington, A.E., Carey, W.A., Rodriguez, M. Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study.",Non-OADS,/arxiv_data1/oa_pdf/51/46/jove-112-54139.PMC4993309.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/54139/ Introduction Antibodies of the IgM isotype demonstrate great therapeutic potential for the treatment of various diseases including cancer and CNS disorders 1-7.,Non-OADS,/arxiv_data1/oa_pdf/51/46/jove-112-54139.PMC4993309.pdf
Available from: http://1.usa.gov/1N2gsHJ (2015).,OADS,/arxiv_data1/oa_pdf/51/46/jove-112-54139.PMC4993309.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2016 |  113  | e54247 | Page 1 of 8Video Article Preparation and 3D Tracking of Catalytic Swimming Devices Andrew Campbell1, Richard Archer1, Stephen Ebbens1 1Department of Chemical and Biological Engineering, University of Sheffield Correspondence to: Stephen Ebbens at s.ebbens@sheffield.ac.uk URL: http://www.jove.com/video/54247 DOI: doi:10.3791/54247 Keywords: Engineering, Issue 113, Microscopy, Catalysis, Colloids, Diffusion, Polymers, Transport Date Published: 7/1/2016 Citation: Campbell, A., Archer, R., Ebbens, S. Preparation and 3D Tracking of Catalytic Swimming Devices.",Non-OADS,/arxiv_data1/oa_pdf/6b/25/jove-113-54247.PMC4993318.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54247/ Introduction Catalytic swimming devices are small scale, untethered colloids capable of autonomously generating motion in fluidic environments.1,2 These devices are attracting significant research interest as they have the potential to enable exciting new functions such as drug delivery,3 lab-on a chip transport4 and environmental remediation.5 One widely studied example are catalytic ""Janus"" swimmers.6 These particles get their name from having two distinct sides, or faces (Janus is a two faced Roman god).",Non-OADS,/arxiv_data1/oa_pdf/6b/25/jove-113-54247.PMC4993318.pdf
"85 (2 Pt 1), 020401at <http://www.ncbi.nlm.nih.gov/pubmed/22463141> (2012).",Non-OADS,/arxiv_data1/oa_pdf/6b/25/jove-113-54247.PMC4993318.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2016 |  113  | e54116 | Page 1 of 5Video Article Preparation of Biopolymer Aerogels Using Green Solvents Raman Subrahmanyam1, Pavel Gurikov1, Imke Meissner1, Irina Smirnova1 1Institute of Thermal Separation Processes, Hamburg University of Technology Correspondence to: Raman Subrahmanyam at raman.subrahmanyam@tuhh.de URL: http://www.jove.com/video/54116 DOI: doi:10.3791/54116 Keywords: Chemistry, Issue 113, Biopolymers, aerogels, supercritical CO2 drying, green solvents, amidated pectin, hydrogels Date Published: 7/4/2016 Citation: Subrahmanyam, R., Gurikov, P., Meissner, I., Smirnova, I.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/jove-113-54116.PMC4993321.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54116/ Introduction Aerogels are a class of porous materials that can be prepared using a variety of precursors ranging from inorganic (such as silica, titania, zirconia and others), synthetic (such as resorcinol formaldehyde, polyurethane and others) or biopolymers (polysaccharides, proteins and others)2.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/jove-113-54116.PMC4993321.pdf
"A. Slater1, Edward A. Lewis1, Sarah J. Haigh1 1School of Materials, University of Manchester Correspondence to: Sarah J. Haigh at sarah.haigh@manchester.ac.uk URL: http://www.jove.com/video/52815 DOI: doi:10.3791/52815 Keywords: Engineering, Issue 113, Nanomaterials, energy dispersive X-ray spectroscopy, transmission electron microscopy, electron tomography, bimetallic nanoparticles, heterogeneous catalysis Date Published: 7/5/2016 Citation: Slater, T.J., Lewis, E.A., Haigh, S.J.",Non-OADS,/arxiv_data1/oa_pdf/4e/a2/jove-113-52815.PMC4993322.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52815/ Introduction The aim of this method is to provide accurate determination of the three dimensional distribution of elements within single nanoparticles.,OADS,/arxiv_data1/oa_pdf/4e/a2/jove-113-52815.PMC4993322.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2016 |  113  | e54117 | Page 1 of 9Video Article Unbiased Deep Sequencing of RNA Viruses from Clinical Samples Christian B. Matranga1, Adrianne Gladden-Young1, James Qu1, Sarah Winnicki1, Dolo Nosamiefan1, Joshua Z. Levin1, Pardis C. Sabeti1,2 1Broad Institute of MIT and Harvard 2Harvard University Correspondence to: Christian B. Matranga at matranga@broadinstitute.org URL: http://www.jove.com/video/54117 DOI: doi:10.3791/54117 Keywords: Medicine, Issue 113, RNA viruses, Ebola virus, Lassa virus, intra-host variants, Lassa fever, poly(rA) carrier, rRNA, RNase H, RT-PCR Date Published: 7/2/2016 Citation: Matranga, C.B., Gladden-Young, A., Qu, J., Winnicki, S., Nosamiefan, D., Levin, J.Z., Sabeti, P.C.",Non-OADS,/arxiv_data1/oa_pdf/83/af/jove-113-54117.PMC4993327.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54117/ Introduction Next generation sequencing of viruses from clinical sources can inform transmission and the epidemiology of infections, as well as help support novel diagnostic, vaccine and therapeutic development.",Non-OADS,/arxiv_data1/oa_pdf/83/af/jove-113-54117.PMC4993327.pdf
These tools are available at https://github.com/broadinstitute/viral-ngs or through commercial cloud platforms4.,Non-OADS,/arxiv_data1/oa_pdf/83/af/jove-113-54117.PMC4993327.pdf
"13.Andrews, S. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.",Non-OADS,/arxiv_data1/oa_pdf/83/af/jove-113-54117.PMC4993327.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2016 |  113  | e53609 | Page 1 of 9Video Article Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models Jeremie Cosette1,2,3, Rym Ben Abdelwahed2, Sabrina Donnou-Triffault1,4,5, Catherine Sautès-Fridman2, Patrice Flaud*3, Sylvain Fisson*1,4,5 1Genethon 2Cordeliers Research Center, INSERM U872 3Matter and Complex Systems Laboratory, Université Paris Diderot 4INSERM U951 5UMR_S951, Université d'Evry Val d'Essonne *These authors contributed equally Correspondence to: Jeremie Cosette at jcosette@genethon.fr URL: http://www.jove.com/video/53609 DOI: doi:10.3791/53609 Keywords: Medicine, Issue 113, Bioluminescence imaging, Quantification, Luminoscore, Murine B-cell lymphoma, Syngeneic, CpG-DNA, Cancer biology Date Published: 7/7/2016 Citation: Cosette, J., Ben Abdelwahed, R., Donnou-Triffault, S., Sautès-Fridman, C., Flaud, P., Fisson, S. Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models.",Non-OADS,/arxiv_data1/oa_pdf/97/f7/jove-113-53609.PMC4993383.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/53609/ Introduction Early tumor cell detection remains a challenge and is crucial for enhancing cancer treatment efficacy.,Non-OADS,/arxiv_data1/oa_pdf/97/f7/jove-113-53609.PMC4993383.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/6c/ppa-10-1583.PMC4993391.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1583–1589Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1583OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10904 0 intricate decision making: ambivalences and  barriers when fulfilling an advance directive lars schröder1 gerhard hommel2 stephan sahm3,4 1Department of gynecology and  Obstetrics, center of integrated  Oncology, University hospital Bonn,   Bonn, 2institute of Medical Biometry,   epidemiology and informatics,   Johannes gutenberg University, Mainz,   3Department of gastroenterology  and Oncology, Ketteler hospital,   Offenbach, 4institute for ethics and  history of Medicine, Johann Wolfgang  goethe University, Frankfurt,   germanyBackground:  Despite a recent statutory ruling stating the binding nature of advance directives  (ADs), only a minority of the population has signed one.",Non-OADS,/arxiv_data1/oa_pdf/89/6c/ppa-10-1583.PMC4993391.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/89/6c/ppa-10-1583.PMC4993391.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1531–1534Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1531Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11152 6 long-term surgical outcomes of retinal  detachment in patients with stickler syndrome Devasis n reddy1 Y oshihiro Y onekawa1–4 Benjamin J Thomas1,2,5 eric D nudleman6 george a Williams1,2 1Oakland University William  Beaumont school of Medicine,   rochester, M i, 2associated  retinal Consultants, William  Beaumont hospital, royal Oak,   Mi, 3Massachusetts eye and ear  infirmary, Boston, M a, 4Boston  Children’s hospital, harvard Medical  school, Boston, M a, 5Florida retina  institute, Jacksonville, Fl, 6shiley eye  institute, University of California  san Diego  school of Medicine,   san Diego,  Ca, UsaPurpose:  The aim of the study was to present the long-term anatomical and visual outcomes  of retinal detachment repair in patients with Stickler syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
"Keywords:  pediatric retina, proliferative vitreoretinopathy, retina, scleral buckle, vitrectomy,  vitreoretinal surgery Introduction Stickler syndrome – alternately known as hereditary arthro-ophthalmopathy – is an  inherited disorder of collagen formation manifesting itself through a spectrum of  ocular, orofacial, auditory, and musculoskeletal abnormalities.1,2 The disease is rela - tively uncommon, with a reported incidence of one in 7,500–9,000 births, and presents  with highly variable signs and symptoms in affected individuals.3 This diversity of  phenotypes reflects the heterogeneous mutations affecting the formation of Types II,  IX, and XI collagen, which are integral to the structure and function of the vitreous,  cartilage, and other connective tissues.4,5 Specific ocular manifestations include high myopia, optically empty vitreous, open- angle glaucoma (from dysgenesis of the anterior chamber drainage angle), cortical  cataract, and perivascular retinal lattice degeneration with strong vitreous adhesions  along the borders of these lesions.6 These vitreoretinal changes predispose patients to  the development of giant retinal tears (GRTs) and associated rhegmatogenous retinal  detachments (RRD) relatively early in life, often in the second and third decades of  life.4,6,7 Stickler syndrome is the most common inherited cause of RRD, in spite of its  low incidence overall.8Correspondence: george a Williams associated retinal Consultants, William  Beaumont hospital, 3535 West Thirteen  Mile road, suite 344, royal Oak,  Mi 48073, Usa Tel +1 248 288 2280 Fax +1 248 288 5644 email george_williams@beaumont.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Reddy et al Running head recto: Retinal detachment in Stickler syndrome patients DOI: http://dx.doi.org/10.2147/OPTH.S111526",Non-OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
"Available from: http://ghr.nlm.nih.gov/condition/ stickler-syndrom e. Accessed February 23, 2013.",OADS,/arxiv_data1/oa_pdf/a5/4c/opth-10-1531.PMC4993392.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/14/ott-9-5091.PMC4993393.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5091–5099OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5091Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10106 7 Mir-200c promotes bladder cancer cell migration  and invasion by directly targeting recK Yidong cheng* Xiaolei Zhang* Peng li* chengdi Yang Jinyuan Tang Xiaheng Deng Xiao Yang Jun Tao Qiang lu Pengchao li Department of Urology, The First  affiliated hospital of nanjing Medical  University, nanjing, People’s republic  of china *These authors contributed equally  to this workBackground:  Increasing evidence suggests that the dysregulation of certain microRNAs plays  an important role in tumorigenesis and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/75/14/ott-9-5091.PMC4993393.pdf
"correspondence: Qiang lu; Pengchao li Department of Urology, The First  Affiliated Hospital of Nanjing Medical  University, 300 guangzhou road, nanjing  210029, Jiangsu Province, People’s  republic of china Tel +86 25 8371 0079 email doctorlvqiang@sina.co m;  superkulian@aliyun.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cheng et al Running head recto: MiR-200c promotes BC by targeting RECK DOI: http://dx.doi.org/10.2147/OTT.S101067",Non-OADS,/arxiv_data1/oa_pdf/75/14/ott-9-5091.PMC4993393.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/14/ott-9-5091.PMC4993393.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/14/ott-9-5091.PMC4993393.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1561–1572Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1561Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8285 7 Patients’ perspectives and preferences in  the choice of inhalers: the case for Respimat®  or HandiHaler® Pieter Nicolaas Richard  Dekhuijzen1 Federico Lavorini2 Omar S Usmani3 1Department of Pulmonary Diseases,   Radboud University Medical  Center, Nijmegen, the Netherlands;   2Department of experimental and  Clinical Medicine, Careggi University  Hospital, Florence, italy; 3National  Heart and Lung institute, imperial  College London and Royal Brompton  Hospital, London, UKAbstract:  Poor inhaler technique hampers the efficacy of drug therapy in asthma and chronic  obstructive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
"This review examines the key considerations for selecting devices most suited  to patients’ needs; it also discusses the importance of correct inhaler technique for Correspondence: Pieter Nicolaas Richard  Dekhuijzen Department of Pulmonary Diseases,  Radboud University Medical Center,  6500 HB Nijmegen, the Netherlands Tel +31 24 361 0325 Fax +31 24 361 0324 email richard.dekhuijzen@radboudumc.n l Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Dekhuijzen et al Running head recto: Perspectives and preferences in choice of inhalers DOI: http://dx.doi.org/10.2147/PPA.S82857",Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
Available from: http://ginasthma.org/2016- gina-report-global-strategy-for-asthma-management-and-prevention /.,Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
Available from: http://products.boehringer-ingelheim.,Non-OADS,/arxiv_data1/oa_pdf/aa/2f/ppa-10-1561.PMC4993394.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4993–5003OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10112 5 effect of image-guided hypofractionated  stereotactic radiotherapy on peripheral  non-small-cell lung cancer shu-wen Wang1 Juan ren1 Yan-li Yan2 chao-fan Xue2 li Tan2 Xiao-wei Ma2 1Department of radiotherapy, First  affiliated hospital of Xian Jiaotong  University, 2Medical school of Xian  Jiaotong University, Xi’an, shaanxi,   People’s republic of chinaAbstract:  The objective of this study was to compare the effects of image-guided  hypofractionated radiotherapy and conventional fractionated radiotherapy on non-small-cell lung  cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
"This technique correspondence: Juan ren Department of radiotherapy, First  Affiliated Hospital of Xian Jiaotong  University, 277 Yan Ta Xi lu, Xi’an,  shaanxi 710061, People’s republic of china Tel +86 29 8532 4029 email 869491533@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Hypofractionated stereotactic radiotherapy for peripheral NSCLC DOI: http://dx.doi.org/10.2147/OTT.S101125",Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
Available from: http://www.icru.org/home/reports/ prescribing-recording-and-reporting-photon-beam-therapy-report-50.,Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
Available from: http://www.icru.org/home/reports/ prescribing-recording-and-reporting-photon-beam-therapy-report-6 2.,Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/ba/ott-9-4993.PMC4993395.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2016:9 79–84Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  79 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S106570Use of combinatorial pharmacogenomic testing in  two cases from community psychiatry Eve S Fields1 Raymond A Lorenz2 Joel G Winner2 1Northwest Center for Community  Mental Health, Reston, VA, USA;   2Assurex Health, Mason, OH, USA Abstract:  This report describes two cases in which pharmacogenomic testing was utilized to  guide medication selection for difficult to treat patients.",Non-OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
"For a given CYP450 pathway, extensive indicates normal metabolism, ultrarapid indicates faster than normal metabolism, intermediate indicates slower than normal metabolism, and poor indicates little to no  Correspondence: Raymond A Lorenz  Assurex Health, 6030 Mason‑Montgomery Road, Mason, OH 45040, USA Tel +1 513 701 5047 Fax +1 513 426 7306 Email rlorenz@assurexhealth.comJournal name: Pharmacogenomics and Personalized Medicine Article Designation: CASE SERIESY ear: 2016V olume: 9Running head verso: Fields et alRunning head recto: Pharmacogenomics in community psychiatryDOI: http://dx.doi.org/10.2147/PGPM.S106570",Non-OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
"Pharmacogenomics and Personalized Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics‑and‑personalized‑medicine‑journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 84 Fields et al  13.,Non-OADS,/arxiv_data1/oa_pdf/f7/af/pgpm-9-079.PMC4993396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 145–158Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  145 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S58262A comparison of robotic arm versus gantry linear  accelerator stereotactic body radiation therapy  for prostate cancer Vladimir Avkshtol Yanqun Dong Shelly B Hayes Mark A HallmanRobert A PriceMark L Sobczak Eric M Horwitz* Nicholas G Zaorsky* Department of Radiation Oncology,   Fox Chase Cancer Center,  Philadelphia, PA, USA *These authors contributed equally to  this workAbstract: Prostate cancer is the most prevalent cancer diagnosed in men in the United States  besides skin cancer.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
"Advances in technology have allowed for the safe delivery of higher doses per fraction, ie, hypo-fractionated RT (HFRT; 2.1–3.5 Gy per fraction, 15 minutes per day, 5 days per week, for approximately 4 weeks) 3 and stereotactic body RT (SBRT, for five fractions of Correspondence: Nicholas G Zaorsky Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USATel +1 215 728 2581Fax +1 215 214 4038Email nicholaszaorsky@gmail.comJournal name: Research and Reports in Urology Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Avkshtol et alRunning head recto: SBRT for prostate cancer: robotic arm vs gantryDOI: http://dx.doi.org/10.2147/RRU.S58262",Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01434290.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFS-Carrier-Specific-Files-Items/CMS1254049.html.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01584258.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 158 Avkshtol et al,Non-OADS,/arxiv_data1/oa_pdf/53/a5/rru-8-145.PMC4993397.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/7e/opth-10-1553.PMC4993398.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1553–1556Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1553MethO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S10848 6 Measuring phacoemulsification groove depth using  probe tip dimensions and biometry lens thickness  readings Kevin dunne Alex J Buller department of Ophthalmology,   hawkes Bay district health Board,   hastings, New ZealandAim:  To describe a useful technique utilizing lens thickness from biometric data as well as  phacoemulsification (phaco) probe tip dimensions, in order to more accurately determine safe  groove depth during divide and conquer techniques for cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/82/7e/opth-10-1553.PMC4993398.pdf
"The literature differs in the estimates of how many phaco tips should fit  vertically inside a groove, ranging from 2–4.4–6 Other visual cues include observing  the red reflex, with brightening red reflex suggesting thinning posterior plate;4–6 as well  as observing for groove floor linear striations parallel to trench long axis, meeting at Correspondence: Kevin dunne department of Ophthalmology, hawkes  Bay district health Board, Omahu Road,  hastings 4120, New Zealand tel +64 6 878 8109 email kevindunne86@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Methodology Y ear: 2016 Volume: 10 Running head verso: Dunne and Buller Running head recto: Probe dimensions and biometry lens thickness for measuring groove depth DOI: http://dx.doi.org/10.2147/OPTH.S108486",Non-OADS,/arxiv_data1/oa_pdf/82/7e/opth-10-1553.PMC4993398.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/82/7e/opth-10-1553.PMC4993398.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/7e/opth-10-1553.PMC4993398.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/opth-10-1543.PMC4993401.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1543–1551Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1543Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11093 0 Osmolarity and spectrophotometric property of  brilliant blue green define the degree of toxicity  on retinal pigment epithelial cells exposed to  surgical endoilluminator sankarathi Balaiya Kumar sambhav William B Cook Kakarla V Chalam Department of Ophthalmology,   University of Florida College of  Medicine, Jacksonville, Fl, UsaObjective:  To evaluate the effect of varying concentrations of brilliant blue green (BBG)  and their different biochemical characteristics on retinal pigment epithelial (RPE) cells  under xenon light source illumination at varying distances to identify safe parameters for  intraoperative use.",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/opth-10-1543.PMC4993401.pdf
"However, there are established Correspondence: Kakarla V Chalam Department of Ophthalmology,  University of Florida College of  Medicine, 580, W, 8th street, Tower-2,  Jacksonville, Fl 32209, Usa Tel +1 904 244 9361 Fax +1 904 244 9391 email kvchalam@aol.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Balaiya et al Running head recto: BBG toxicity on RPE cells exposed to surgical endoilluminator DOI: http://dx.doi.org/10.2147/OPTH.S110930",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/opth-10-1543.PMC4993401.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/opth-10-1543.PMC4993401.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/8f/opth-10-1543.PMC4993401.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1573–1581Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1573OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10754 3 Associations between adherence and outcomes  among older, type 2 diabetes patients: evidence  from a Medicare supplemental database Kristina secnik Boye1 sarah e curtis1 Maureen J lage2 luis-emilio garcia-Perez3 1global Patient Outcomes and  real World evidence, eli lilly and  company, lilly corporate center,   indianapolis, in, 2healthMetrics  Outcomes research, llc, Bonita  springs, Fl, 3global Medical Affairs,   lilly Diabetes, eli lilly and company,   lilly corporate center, indianapolis,   in, UsAObjective:  To examine the association between adherence to glucose-lowering agents and  patient outcomes, including costs, acute-care resource utilization, and complications, in an  older, type 2 diabetic population.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Keywords:  proportion of days covered, complications, costs, resource utilization, retrospec - tive study Introduction The world population is aging at an unprecedented and accelerating rate.1 Corres- pondingly, the US population is aging faster than at any other time in history,2 with the  current number of Americans aged 65 years or older projected to more than double to  98 million by 2060.3 Older age is a nonmodifiable risk factor for a number of chronic  diseases, including type 2 diabetes (T2D).4,5 In the US, the 65 and older demographic  has approximately twice the rate of diabetes relative to the overall adult population  (25.9% vs 12.3%).6correspondence: Maureen J lage healthMetrics Outcomes research,  27576 river reach Drive, Bonita springs,  Fl 34134, UsA Tel +1 860 245 0685 email lagemj@hlthmetrics.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Boye et al Running head recto: Adherence and outcomes among older, type 2 diabetes patients DOI: http://dx.doi.org/10.2147/PPA.S107543",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available from: http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WorldPopulationAgeing2013.pd f. Accessed  April 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available  from: http://www.cdc.gov/features/agingandhealth/state_of_aging_ and_health_in_america_2013.pd f. Accessed April 27, 2016.",OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available from: http://www.census.gov/ population / projections /data/national/2012/summarytables.htm l. Accessed  March 1, 2016.",OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available  from: http://www.heart.org/HEARTORG/Conditions/Diabetes/ UnderstandY ourRiskforDiabetes /Understand-Y our-Risk-for-Diabe - tes_UCM_002034_Article.jsp#.VtXhJ2fSmU k. Accessed March 1,  2016.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
Available from: http://www.who.int/mediacentre/factsheets/en /.,Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/ national-diabetes-report-web.pd f. Accessed March 1, 2016.",OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"Available from: https://www.cms.gov/Medicare/Quality- Initiatives-Patient-Assessment-Instruments/ QualityInitiativesGenInfo / Downloads/2015-QRS-Measure-Technical-Specifications.pd f.  Accessed March 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/ppa-10-1573.PMC4993402.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/83/ott-9-5117.PMC4993403.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5117–5121OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5117Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10898 9 comparison of long-term survival between  temozolomide-based chemoradiotherapy and  radiotherapy alone for patients with low-grade  gliomas after surgical resection Xiu-juan gai1,2 Yu-mei Wei2 heng-min Tao1,2 Dian-zheng an2 Jia-teng sun1,2 Bao-sheng li2 1school of Medicine and life sciences,   University of Jinan-shandong  academy of Medical sciences,   Jinan, shandong, People’s republic  of china; 2Department of radiation  Oncology V i, shandong cancer  hospital affiliated to shandong  University, Jinan, shandong,   People’s republic of chinaPurpose:  This study was designed to compare the survival outcomes of temozolomide-based  chemoradiotherapy (TMZ + RT) vs radiotherapy alone (RT-alone) for low-grade gliomas  (LGGs) after surgical resection.",Non-OADS,/arxiv_data1/oa_pdf/ce/83/ott-9-5117.PMC4993403.pdf
"A Phase III trial investigated differences in patients  with LGGs, who underwent incomplete resection and subsequent RT with or without  chemotherapy (procarbazine or lomustine [CCNU]), but no statistically significant  differences were observed owing to its premature termination.2 In another Phase III  trial by the Radiation Therapy Oncology Group, RTOG 9802,3 a categorical benefit in correspondence: Bao-sheng li Department of radiation Oncology Vi,  Shandong Cancer Hospital Affiliated to  shandong University, 440 Jiyan road,  Jinan, shandong 250117,   People’s republic of china  Tel +86 186 1519 3697 email baoshli1963@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gai et al Running head recto: Comparison of long-term survival between TMZ + RT and RT alone DOI: http://dx.doi.org/10.2147/OTT.S108989",Non-OADS,/arxiv_data1/oa_pdf/ce/83/ott-9-5117.PMC4993403.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/83/ott-9-5117.PMC4993403.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/83/ott-9-5117.PMC4993403.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 133–143Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  133 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S107852Integrating diet and exercise into care of prostate  cancer patients on androgen deprivation therapy Mark A Moyad1 Robert U Newton2 Ulf W T unn3 Damian Gruca4 1Department of Urology, University  of Michigan Medical Center, Ann  Arbor, MI, USA; 2Exercise Medicine  Research Institute, Edith Cowan University, Joondalup, WA, Australia;   3Urological Clinic, Facharztzentrum  Academic Hospital Sana Klinikum Offenbach, Offenbach/Main,  4Global  Medical Affairs, AbbVie Deutschland,  Ludwigshafen, GermanyAbstract:  Improved diagnosis and treatment regimens have resulted in greater longevity for  men with prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
"3–8 Indeed, over a third of the roughly 3 million men in the  USA presently diagnosed with prostate cancer have received or are receiving ADT.2  Although ADT has been found to improve the overall survival, it is also associated with Correspondence: Mark A Moyad  Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0330, USATel +1 734 998 6078Fax +1 734 936 9127Email moyad@umich.eduJournal name: Research and Reports in Urology Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Moyad et alRunning head recto: Diet and exercise for patients on ADTDOI: http://dx.doi.org/10.2147/RRU.S107852",Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm229986.htm.,Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 143 Diet and exercise for patients on ADT  70.,Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
Available from: https://uroweb.org/.../1607-Prostate-Cancer_LRV3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
Available from: http://www.fda.gov/SiteIndex/ucm108351.htm.,Non-OADS,/arxiv_data1/oa_pdf/25/df/rru-8-133.PMC4993404.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 111–118Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 111 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S94264 E-cigarettes for the management of nicotine  addiction Oliver Knight-West   Christopher Bullen The National Institute for Health  Innovation, School of Population Health, The University of Auckland,  Auckland, New ZealandAbstract:  In this review, we discuss current evidence on electronic cigarettes (ECs), a rapidly  evolving class of nicotine delivery system, and their role in managing nicotine addiction, spe- cifically in helping smokers to quit smoking and/or reduce the amount of tobacco they smoke.",Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
"In the UK, the number of current  EC users increased from ~400,000 in 2010 to 800,000 in 2012 and to 2.6 million by 2015, 1–3 such that they have replaced nicotine replacement treatment (NRT) as the  most popular alternative to smoking for people trying to quit.2 Remarkably, ECs are  also contributing to a decline in the sales of conventional tobacco cigarettes.4 There is  also considerable product diversity: >460 EC brands and tens of thousands of liquid flavors were available in 2013, 5 and this is likely to have grown since then.Correspondence: Christopher Bullen   The National Institute for Health  Innovation, School of Population Health, The University of Auckland, Private Bag 92019, AMC, Auckland 1142, New ZealandEmail c.bullen@auckland.ac.nzJournal name: Substance Abuse and Rehabilitation Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Knight-West and BullenRunning head recto: ECs in managing nicotine addictionDOI: http://dx.doi.org/10.2147/SAR.S94264",Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
Available from: http://www.ash.org.uk/files/documents/ASH_891.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
Available from: http://www.journalnow.com/business/business_news/local/analyst-projection-e-cigs-will-overtake-traditional-tobacco-revenue-at/article_948674ca-1ca9-11e3-a0ae-0019bb30f31a.html.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
Available from: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm172906.htm.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 118 Knight-West and Bullen,Non-OADS,/arxiv_data1/oa_pdf/df/8b/sar-7-111.PMC4993405.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/31/opth-10-1557.PMC4993406.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1557–1564Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1557Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9974 6 Ab interno trabeculectomy: patient selection  and perspectives Kateki vinod Steven J Gedde Bascom Palmer eye institute,   University of Miami Miller School  of Medicine, Miami, FL, USAAbstract:  Ab interno trabeculectomy is one among several recently introduced minimally  invasive glaucoma surgeries that avoid a conjunctival incision and full-thickness sclerostomy  involved in traditional glaucoma surgery.",Non-OADS,/arxiv_data1/oa_pdf/30/31/opth-10-1557.PMC4993406.pdf
"After  positioning the patient’s head and operating microscope to facilitate visualization of  the nasal angle with a gonioscopy lens, the electrode tip is introduced into the anterior Correspondence: Steven J Gedde Bascom Palmer eye institute, University  of Miami Miller School of Medicine,  900 Nw 17th Street, Miami,   FL 33136, USA email sgedde@med.miami.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Vinod and Gedde Running head recto: Ab interno trabeculectomy DOI: http://dx.doi.org/10.2147/OPTH.S99746",Non-OADS,/arxiv_data1/oa_pdf/30/31/opth-10-1557.PMC4993406.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/30/31/opth-10-1557.PMC4993406.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/31/opth-10-1557.PMC4993406.pdf
"Kooiker at m.kooiker@erasmusmc.nl URL: http://www.jove.com/video/54031 DOI: doi:10.3791/54031 Keywords: Behavior, Issue 113, Remote eye tracking, reaction time, fixation duration, fixation accuracy, preferential looking, cerebral visual impairment, visual information processing, visual profile, children Date Published: 7/9/2016 Citation: Kooiker, M.J., Pel, J.J., van der Steen-Kant, S.P., van der Steen, J.",Non-OADS,/arxiv_data1/oa_pdf/98/a9/jove-113-54031.PMC4993407.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/54031/ Introduction The prevalence of brain damage-related visual problems in children has increased.,Non-OADS,/arxiv_data1/oa_pdf/98/a9/jove-113-54031.PMC4993407.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2016:9 85–87Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  85 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S111666Comments on Lucire and Crotty, 2011 Anton JM Loonen1 Robbert-Jan Verkes2 1Pharmacotherapy of Psychiatric  Patients, University of Groningen,   Groningen, the Netherlands; 2Forensic  Psychiatry, Radboud University,  Nijmegen, the NetherlandsDear editor In a recent article, Y olande Lucire and Christopher Crotty presented their findings in an  ongoing naturalistic study concerning a possible relationship between variant alleles in three CYP450 genes and a variety of behavioral problems.",Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
4. http://www.rechtspraak.nl [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"Dutch.Correspondence: Anton JM Loonen Pharmacotherapy of Psychiatric Patients, University of Groningen, 9712 CP Groningen, the NetherlandsEmail a.j.m.loonen@rug.nlJournal name: Pharmacogenomics and Personalized Medicine Article Designation: LETTERY ear: 2016V olume: 9Running head verso: Loonen and VerkesRunning head recto: Comments on Lucire and Crotty, 2011DOI: http://dx.doi.org/10.2147/PGPM.S111666",Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"Pharmacogenomics and Personalized Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 87 Comments on Lucire and Crotty, 2011 others who saw him before it developed.",Non-OADS,/arxiv_data1/oa_pdf/01/fc/pgpm-9-085.PMC4993408.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5081–5090OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10634 5 The clinicopathological significance of hMLH1   hypermethylation in non-small-cell lung cancer:  a meta-analysis and literature review Yi han Kang shi shi-Jie Zhou Da-Ping Yu Zhi-Dong liu Department of Thoracic Surgery,   Beijing Chest Hospital, Capital  Medical University, Beijing, People’s  Republic of ChinaAbstract:  The hMLH1  gene plays an essential role in DNA repair.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"The hMLH1  (human correspondence: Zhi-Dong liu Department of Thoracic Surgery,  Beijing Chest Hospital, Capital  Medical University, No 97 Machang,  Tongzhou, Beijing 101149,  People’s Republic of China Tel +86 10 8950 9359 email z hidongliu@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Han et al Running head recto: Clinicopathological significance of hMLH1  hypermethylation in NSCLC  DOI: http://dx.doi.org/10.2147/OTT.S106345",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"Briefly, hMLH1 gene was entered into the database  (http://kmplot.com/breast /) to obtain Kaplan–Meier survival  plots where the number-at-risk is indicated below the main  plot.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"Notes:  This assessment of clinical relevance was further corroborated in a patient  survival analysis using an online database containing the expression of 22,277 genes  and 20-year survival information of 1,928 lung cancer patients ( http://www.kmplot.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"       ([SUHVVLRQ+5 ± /RJUDQN 3 H±    7LPHPRQWKV3UREDELOLW\ 1XPEHUDWULVN /RZ +LJK    +LJK /RZ (http://www.kmplot.com/analysis /).27 hMLH1  downregula - tion was found to correlated strongly with poor OS for all  lung cancer patients followed for 20 years (Figure 7, HR  0.74 [95% CI 0.65–0.84], P=2.6e–06).",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/e7/ott-9-5081.PMC4993409.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 107–109Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 107 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S69715 Primary care for opioid use disorder Paolo Mannelli1 Li-Tzy Wu1–4 1Department of Psychiatry and  Behavioral Sciences, 2Department of  Medicine, 3Duke Clinical Research  Institute, Duke University Medical  Center, 4Center for Child and Family  Policy, Sanford School of Public Policy,  Duke University, Durham, NC, USARecent reports on prescription opioid misuse and abuse have described unprecedented  peaks of a national crisis and the only answer is to expand prevention and treatment, including different levels of care.",Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
"In some areas of the US, there are less than three  prescribers Correspondence: Paolo Mannelli Duke University Medical Center, 2213 Elba Street, Suite 156, DUMC 3074, Durham, NC 27705, USATel +1 919 668 3757Fax +1 919 668 5418Email paolo.mannelli@duke.edu Li-Tzy Wu Department of Psychiatry and Behavioral Sciences, Psychiatry Box 3903, Duke University Medical Center, Durham, NC 27710, USAEmail litzy.wu@duke.eduJournal name: Substance Abuse and Rehabilitation Article Designation: EDITORIALY ear: 2016V olume: 7Running head verso: Mannelli and WuRunning head recto: Opioid use disorderDOI: http://dx.doi.org/10.2147/SAR.S69715",Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 109 Opioid use disorder Disclosure Paolo Mannelli has received research funding from Orexo  and Alkermes Inc and has served on a Scientific Advisory Board for Alkermes Inc.,Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
Available from: http://pcssmat.org/.,Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm503719.htm.,Non-OADS,/arxiv_data1/oa_pdf/97/89/sar-7-107.PMC4993411.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1565–1571Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1565Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11240 3 argus ii retinal prosthesis implantation with  scleral flap and autogenous temporalis fascia as  alternative patch graft material: a 4-year follow-up alexandre Matet1,2 nawel amar1,2 Saddek Mohand-Said1–4 José-Alain Sahel1–7 Pierre-Olivier Barale1,2 1inser M and D hOs, ChnO des  Quinze-Vingts, 2sorbonne Universités,   UPMC Univ Paris 6, institut de la  Vision, 3inserM, 4Cnrs, Paris,   France; 5Institute of Ophthalmology,   University College london, london,   UK; 6Fondation Ophtalmologique  adolphe de rothschild, 7académie  des sciences, institut de France,   Paris,  FranceIntroduction:  The Argus II retinal prosthesis is composed of an epiretinal electrode array positioned  over the macula and connected to an extrascleral electronics case via a silicone cable, running through  a sclerotomy.",Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
"In several countries, includ - ing Germany, the Netherlands, UK, Spain, Italy, France, Switzerland, Saudi Arabia,  the US, and Canada, patients presenting end-stage retinitis pigmentosa but maintain - ing a functional inner retinal circuitry are potential candidates for implantation.1  A 30-participant prospective study2,3 and additional investigations demonstrated  visual and behavioral improvement in a majority of implanted subjects after visual  rehabilitation.4–8 The retinal prosthesis consists of an electrode array placed on the Correspondence: Pierre-Olivier Barale CHNO des Quinze-Vingts, 28 rue  de Charenton, F-75012 Paris, France Tel +33 1 40 02 14 04 Fax +33 1 40 02 14 45 email pobarale@wanadoo.f r Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Matet et al Running head recto: Modified technique for retinal prosthesis implantation DOI: http://dx.doi.org/10.2147/OPTH.S112403",Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
Available from: http://www.secondsight.com/system-overview-en.html .,Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
Available from: http://www.secondsight.,Non-OADS,/arxiv_data1/oa_pdf/f1/03/opth-10-1565.PMC4993412.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2016 |  113  | e54193 | Page 1 of 7Video Article Microfluidic Pneumatic Cages: A Novel Approach for In-chip Crystal Trapping, Manipulation and Controlled Chemical Treatment Afshin Abrishamkar1,2, Markos Paradinas3, Elena Bailo4, Romen Rodriguez-Trujillo5, Raphael Pfattner5, René M. Rossi1, Carmen Ocal5, Andrew J. deMello2, David B. Amabilino6, Josep Puigmartí-Luis1 1Empa - Swiss Federal Laboratories for Materials Science and Technology 2Institute of Chemical and Bioengineering, Department of Chemistry and Applied Bioscience, ETH Zurich 3ICN2-Institut Catala de Nanociencia i Nanotecnologia 4WITec GmbH 5Institut de Ciència de Materials de Barcelona 6School of Chemistry, The University of Nottingham Correspondence to: Josep Puigmartí-Luis at Josep.Puigmarti@empa.ch URL: http://www.jove.com/video/54193 DOI: doi:10.3791/54193 Keywords: Chemistry, Issue 113, Controlled chemical treatment, Double-layer chips, Microfluidics, Micro-valves, Pneumatic cages, Self-assembly, Chemical engineering Date Published: 7/12/2016 Citation: Abrishamkar, A., Paradinas, M., Bailo, E., Rodriguez-Trujillo, R., Pfattner, R., Rossi, R.M., Ocal, C., deMello, A.J., Amabilino, D.B., Puigmartí-Luis, J. Microfluidic Pneumatic Cages: A Novel Approach for In-chip Crystal Trapping, Manipulation and Controlled Chemical Treatment.",Non-OADS,/arxiv_data1/oa_pdf/05/f0/jove-113-54193.PMC4993413.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/54193/ Introduction Molecular materials have long been studied in the scientific community because of their broad number of applications in fields such as molecular electronics, optics and sensors1-4.",Non-OADS,/arxiv_data1/oa_pdf/05/f0/jove-113-54193.PMC4993413.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 211–218Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 211 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S112129 Psychological distress, perceived stigma, and  coping among caregivers of patients with  schizophrenia Hui Chien Ong¹ Norhayati Ibrahim² Suzaily Wahab³ ¹Biomedical Science Programme,   ²Health Psychology Programme,  Faculty of Health Sciences, Universiti Kebangsaan Malaysia, ³Department of Psychiatry, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur,  MalaysiaAbstract:  Nowadays, family members are gradually taking on the role of full-time caregivers  for patients suffering from schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
"Magaña et al10 found that perceived stigma and symptoms of depression among Correspondence: Norhayati Ibrahim Health Psychology Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda A. Aziz, 50300 Kuala Lumpur, MalaysiaTel +603 2687 8174Fax +603 2687 8192Email norhayati70@gmail.comJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ong et alRunning head recto: Distress, stigma, and coping among caregiversDOI: http://dx.doi.org/10.2147/PRBM.S112129",Non-OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
Available from   https://www2.health.vic.gov.au/getfile/?sc_itemid=%7BF5D69CF4-83FF- 4EC2-9610-9AC1F63F1407%7D&title=Victorian%20population%20health%20survey%202001%3A%20Selected%20findings.33.,Non-OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/d8/77/prbm-9-211.PMC4993414.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Hypnotic effect of the essential oil from the leaves  of Myrtus communis  on mice Muluken Walle Birhanie1 Bizuayehu Walle1 Kidist Rebba2 1Department of Physiology,   2Department of Nursing, College of  Medicine and Health Sciences, Bahir  Dar University, Bahir Dar, Ethiopia Correspondence: Muluken Walle Birhanie   Department of Physiology, College of  Medicine and Health Sciences, Bahir Dar  University, P .O.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
Available from: http://www.desert-tropicals.com.,Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
"Available from: http://www.organicfacts.net/health-benefits/ essential-oils/myrtle-essential-oil.htm l. Assessed on April 24, 2016.",OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
http://aromatherapy.com/article.cfm/myrtle_essential_oil.,Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/51/nss-8-267.PMC4993415.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/tcrm-12-1261.PMC4993416.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1261–1270Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1261Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10296 6 Clinical management of a challenging malignancy,  osteoblastoma-like osteosarcoma: a report of  four cases and a review of the literature Harzem Ozger1 Bugra alpan1 Mehmet salih söylemez2 Korhan Ozkan3 ahmet salduz4 Bilge Bilgic5 Basak Kumbasar sirin6 1Department of Orthopaedics and  Traumatology, Maslak Acıbadem  Hospital, istanbul, 2Department of  Orthopaedics and Traumatology,   Bingöl state Hospital, Bingöl,   3Department of Orthopaedics and  Traumatology, Faculty of Medicine,   istanbul Medeniyet University,   4Department of Orthopaedics  and Traumatology, 5Department  of Pathology, Faculty of Medicine,   istanbul University, 6Department of  Radiology, Maslak Acıbadem Hospital,   istanbul, T urkeyAbstract:  Osteoblastoma-like osteosarcoma, a rare form of osteosarcoma, is a malignant lesion  associated with risks of both local recurrence and distant metastasis.",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/tcrm-12-1261.PMC4993416.pdf
"The Institutional  Review Board of Acibadem University, Faculty of Medicine deemed it unnecessary  to obtain ethics approval for this case series because treatment modalities performed Correspondence: Mehmet salih söylemez Department of Orthopaedics and  Traumatology, Bingöl state Hospital,  Kültür Mahallesi, Oguzhan Caddesi  No 22, 12000 Bingöl, Turkey email slhsylmz@gmail.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Case Series Y ear: 2016 Volume: 12 Running head verso: Ozger et al Running head recto: Clinical management of osteoblastoma-like osteosarcoma DOI: http://dx.doi.org/10.2147/TCRM.S102966",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/tcrm-12-1261.PMC4993416.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c8/4d/tcrm-12-1261.PMC4993416.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/4d/tcrm-12-1261.PMC4993416.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/88/tcrm-12-1239.PMC4993417.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1239–1247Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1239ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10778 3 investigation of cerebral iron deposition in aged  patients with ischemic cerebrovascular disease  using susceptibility-weighted imaging Yin liu Jun liu huanghui liu Yunjie liao lu Cao Bin Ye Wei Wang Department of Radiology,   The Third Xiangya hospital,   Central south University,   Changsha, hunan, People’s  Republic of ChinaObjective:  The aim of this study was to investigate focal iron deposition level in the brain in  patients with ischemic cerebrovascular disease and its correlation with cerebral small vessel  disease imaging markers.",Non-OADS,/arxiv_data1/oa_pdf/21/88/tcrm-12-1239.PMC4993417.pdf
"Unlike other hemoglobin  degradation products, hemosiderin is formed within secondary lysosomes8 and may be Correspondence: Wei Wang Department of Radiology, The Third  Xiangya hospital, Central south  University, Tongzipo Road 138, Changsha,  hunan 410013, People’s Republic  of China Tel/fax +86 731 8861 8411 email cjr.wangwei@vip.163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Liu et al Running head recto: Cerebral iron deposition in ischemic cerebrovascular disease DOI: http://dx.doi.org/10.2147/TCRM.S107783",Non-OADS,/arxiv_data1/oa_pdf/21/88/tcrm-12-1239.PMC4993417.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/21/88/tcrm-12-1239.PMC4993417.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/88/tcrm-12-1239.PMC4993417.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1535–1541Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1535Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11164 8 Direct ophthalmoscopy on Y ouT ube: analysis  of instructional Y ouT ube videos’ content and  approach to visualization nanna Jo Borgersen1–3 Mikael Johannes Vuokko  henriksen2,3 lars Konge2,3 T orben lykke sørensen1,3 ann sofia skou Thomsen2–4 Y ousif subhi1,3 1Department of Ophthalmology,   Zealand University hospital, roskilde,   2Copenhagen academy for Medical  education and simulation, the Capital  region of Denmark, 3Faculty of health  and Medical sciences, University  of Copenhagen, 4Department  of Ophthalmology, Copenhagen  University hospital rigshospitalet,   Copenhagen, DenmarkBackground:  Direct ophthalmoscopy is well-suited for video-based instruction, particularly  if the videos enable the student to see what the examiner sees when performing direct ophthal - moscopy.",Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
"Table 2  YouTube videos included in this study https://www.youtube.com/watch?v=ne_ephjnpf o https://www.youtube.com/watch?v=leMexvs9hV U https://www.youtube.com/watch?v=PUz2hlromx Y https://www.youtube.com/watch?v=wPzCa9k8gr Q https://www.youtube.com/watch?v=-7sh2h1jgU U https://www.youtube.com/watch?v=azxngz1cjg i https://www.youtube.com/watch?v=bhP2rn4W-p M https://www.youtube.com/watch?v=D7lyv0oTjV 0 https://www.youtube.com/watch?v=9xxTninsrF s https://www.youtube.com/watch?v=7lhvhKvK_i M https://www.youtube.com/watch?v=autUi09JiX Y https://www.youtube.com/watch?v=tTU2jiWhpJ Q https://www.youtube.com/watch?v=7Uha40rUip M https://www.youtube.com/watch?v=czw_8fWlib e https://www.youtube.com/watch?v=2s8nUBds8K c https://www.youtube.com/watch?v= Kyrfe4ub2q g https://www.youtube.com/watch?v=yhDm8llF-z 4 https://www.youtube.com/watch?v=-iVsQ1zaoa Q https://www.youtube.com/watch?v=-iuumsgWo6 k https://www.youtube.com/watch?v=5lvUmOFOsg a https://www.youtube.com/watch?v=xomOeqw-lD k https://www.youtube.com/watch?v =KidtiY7mwj k https://www.youtube.com/watch?v=4zafhf5Y4e M https://www.youtube.com/watch?v=vg8n3ZCr80 Q https://www.youtube.com/watch?v=34z5Q0z8oc g https://www.youtube.com/watch?v=Um8csYmoyw 8 https://www.youtube.com/watch?v=sjgy4TwT5V kTable 3  summary of video statistics based on YouTube data Median Interquartile   rangeRange Duration, seconds 213 98–357 23–717 ratings1 Positive, n 20 1–56 0–640 negative, n 0 0–2 0–14 Total views, n 11,636 579–54,022 19–196,519 available online, days 1,634 577–2,783 30–3,176 Views per week, n 43 12–213 2–857 Note:  1ratings were disabled by the uploader in one video.Figure 1 selection of eligible YouTube videos for the study.9LGHRVLGHQWLILHGXVLQJVHDUFKDOJRULWKP Q  9LGHRVVFUHHQHGXVLQJWLWOHDQGGHVFULSWLRQ Q ,UUHOHYDQWYLGHRVH[FOXGHGQ  9LGHRVH[FOXGHGQ  ±1RWLQVWUXFWLRQDOQ  ±'XSOLFDWHQ  ±1RWGLUHFWRSKWKDOPRVFRS\Q  ±1RW(QJOLVKQ 9LGHRVYLHZHGLQIXOOIRUHOLJLELOLW\DVVHVVPHQW Q  9LGHRVGHHPHGHOLJLEOHDQGLQFOXGHG Q ",Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
Available from:  https://www.sireninteractive.com/sirensong/new-data-on-physicians- search-youtube /.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/opth-10-1535.PMC4993418.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5101–5116OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5101Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11120 9 immune checkpoint inhibitors: the new frontier  in non-small-cell lung cancer treatment Hazem el-Osta Kamran Shahid Glenn M Mills Prakash Peddi Department of Medicine, Division of  Hematology-Oncology, Louisiana State  University Health Sciences Center,   Shreveport, LA, USAAbstract:  Lung cancer is the major cause for cancer-related death in the US.",Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
"Available from: http://seer.cancer.gov/statfacts/ html/lungb.htm l. Accessed August 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
"Available  from: http://packageinserts.bms.com/pi/pi_yervoy.pd f. Accessed:  August 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/b8/ott-9-5101.PMC4993420.pdf
"16, 2102 –2107 http://dx.doi.org/10.1080/15384101.2016.1189044",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Acta Neu- ropathol 2012; 123:465-72; PMID:22134537; http://dx.doi.org/10.1007/s00401-011-0922-z [2] Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, North- cott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Acta Neu- ropathol 2012; 123:473-84; PMID:22358457; http://dx.doi.org/ 10.1007/s00401-012-0958-8 [3] Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cancer Cell 2014; 25:393-405;PMID:24651015; http://dx.doi.org/10.1016/j.ccr.2014.02.004 [4] Adesina AM, Nalbantoglu J, Cavenee WK.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Science 2011; 331:435-9; PMID:21163964; http://dx.doi.org/10.1126/science.1198056 [7] Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"J Clin Oncol 2013; 31:2927-35; PMID:23835706; http://dx.doi.org/ 10.1200/JCO.2012.48.5052 [8] Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nature 2016; 529:351-7; PMID:26760213; http://dx.doi.org/10.1038/nature16478 [9] Hill RM, Kuijper S, Lindsey JC, Petrie K, Schwalbe EC, Barker K, Boult JK, Williamson D, Ahmad Z, Hallsworth A, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
Cancer Cell 2015; 27:72-84; PMID:25533335; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cell 2012; 148:59-71; PMID:22265402; http://dx.doi.org/10.1016/j.cell.2011.12.013 [13] Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, Huynh TT, Lin SM, Wechsler-Reya RJ.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Development 2005; 132:2425-39; PMID:15843415; http://dx.doi.org/ 10.1242/dev.01793 [14] Schuller U, Heine VM, Mao J, Kho AT, Dillon AK, Han YG, Huillard E, Sun T, Ligon AH, Qian Y, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cancer cell 2008; 14:123-34;PMID:18691547; http://dx.doi.org/10.1016/j.ccr.2008.07.005 [15] Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, Schuller U, Machold R, Fishell G, Rowitch DH, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cancer Cell 2008; 14:135-45; PMID:18691548; http://dx.doi.org/10.1016/j.ccr.2008.07.003 [16] Jones MJ, Jallepalli PV.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Dev Cell 2012; 23:908-17; PMID:23153487; http://dx.doi.org/10.1016/j.devcel.2012.10.010 [17] Wechsler-Reya RJ, Scott MP.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Neuron 1999; 22:103-14;PMID:10027293; http://dx.doi.org/10.1016/S0896-6273(00)80682-0 [18] Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bron- son RT, Weinberg RA.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Curr Biol 1994; 4:1-7; PMID:7922305; http://dx.doi.org/10.1016/S0960-9822(00)00002-6 [19] Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. Mutant p53 gain of function in two mouse mod-els of Li-Fraumeni syndrome.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cell 2004; 119:847-60;PMID:15607980; http://dx.doi.org/10.1016/j.cell.2004.11.004 [20] Frappart PO, Lee Y, Russell HR, Chalhoub N, Wang YD, Orii KE, Zhao J, Kondo N, Baker SJ, McKinnon PJ.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cell 1990; 61:759-67; PMID:2188735; http://dx.doi.org/10.1016/ 0092-8674(90)90186-I [23] Mille F, Tamayo-Orrego L, Levesque M, Remke M, Korshunov A, Cardin J, Bouchard N, Izzi L, Kool M, Northcott PA, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Dev Cell 2014; 31:34-47; PMID:25263791; http://dx.doi.org/10.1016/j.devcel.2014.08.010[24] Campisi J, d ’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nat Rev Mol Cell Biol 2007; 8:729-40;PMID:17667954; http://dx.doi.org/10.1038/nrm2233 [25] Itahana K, Dimri G, Campisi J.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"EMBO J 2003; 22:4212-22; PMID:12912919;http://dx.doi.org/10.1093/emboj/cdg417 [27] Tamayo-Orrego L, Wu CL, Bouchard N, Khedher A, Swikert SM, Remke M, Skowron P, Taylor MD, Charron F. Evasion of cell senes- cence leads to medulloblastoma progression.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cell Rep 2016; 14:2925-37; PMID:26997276; http://dx.doi.org/10.1016/j.celrep.2016.02.061 [28] He X, Zhang L, Chen Y, Remke M, Shih D, Lu F, Wang H, Deng Y, Yu Y, Xia Y, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nat Med 2014;20:1035-42; PMID:25150496; http://dx.doi.org/10.1038/nm.3666 [29] Dahmane N, Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Curr Biol 1999; 9:445-8; PMID:10226030; http://dx.doi.org/10.1016/S0960-9822(99)80195-X [31] Lai K, Kaspar BK, Gage FH, Schaffer DV.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nat Neuro- sci 2003; 6:21-7; PMID:12469128; http://dx.doi.org/10.1038/nn983 [32] Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J. p53 suppresses the self-renewal of adult neural stem cells.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Development 2006; 133:363-9; PMID:16368933; http://dx.doi.org/10.1242/ dev.02208 [33] Kippin TE, Martens DJ, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Genes Dev 2005; 19:756-67; PMID:15769947; http://dx.doi.org/10.1101/gad.1272305 [34] Louis JM, McFarland VW, May P, Mora PT.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Biochim Biophys Acta 1988; 950:395-402;PMID:3048409; http://dx.doi.org/10.1016/0167-4781(88)90136-4 [35] Stecca B, Ruiz i Altaba A.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"EMBO J 2009; 28:663-76; PMID:19214186; http://dx.doi.org/10.1038/emboj.2009.16 [36] Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, Oren M, Tanaka N. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"PloS One 2011; 6:e17884; PMID:21437245; http://dx.doi.org/10.1371/journal.pone.0017884 [38] Castellino RC, De Bortoli M, Lu X, Moon SH, Nguyen TA, Shepard MA, Rao PH, Donehower LA, Kim JY.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"J Neurooncol2008; 86:245-56; PMID:17932621; http://dx.doi.org/10.1007/s11060- 007-9470-8 [39] Doucette TA, Yang Y, Pedone C, Kim JY, Dubuc A, Northcott PD, Taylor MD, Fults DW, Rao G. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Neurosurgery 2012; 70:1003-10; discussion 10; PMID:22037313; http://dx.doi.org/10.1227/NEU.0b013e31823e5332 [40] Wetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accel- erates medulloblastoma in mice heterozygous for patched.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nat Neurosci 2013; 16:1523-9; PMID:24165679; http://dx.doi.org/ 10.1038/nn.3537 [42] Narita M, Lowe SW. Senescence comes of age.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
Nat Med 2005; 11:920-2; PMID:16145569; http://dx.doi.org/10.1038/nm0905-9202106 L. TAMAYO-ORREGO ET AL.,OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
Nature 2006; 444:633-7;PMID:17136093; http://dx.doi.org/10.1038/nature05268 [45] d ’Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response.,OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nat Rev Cancer 2008; 8:512-22; PMID:18574463; http://dx.doi.org/10.1038/nrc2440 [46] Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nature 2005; 436:725-30; PMID:16079851; http://dx.doi.org/10.1038/nature03918 [47] Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K. A negative feedback signaling network underlies onco-gene-induced senescence.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Cancer Cell 2006; 10:459-72; PMID:17157787; http://dx.doi.org/10.1016/j.ccr.2006.10.003 [48] Damalas A, Ben-Ze ’ev A, Simcha I, Shtutman M, Leal JF, Zhur- insky J, Geiger B, Oren M. Excess b-catenin promotes accumula- tion of transcriptionally acti ve p53.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"EMBO J 1999; 18:3054-63; PMID:10357817; http://dx.doi.org/10.1093/emboj/18.11.3054 [49] Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Mol Cell Biol 2008; 28:1713-23; PMID:18160717; http://dx.doi.org/10.1128/MCB.01360-07 [52] Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
Sub-types of medulloblastoma have distinct developmental origins.Nature 2010; 468:1095-9; PMID:21150899; http://dx.doi.org/ 10.1038/nature09587 [53] Cancer Genome Atlas Research N. Comprehensive genomic charac- terization de ﬁnes human glioblastoma genes and core pathways.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Nature 2008; 455:1061-8; PMID:18772890; http://dx.doi.org/ 10.1038/nature07385 [54] Bartkova J, Hamerlik P, Stockhausen MT, Ehrmann J, Hlobilkova A, Laursen H, Kalita O, Kolar Z, Poulsen HS, Broholm H, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Oncogene 2010; 29:5095-102; PMID:20581868; http://dx.doi.org/10.1038/onc.2010.249 [55] Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"Can-cer Cell 2010; 18:619-29; PMID:21156285; http://dx.doi.org/10.1016/ j.ccr.2010.10.034 [56] Jacob K, Quang-Khuong DA, Jones DT, Witt H, Lambert S, Albrecht S, Witt O, Vezina C, Shirinian M, Faury D, et al.",OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
Clin Cancer Res 2011; 17:4650-60; PMID:21610151; http://dx.doi.org/10.1158/1078-0432.CCR-11-0127CELL CYCLE 2107,Non-OADS,/arxiv_data1/oa_pdf/07/0e/kccy-15-16-1189044.PMC4993422.pdf
"16, 2145 –2156 http://dx.doi.org/10.1080/15384101.2016.1195531",Non-OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Can- cer Sci 2009; 100:2115-25; PMID:19709076; http://dx.doi.org/ 10.1111/j.1349-7006.2009.01282.x [3] Wang HF, Takenaka K, Nakanishi A, Miki Y. BRCA2 and nucleo- phosmin coregulate centrosome ampli ﬁcation and form a complex with the rho effector kinase ROCK2.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Cancer Res 2011; 71:68-77;PMID:21084279; http://dx.doi.org/10.1158/0008-5472.CAN-10-0030 [4] Nakanishi A, Han X, Saito H, Taguchi K, Ohta Y, Imajoh-Ohmi S, Miki Y.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Bio-chem Biophys Res Commun 2007; 355:34-40; PMID:17286961;http://dx.doi.org/10.1016/j.bbrc.2007.01.100 [5] Matsumoto Y, Maller JL.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
Science 2004;306:885-8; PMID:15514162; http://dx.doi.org/306/5697/885.,OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Proc Natl Acad SciU S A 2010; 107:2932-7; PMID:20133761; http://dx.doi.org/ 10.1073/pnas.0914874107 [7] Tynan SH, Gee MA, Vallee RB.",Non-OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"J Biol Chem 2000; 275:32769-74; PMID:10893223; http://dx.doi.org/10.1074/jbc.M001537200 [8] Schroeder CM, Ostrem JM, Hertz NT, Vale RD.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Elife 2014; 3:e03351; PMID:25272277; http://dx.doi.org/10.7554/eLife.03351 [9] Tynan SH, Purohit A, Doxsey SJ, Vallee RB.",Non-OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"J Biol Chem 2000; 275:32763-8; PMID:10893222;http://dx.doi.org/10.1074/jbc.M001536200 [10] Schmoranzer J, Fawcett JP, Segura M, Tan S, Vallee RB, Pawson T, Gundersen GG.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
CurrBiol 2009; 19:1065-74; PMID:19540120; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
Curr Opin Cell Biol 1999; 11:45-53; PMID:10047518; http://dx.doi.org/S0955-0674(99)80006-4.,OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Mol Biol Cell 2006; 17:1033-40; PMID:16339073; http://dx.doi.org/10.1091/mbc.E05-10-0943 [14] Fry AM, Mayor T, Meraldi P, Stierhof YD, Tanaka K, Nigg EA.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"J Cell Biol 2005; 171:27-33; PMID:16203858; http://dx.doi.org/ 10.1083/jcb.200504107 [17] Mardin BR, Lange C, Baxter JE, Hardy T, Scholz SR, Fry AM, Schie- bel E. Components of the hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Nat Cell Biol 2010; 12:1166-76; PMID:21076410; http://dx.doi.org/10.1038/ncb2120 [18] Kim D, You E, Rhee S. Dynein regulates cell migration depending on substrate rigidity.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Int J Mol Med 2012; 29(3):440-6; PMID:22200735; http://dx.doi.org/10.3892/ijmm.2011.867 [19] Yang J, Adamian M, Li T. Rootletin interacts with C-Nap1 and may function as a physical linker between the pair of centrioles/basalbodies in cells.",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"Mol Biol Cell 2006; 17:1033-40; PMID:16339073; http://dx.doi.org/10.1091/mbc.E05-10-0943 [20] Wali N, Hosokawa K, Malik S, Saito H, Miyaguchi K, Imajoh-Ohmi S, Miki Y, Nakanishi A. Centrosomal BRCA2 is a target protein ofmembrane type-1 matrix metalloproteinase (MT1-MMP).",OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
J Cell Biol 2006; 174:625-30; PMID:16943179; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/f3/kccy-15-16-1195531.PMC4993541.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 405–419International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  405OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11007 2 exploring australian women’s level of nutrition  knowledge during pregnancy: a cross-sectional  study Khlood Bookari1 Heather Yeatman1 Moira Williamson2,3 1school of Health and society, Faculty  of social sciences, 2school of n ursing,   Faculty of science, Medicine and  Health, University of Wollongong,   Wollongong, nsW, 3school of n ursing  and Midwifery, Higher education  Division, central Queensland  University, noosaville, QlD, australiaBackground:  The Australian Guide to Healthy Eating (AGHE) for pregnancy provides a  number of food- and nutrition-related recommendations to assist pregnant women in optimiz - ing their dietary behavior.",Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
"Poor diet places  women at a higher risk of unhealthy gestational weight gain,1 which can negatively  impact mothers’ and babies’ health, causing a range of poor maternal and infant  outcomes.2 Exposure of the unborn baby to maternal obesity, diabetes, and excessive  gestational weight gain can increase his/her risk of developing childhood obesity and correspondence: Khlood Bookari school of Health and society, Faculty  of social sciences, University of  Wollongong, Northfields Avenue,  Wollongong, nsW 2522, australia email kb391@uowmail.edu.a u Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Bookari et al Running head recto: Australian women’s level of nutrition knowledge during pregnancy DOI: http://dx.doi.org/10.2147/IJWH.S110072",Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
"Available from:  http://www.sciencedirect.com/science/article/pii/S187151921630049 X.  Accessed June 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
Available from: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
Available from: https://www.betterhealth.vic.,Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
Avail - able from: http://paleoleap.com/paleo-guide-to-pregnancy /.,Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/58/ijwh-8-405.PMC4993554.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/88/ndt-12-2063.PMC4993555.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2063–2072Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2063OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10950 4 Mental health care use in medically unexplained  and explained physical symptoms: findings from a  general population study Jonna F van eck van der  sluijs,1,2 Margreet ten Have,3  cees a rijnders,4 harm  WJ van Marwijk,5,6 ron de  Graaf,3 christina M van der  Feltz-cornelis1,2 1Clinical Centre of Excellence for Body,   Mind and Health, GGz Breburg, 2Tranzo  Department, Tilburg University, Tilburg,   3Netherlands Institute of Mental Health  and Addiction, Utrecht, 4Department of  Residency training, GGz Breburg, Tilburg,   the Netherlands; 5Centre for Primary Care,   Institute of Population Health, University of  Manchester, Manchester, UK; 6Department  of General Practice and Elderly Care  Medicine, EMGO Institute for Health and  Care Research, VU University Medical  centre, amsterdam, the NetherlandsObjective:  The aim of this study was to explore mental health care utilization patterns in  primary and specialized mental health care of people with unexplained or explained physical  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/ef/88/ndt-12-2063.PMC4993555.pdf
Or use: http://youtu.be/-kzbGFmaiA QVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/ef/88/ndt-12-2063.PMC4993555.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ef/88/ndt-12-2063.PMC4993555.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/88/ndt-12-2063.PMC4993555.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 291–299Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 291 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S106223 Update on bariatric surgical procedures and  an introduction to the implantable weight loss  device: the Maestro Rechargeable System Stephanie S Hwang1 Mark C Takata1 Ken Fujioka2 William Fuller1 1Division of General/Bariatric  Surgery, Scripps Clinic Weight  Management, 2Division of Diabetes  and Endocrinology, Scripps Clinic, La Jolla, CA, USAAbstract:  There are many different methods of treating obesity, ranging from various medical  options to several surgical therapies.",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
"Surgical procedures LR YGB has emerged as a durable bariatric surgical procedure since the mid-1990s,11  although its open counterpart had been performed for weight loss since the 1960s.12 Correspondence: William Fuller Division of General/Bariatric Surgery, Scripps Clinic Weight Management, 10666 N Torrey Pines Road, La Jolla, CA 92037, USATel +1 858 554 8984Fax +1 858 554 5055Email fuller.william@scrippshealth.orgJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Hwang et alRunning head recto: Update on bariatric surgical proceduresDOI: http://dx.doi.org/10.2147/MDER.S106223",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ObesityDevices/ucm350134.htm.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
Available from: http://www.cdc.gov/obesity/data/adult.html.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ObesityDe-vices/ucm350134.htm.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/mder-9-291.PMC4993556.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 421–428International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  421OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10416 0 can a community-based maternal care package in  rural ethiopia increase the use of health facilities  for childbirth and reduce the stillbirth rate?",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
"Despite this, in 2013,  just 23.1% of women had a skilled birth attendant present at the time of delivery.6  Moreover, while there have been improvements in maternal and fetal outcomes, it  has been estimated that the current maternal mortality ratio remains relatively high correspondence: Karen D Ballard Hamlin Fistula ethiopia, addis  ababa Fistula Hospital, PO Box 3609,  addis ababa, ethiopia Tel +44 7715487233 email k.ballard@surrey.ac.u kJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Atnafu et al Running head recto: Impact of maternal package in Ethiopia DOI: http://dx.doi.org/10.2147/IJWH.S104160",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
Available from:  http://www.mchip.net/sites/default/files/HSS%20and%20MNCH% 20 Framework_final .pdf.,OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
"Avail - able from: http://www.nationalplanningcycles.org/sites/default/files/ country_docs/Ethiopia/ethiopia_hsdp_iv_final_draft_2010-2015.pd f.  Accessed September 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/90/c2/ijwh-8-421.PMC4993557.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 355–363Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 355 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S108891Differences and similarities in the trajectories  of self-esteem and positive and negative affect  in persons with chronic illness: an explorative  longitudinal study T ore Bonsaksen1 Anners Lerdal2,3 Milada Cvancarova  Småstuen4 May Solveig Fagermoen3 1Department of Occupational Therapy,   Prosthetics and Orthotics, Faculty of  Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, Norway;  2Research  Department, Lovisenberg Diakonale Hospital, Oslo, Norway;  3Department  of Nursing Science, Institute of Health and Society, Faculty of Medicine,  University of Oslo, Oslo, Norway;   4Department of Nursing and Health  Promotion, Faculty of Health Sciences,  Oslo and Akershus University College of Applied Sciences, Oslo, NorwayBackground: Chronic illness is a risk factor for low self-esteem, and the research literature  needs to include more studies of self-esteem and its development in chronic illness groups using  longitudinal and comparative designs.",Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
"4–7 Correspondence: Tore Bonsaksen Department of Occupational Therapy, Prosthetics and Orthotics, Faculty of Health Sciences, Oslo and Akershus University College, PO Box 4 St Olavs Plass, Oslo 0130, Norway Tel +47 67 23 66 11Email tore.bonsaksen@hioa.noJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Bonsaksen et alRunning head recto: Self-esteem and positive and negative affect in persons with chronic illnessDOI: http://dx.doi.org/10.2147/JMDH.S108891",Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 363 Self-esteem and positive and negative affect in persons with chronic illness 16.,Non-OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
Avail-able from: http://apps.who.int/bmi/index.jsp.,OADS,/arxiv_data1/oa_pdf/64/19/jmdh-9-355.PMC4993558.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 11–19Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  11 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S110702Comprehensive kinase profile of pacritinib, a  nonmyelosuppressive Janus kinase 2 inhibitor Jack W Singer1 Suliman Al-Fayoumi1 Haiching Ma2 Rami S Komrokji3 Ruben Mesa4 Srdan Verstovsek5 1Translational Medicine, CTI  BioPharma Corp., Seattle, WA,   2Department of Research and  Development, Reaction Biology,   Malvern, PA, 3Department of  Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute,  Tampa, FL,  4Division of Hematology  and Medical Oncology, Mayo Clinic Cancer Center, Scottsdale, AZ,   5Department of Leukemia, Division of  Cancer Medicine, The University of T exas MD Anderson Cancer Center,  Houston, TX, USAAbstract: Pacritinib, potent inhibitor of Janus kinase 2 (JAK2), JAK2V617F , and fms-like  receptor tyrosine kinase 3, is in Phase III development in myelofibrosis.",Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
"Two Phase I–II studies in patients with primary or secondary myelofibrosis showed that pacritinib reduced splenomegaly Correspondence: Jack W Singer CTI BioPharma Corp., 3101 Western Ave., #600, Seattle, WA 98121, USATel +1 206 272 4405Fax +1 206 284 6206Email JSinger@ctibiopharma.comJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Singer et alRunning head recto: Kinase profile of pacritinibDOI: http://dx.doi.org/10.2147/JEP .S110702",Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
2014;124(21):1874 http://www.bloodjournal.org/content/124/21/1874.,Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/2c/jep-8-011.PMC4993559.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 371–385Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 371 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S93454Menkes disease: what a multidisciplinary   approach can do Rahul Ojha1  Asuri N Prasad1–4 1Department of Pediatrics, 2Section  of Pediatric Neurology, 3Division of  Clinical Neurological Sciences, 4Child  Health Research Institute, Schulich  School of Medicine and Dentistry,  University of Western Ontario,  London, ON, CanadaAbstract: Disorders of copper homeostasis are currently recognized across the life span.",Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
"1Correspondence: Asuri N Prasad   London Health Science Centre, B1-174  Children’s Hospital, 800 Commissioners Road East, London, ON N6A 5W9, Canada   Tel +1 519 685 8814   Fax +1 519 685 8625   Email narayan.prasad@lhsc.on.caJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Ojha and PrasadRunning head recto: Menkes disease: what a multidisciplinary approach can doDOI: http://dx.doi.org/10.2147/JMDH.S93454",Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 385 Menkes disease: what a multidisciplinary approach can do  90.,Non-OADS,/arxiv_data1/oa_pdf/68/be/jmdh-9-371.PMC4993560.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 571–585Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  571 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S106177Efficacy, safety, and tolerability of fentanyl  pectin nasal spray in patients with breakthrough  cancer pain Michael A Ueberall1 Stefan Lorenzl2 Eberhard A Lux3,4 Raymond Voltz5 Michael Perelman6 1Institute of Neurological Sciences,   Nuremberg, Germany; 2Institute  of Nursing Science and Practice,   Paracelsus Private Medical University of Salzburg, Salzburg, Austria;  3Faculty  of Medicine, Witten/Herdecke University, Witten, Germany;  4clinic  for Pain and Palliative Care Medicine, St.- Marien-Hospital, Luenen, Germany;  5Department of Palliative Medicine,   University Hospital Cologne, Cologne,  Germany;  6Archimedes Development  Ltd., Nottingham, United KingdomObjective: Assessment of analgesic effectiveness, safety, and tolerability of fentanyl pectin nasal  spray (FPNS) in the treatment of breakthrough cancer pain (BTcP) in routine clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
"1,2 The WHO three-step “ladder” approach to cancer treatment  includes the use of opioids with fixed, around-the-clock dosing in patients who do not Correspondence: Michael A Ueberall Institute of Neurological Sciences, Nordostpark 51, 90411 Nuremberg, GermanyPhone +49 911 2177 3760Fax +49 911 2177 3761Email michael.ueberall@ifnap.deJournal name: Journal of Pain Research  Article Designation: Original ResearchY ear: 2016V olume: 9Running head verso: Ueberall et alRunning head recto: Fentanyl pectin nasal spray for breakthrough cancer painDOI: http://dx.doi.org/10.2147/JPR.S106177",Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
Available from: http://www.who.int/medicines/areas/quality_safety/delphi_study_pain_ guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
Available from: http://www.who.int/cancer/palliative/painladder/en/.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 585 Fentanyl pectin nasal spray for breakthrough cancer pain  6.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
Available from: http://www.meddra.org/.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/jpr-9-571.PMC4993561.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 563–570Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  563 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S107385The effect of intra-articular vanilloid receptor  agonists on pain behavior measures in a murine  model of acute monoarthritis Mishal Abdullah1  Maren L Mahowald2  Sandra P Frizelle2  Christopher W Dorman2  Sonia C Funkenbusch2  Hollis E Krug2,3 1Department of Medicine,   Rheumatology Fellowship Training  Program, University of Minnesota Medical School,  2Department of  Medicine, Minneapolis Veterans’ Affairs Health Care System,  3Department  of Medicine, University of Minnesota Medical School, Minneapolis, MN, USAAbstract:  Arthritis is the most common cause of disability in the US, and the primary mani- festation of arthritis is joint pain that leads to progressive physical limitation, disability, mor - bidity, and increased health care utilization.",Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
"7,8 Measures of evoked Correspondence: Hollis E Krug   Rheumatology Office (111R), Minneapolis  Veterans’ Affairs Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA Tel +1 612 467 4198   Email hollis.krug@va.govJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Abdullah et alRunning head recto: Intra-articular vanilloid receptor agonists for painDOI: http://dx.doi.org/10.2147/JPR.S107385",Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 570 Abdullah et al  19.,Non-OADS,/arxiv_data1/oa_pdf/bb/8c/jpr-9-563.PMC4993562.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 365–370Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 365 Original researcH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S110605Dietary compliance in iranian children and  adolescents with celiac disease Maryam Taghdir1 naser Honar2 seyed Mohammad  Mazloomi3 Mojtaba sepandi4 Mahkameh ashourpour1 Musa salehi5 1student research committee,   Department of clinical nutrition,   school of n utrition and Food  sciences, shiraz University of Medical  sciences, shiraz, iran; 2Department  of Pediatric gastroenterology  and Hepatology, shiraz University  of Medical sciences, shiraz, iran;   3nutrition research center,   Department of Food Hygiene and Quality control, school of nutrition  and Food sciences, shiraz University  of Medical sciences, shiraz, iran;   4Department of epidemiology and  Biostatistics, Baqyiatallah University of Medical sciences, T ehran, iran;   5nutrition research center,   Department of clinical nutrition,   school of n utrition and Food  sciences, shiraz University of Medical sciences, shiraz, iranIntroduction: Celiac disease (CD) is caused due to intake of gluten, a protein component in  wheat, barley, and rye.",Non-OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
"6 Because CD is often clinically silent, many patients remain undiagnosed  and are at risk of complications, such as osteoporosis, infertility, or malignancy.6 The  burden caused by CD is high, and there is growing interest in the social dimensions of correspondence: Musa salehi Department of clinical nutrition, school of nutrition and Food sciences, shiraz University of Medical sciences, razi street, shiraz, Fars, iranTel +98 71 3725 1001 ext 332Fax +98 71 3725 7288email salehi@sums.ac.irJournal name: Journal of Multidisciplinary Healthcare Article Designation: Original ResearchY ear: 2016V olume: 9Running head verso: Taghdir et alRunning head recto: Dietary compliance in celiac diseaseDOI: http://dx.doi.org/10.2147/JMDH.S110605",Non-OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 370 Taghdir et al  11.,Non-OADS,/arxiv_data1/oa_pdf/4e/c9/jmdh-9-365.PMC4993563.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2016:9 45–57Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  45 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S64279Managing anesthesia  for cesarean section in   obese patients: current perspectives Agnes M Lamon Ashraf S Habib Department of Anesthesiology, Duke  University Medical Center, Durham,  NC, USAAbstract:  Obesity is a worldwide epidemic.",Non-OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
"Therefore, in Correspondence: Ashraf S Habib Department of Anesthesiology, Duke University Medical Center, Box 3094, Durham, NC 27710, USAEmail habib001@dm.duke.eduJournal name: Local and Regional Anesthesia Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Lamon and HabibRunning head recto: Cesarean section in obese parturientsDOI: http://dx.doi.org/10.2147/LRA.S64279",Non-OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
"Local and Regional Anesthesia 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 57 Cesarean section in obese parturients  89.,Non-OADS,/arxiv_data1/oa_pdf/95/c9/lra-9-045.PMC4993564.pdf
"4, e1198300 (9 pages)http://dx.doi.org/10.1080/2159256X.2016.1198300",Non-OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Science 1991; 254:1808-10; PMID:1722352; http://dx.doi.org/10.1126/science.1722352 [2] Leibold DM, Swergold GD, Singer MF, Thayer RE, Dombroski BA, Fanning TG.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Cell 1996; 87:905-16;PMID:8945517; http://dx.doi.org/10.1016/S0092-8674(00)81997-2 [5] Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Cell 1996; 87:917-27;PMID:8945518; http://dx.doi.org/10.1016/S0092-8674(00)81998-4 [6] Wallace NA, Belancio VP, Deininger PL.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Gene2008; 419:75-81; PMID:18555620; http://dx.doi.org/ 10.1016/j.gene.2008.04.013[7] Kines KJ, Sokolowski M, deHaro DL, Christian CM, Belancio VP.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"NucleicAcids Res 2014; 42:10488-502; PMID:25143528; http://dx.doi.org/10.1093/nar/gku687 [8] Gasior SL, Wakeman TP, Xu B, Deininger PL.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"J Mol Biol 2006; 357:1383-93; PMID:16490214; http://dx.doi.org/10.1016/j.jmb.2006.01.089 [9] Christian CM, deHaro D, Kines KJ, Sokolowski M, Belancio VP.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Mob DNA 2014; 5:29;PMID:25606060; http://dx.doi.org/10.1186/s13100-014-0029-x [11] Belancio VP, Roy-Engel AM, Deininger PL.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Semin Cancer Biol 2010; 20:200-10; PMID:20600922; http://dx.doi.org/ 10.1016/j.semcancer.2010.06.001 [12] Belancio VP, Deininger PL, Roy-Engel AM.",Non-OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Genome Med 2009; 1:97; PMID:19863772; http://dx.doi.org/10.1186/gm97 [13] Kelman Z. PCNA: structure, functions and interactions.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Oncogene 1997; 14:629-40; PMID:9038370; http://dx.doi.org/10.1038/sj.onc.1200886 [14] Andersen PL, Xu F, Xiao W. Eukaryotic DNA damage tolerance and translesion synthesis through covalentmodi ﬁcations of PCNA.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Cell Res 2008; 18:162-73; PMID:18157158; http://dx.doi.org/10.1038/cr.2007.114 [15] Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regula- tion of PCNA-protein interactions for genome stability.Nat Rev Mol Cell Biol 2013; 14:269-82; PMID:23594953;http://dx.doi.org/10.1038/nrm3562 [16] Zhu Q, Chang Y, Yang J, Wei Q. Post-translational modi- ﬁcations of proliferating cell nuclear antigen: A key signal integrator for DNA damage response (Review).",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
DNA Repair (Amst) 2016;42:63-71; PMID:27156098; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"DNA Repair (Amst) 2008;7:983-9; PMID:18396111; http://dx.doi.org/10.1016/j.dnarep.2008.02.006 [19] Wallace NA, Gasior SL, Faber ZJ, Howie HL, Deininger PL, Galloway DA.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Mol Cell Biol 2007;27:1264-70; PMID:17145770; http://dx.doi.org/10.1128/MCB.01888-06 [23] Kubo S, Seleme MC, Soifer HS, Perez JL, Moran JV, Kazazian HH, Kasahara N. L1 retrotransposition in non-dividing and primary human somatic cells.",Non-OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Mob DNA 2013; 4:10; PMID:23497436; http://dx.doi.org/10.1186/1759-8753-4-10 [25] Perepelitsa-Belancio V, Deininger P. RNA truncation by premature polyadenylation attenuates human mobile ele- ment activity.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"Nat Genet 2003; 35:363-6; PMID:14625551; http://dx.doi.org/10.1038/ng1269 [26] Sokolowski M, Deharo D, Christian CM, Kines KJ, Belancio VP.",OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
PLoS One 2013; 8:e82021; PMID:24324740; http://dx.doi.org/10.1371/journal.pone.0082021MOBILE GENETIC ELEMENTS e1198300-9,Non-OADS,/arxiv_data1/oa_pdf/8e/bc/kmge-06-04-1198300.PMC4993571.pdf
"3, e1178368 (17 pages)http://dx.doi.org/10.1080/21688370.2016.1178368",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Integr Comp Biol 2003; 43:55-63; PMID:21680409; http://dx.doi.org/10.1093/icb/43.1.55 [2] Fahey B, Degnan BM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Evol Dev 2010; 12:601-17;http://dx.doi.org/10.1111/j.1525-142X.2010.00445.x [3] Salinas-Saavedra M, Stephenson TQ, Dunn CW, Martin- dale MQ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Evodevo 2015; 6:20; PMID:26101582; http://dx.doi.org/10.1186/s13227-015-0014-6 [4] Ganot P, Zoccola D, Tambutte E, Voolstra CR, Aranda M, Allemand D, Tambutt /C19e S. Structural molecular com- ponents of septate junctions in cnidarians point to theorigin of epithelial junctions in eukaryotes.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol BiolEvol 2015; 32:44-62; PMID:25246700; http://dx.doi.org/ 10.1093/molbev/msu265[5] Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pal- lari HM, Goldman RD.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
J Clin Invest 2009;119:1763-71; PMID:19587451; http://dx.doi.org/10.1172/JCI38339 [6] Blumenberg M. Evolution of homologous domains of cytoplasmic intermediate ﬁlament proteins and lamins.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Am J Physiol RenalPhys 2011; 300:F589-601; http://dx.doi.org/10.1152/ajprenal.00615.2010 [8] Guo S, Kemphues KJ.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Curr Opin Genet Dev 1996; 6:408-15; PMID:8791533; http://dx.do i.org/10.1016/S0959-437X (96)80061-X [9] Gilmore TD, Wolenski FS.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Immun Rev 2012; 246:14-35;PMID:22435545; http://dx.doi.org/10.1111/j.1600-065X.2012.01096.x [10] Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Journal Cell Biol 2006; 174:169-74; http://dx.doi.org/10.1083/jcb.200603161 [11] Moll R, Divo M, Langbein L. The human keratins: biol- ogy and pathology.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Histochem Cell Biol 2008; 129:705-33; PMID:18461349; http://dx.doi.org/10.1007/s00418-008-0435-6 [12] Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expres- sion in normal epithelia, tumors and cultured cells.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Cell1982; 31:11-24; PMID:6186379; http://dx.doi.org/10.1016/0092-8674(82)90400-7 [13] Snider NT, Omary MB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Nature Rev Mol Cell Biol 2014; 15:163-77;http://dx.doi.org/10.1038/nrm3753 [14] Grin B, Mahammad S, Wedig T, Cleland MM, Tsai L, Herrmann H, Goldman RD.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One 2012; 7:e39065; PMID:22720028; http://dx.doi.org/10.1371/journal.pone.0039065 [15] Sun J, Groppi VE, Gui H, Chen L, Xie Q, Liu L, Omary MB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Methods Enzymol 2016; 568:163-85; PMID:26795471; http://dx.doi.org/ 10.1016/bs.mie.2015.09.029 [16] Baribault H, Price J, Miyai K, Oshima RG.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Genes Develop 1993;7:1191-202; http://dx.doi.org/10.1101/gad.7.7a.1191 [17] Bar J, Kumar V, Roth W, Schwarz N, Richter M, Leube RE, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
J Invest Dermatol 2014; 134:1012-22; PMID:24121403; http://dx.doi.org/ 10.1038/jid.2013.416TISSUE BARRIERS e1178368-11,Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One2013; 8:e64404; PMID:23741325; http://dx.doi.org/10.1371/journal.pone.0064404 [19] Koster S, Weitz DA, Goldman RD, Aebi U, Herrmann H. Intermediate ﬁlament mechanics in vitro and in the cell: from coiled coils to ﬁlaments, ﬁbers and networks.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Curr Opinion Cell Biol 2015; 32c:82-91; http://dx.doi.org/10.1016/j.ceb.2015.01.001 [20] Coulombe PA, Lee CH.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2012; 132:763-75;PMID:22277943; http://dx.doi.org/10.1038/jid.2011.450 [21] Bolling MC, Jongbloed JD, Boven LG, Diercks GF, Smith FJ, McLean WH, Jonkman MF.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2014; 134:273-6;PMID:23774525; http://dx.doi.org/10.1038/jid.2013.277 [22] Wagner M, Trost A, Hintner H, Bauer JW, Onder K. Imbalance of intermediate ﬁlament component keratin 14 contributes to increased stress signalling in epider- molysis bullosa simplex.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Experiment Dermatol 2013; 22:292-4; http://dx.doi.org/10.1111/exd.12112 [23] Yoneda K, Furukawa T, Zheng YJ, Momoi T, Izawa I, Inagaki M, Manabe M, Inagaki N. An autocrine/para-crine loop linking keratin 14 aggregates to tumor necro-sis factor a-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Biol Chem2004; 279:7296-303; PMID:14660619; http://dx.doi.org/ 10.1074/jbc.M307242200 [24] El-HawarSy MS, Abdel-Halim MR, Sayed SS, Abdelkader HA.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Arch DermatolRes 2015; 307:371-7; PMID:25822146; http://dx.doi.org/10.1007/s00403-015-1560-4 [25] Homberg M, Ramms L, Schwarz N, Dreissen G, Leube R E ,M e r k e lR ,H o f f m a n nB ,M a g i nT M .D i s t i n c tI m p a c t of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J InvestDermatol 2015; 135:2437-45; PMID:25961909; http://dx.doi.org/10.1038/jid.2015.184 [26] Bordeleau F, Myrand Lapierre ME, Sheng Y, Marceau N. Keratin 8/18 regulation of cell stiffness-extracellu-lar matrix interplay through modulation of Rho-mediated actin cytoskeleton dynamics.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One 2012; 7:e38780; PMID:22685604; http://dx.doi.org/ 10.1371/journal.pone.0038780 [27] Caulin C, Ware CF, Magin TM, Oshima RG.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2000; 149:17-22;PMID:10747083; http://dx.doi.org/10.1083/jcb.149.1.17 [28] Jaquemar D, Kupriyanov S, Wankell M, Avis J, Benirschke K, Baribault H, Oshima RG.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2003; 161:749-56; PMID:12771125; http://dx.doi.org/10.1083/jcb.200210004[29] Leifeld L, Kothe S, Sohl G, Hesse M, Sauerbruch T, Magin TM, Spengler U. Keratin 18 provides resistanceto Fas-mediated liver failure in mice.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Europ J Clin Invest2009; 39:481-8; PMID:19397691; http://dx.doi.org/10.1111/j.1365-2362.2009.02133.x [30] McGowan KM, Tong X, Colucci-Guyon E, Langa F, Babi- net C, Coulombe PA. Keratin 17 null mice exhibit age- and strain-dependent alopecia.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Genes Dev 2002; 16:1412-22; PMID:12050118; http://dx.doi.org/10.1101/gad.979502 [31] Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Genes Develop2006; 20:1353-64; http://dx.doi.org/10.1101/gad.1387406 [32] Lugassy J, McGrath JA, Itin P, Shemer R, Verbov J, Murphy HR, Ishida-Yamamoto A, Digiovanna JJ, Bercovich D,Karin N, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2008; 128:1517-24;PMID:18049449; http://dx.doi.org/10.1038/sj.jid.5701187 [33] Ameen NA, Figueroa Y, Salas PJ.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Hepatology2003; 37:1006-14; PMID:12717381; http://dx.doi.org/10.1053/jhep.2003.50181 [36] Chen J, Cheng X, Merched-Sauvage M, Caulin C, Roop DR, Koch PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2006; 119:5067-76;PMID:17118961; http://dx.doi.org/10.1242/jcs.03298 [37] Usachov V, Urban TJ, Fontana RJ, Gross A, Iyer S, Omary MB, Strnad P. Prevalence of genetic variants ofkeratins 8 and 18 in patients with drug-induced liverinjury.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"BMC Med 2015; 13:196; PMID:26286715; http://dx.doi.org/10.1186/s12916-015-0418-0 [38] Strnad P, Zhou Q, Hanada S, Lazzeroni LC, Zhong BH, So P, Davern TJ, Lee WM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Hepatol 2009; 50:546-54; PMID:19585610;http://dx.doi.org/10.1002/hep.23041 [40] Inada H, Izawa I, Nishizawa M, Fujita E, Kiyono T, Takaha- shi T, Momoi T, Inagaki M. Keratin attenuates tumore1178368-12 P. J. SALAS ET AL.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2001; 155:415-26;PMID:11684708; http://dx.doi.org/10.1083/jcb.200103078 [41] Gilbert S, Loranger A, Marceau N. Keratins modulate c- Flip/extracellular signal-regulated kinase 1 and 2 antia-poptotic signaling in simple epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
Mol CellBiol 2004; 24:7072-81; PMID:15282307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Apoptosis 2006; 11:1561-72; PMID:16820959;http://dx.doi.org/10.1007/s10495-006-9113-0 [43] Lin YM, Chen YR, Lin JR, Wang WJ, Inoko A, Inagaki M, Wu YC, Chen RH.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2008; 121:2382-93; PMID:18577580; http://dx.doi.org/10.1242/jcs.021394 [44] Duan S, Yao Z, Zhu Y, Wang G, Hou D, Wen L, Wu M. The Pirh2-keratin 8/18 interaction modulates the cellu-lar distribution of mitochondria and UV-induced apo-ptosis.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Cell Death Diff 2009; 16:826-37; http://dx.doi.org/10.1038/cdd.2009.12 [45] Bordeleau F, Galarneau L, Gilbert S, Loranger A, Marceau N. Keratin 8/18 modulation of protein kinase C-mediated integrin-dependent adhesion and migration of liver epithe-lial cells.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell 2010; 21:1698-713; PMID:20357007;http://dx.doi.org/10.1091/mbc.E09-05-0373 [46] Izawa I, Nishizawa M, Ohtakara K, Ohtsuka K, Inada H, Inagaki M. Identi ﬁcation of Mrj, a DnaJ/Hsp40 family protein, as a keratin 8/18 ﬁlament regulatory protein.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
J Biol Chem 1995; 270:915-22; PMID:7529764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell 2005;16:1427-38; PMID:15647384; http://dx.doi.org/10.1091/mbc.E04-06-0498 [50] Wiche G, Osmanagic-Myers S, Castanon MJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Curr Opin Cell Biol2015; 32:21-9; PMID:25460778; http://dx.doi.org/10.1016/j.ceb.2014.10.002 [51] Nekrasova O, Green KJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Trends Cell Biol 2013; 23:537-46; PMID:23891292;http://dx.doi.org/10.1016/j.tcb.2013.06.004 [52] Mashukova A, Oriolo AS, Wald FA, Casanova ML, Kroger C, Magin TM, Omary MB, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2009; 122:2491-503; PMID:19549684; http://dx.doi.org/10.1242/jcs.046979 [53] Mashukova A, Kozhekbaeva Z, Forteza R, Dulam V, Figueroa Y, Warren R, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2014; 127:3568-77; PMID:24876225; http://dx.doi.org/10.1242/jcs.151084 [54] Quinlan RA, Carte JM, Sandilands A, Prescott AR.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Trends in Cell Biol 1996; 6:123-6; http://dx.doi.org/10.1016/0962-8924(96)20001-7 [55] Chen L, Wang Y, Zhao L, Chen W, Dong C, Zhao X, Li X. Hsp74, a potential bladder cancer marker, has directinteraction with keratin 1.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Immunol Res 2014;2014:492849; PMID:25050384; http://dx.doi.org/10.1155/2014/492849 [56] Kayser J, Haslbeck M, Demp ﬂe L, Krause M, Grashoff C, Buchner J, Herrmann H, Bausch AR.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Biophys J 2013; 105:1778-85; PMID:24138853; http://dx.doi.org/10.1016/j.bpj.2013.09.007 [57] Gao T, Newton AC.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Biol Chem 2006;281:32461-8; PMID:16954220; http://dx.doi.org/10.1074/jbc.M604076200 [58] Gould CM, Newton AC.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"The life and death of protein kinase C. Curr Drug Targets 2008; 9:614-25;PMID:18691009; http://dx.doi.org/10.2174/138945008785132411 [59] Mashukova A, Forteza R, Wald FA, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell 2012; 23:1664-74; PMID:22398726; http://dx.doi.org/10.1091/ mbc.E11-12-0988 [60] Yamazaki S, Uchiumi A, Katagata Y. Hsp40 regulates the amount of keratin proteins via ubiquitin-protea-some pathway in cultured human cells.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Hum Mutation 2010; 31:466-76; PMID:20151404; http://dx.doi.org/10.1002/humu.21222 [62] Watson ED, Geary-Joo C, Hughes M, Cross JC.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Develop 2007; 134:1809-17; http://dx.doi.org/10.1242/dev.02843 [63] Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A,TISSUE BARRIERS e1178368-13",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Am J Pathol2002; 160:255-63; PMID:11786419; http://dx.doi.org/10.1016/S0002-9440(10)64369-6 [64] Wald FA, Oriolo AS, Casanova ML, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell 2005; 16:4096-107; PMID:15987737; http://dx.doi.org/10.1091/mbc.E05- 03-0242 [65] Lu R, Dalgalan D, Mandell EK, Parker SS, Ghosh S, Wilson JM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol2012; 196:623-39; PMID:22371556; http://dx.doi.org/10.1083/jcb.201104143 [67] Helfrich I, Schmitz A, Zigrino P, Michels C, Haase I, le Bivic A, Leitges M, Niessen CM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2007; 127:782-91;PMID:17110935; http://dx.doi.org/10.1038/sj.jid.5700621 [68] Kim B, Breton S. The MAPK/ERK-Signaling Pathway Regulates the Expression and Distribution of TightJunction Proteins in the Mouse Proximal Epididymis.Biol Reprod 2015; 94(1):22 [69] Elsum IA, Martin C, Humbert PO.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci2013; 126:3990-9; PMID:23813956; http://dx.doi.org/10.1242/jcs.129387 [70] Lei S, Cheng T, Guo Y, Li C, Zhang W, Zhi F. Somato- statin ameliorates lipopolysaccharide-induced tightjunction damage via the ERK-MAPK pathway in Caco2 cells.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Eur J Cell Biol 2014; 93:299-307; PMID:24950815; http://dx.doi.org/10.1016/j.ejcb.2014.05.003 [71] Tanos BE, Perez Bay AE, S alvarezza S, Vivanco I, Mellinghoff I, Osman M, Sacks DB, Rodriguez-Bou-lan E. IQGAP1 controls tight junction formationthrough differential regul ation of claudin recruit- ment.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2015; 128:853-62; PMID:25588839;http://dx.doi.org /10.1242/jcs.118703 [72] Minakami M, Kitagawa N, Iida H, Anan H, Inai T. p38 Mitogen-activated protein kinase and c-Jun NH2-termi-nal protein kinase regulate the accumulation of a tightjunction protein, ZO-1, in cell-cell contacts in HaCaTcells.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Tissue Cell 2015; 47:1-9; PMID:25435485; http://dx.doi.org/10.1016/j.tice.2014.10.001 [73] DiTommaso T, Cottle DL, Pearson HB, Schluter H, Kaur P, Humbert PO, Smyth IM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
PLoS Genet 2014; 10:e1004706;PMID:25340345; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Genet Genomics 2015; 42:531-47; PMID:26554908; http://dx.doi.org/10.1016/j.jgg.2015.09.002 [75] Ku NO, Michie S, Resurreccion EZ, Broome RL, Omary MB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Proc Natl Acad Sci USA 2002; 99:4373-8; PMID:11917136;http://dx.doi.org/10.1073/pnas.072624299 [76] Satoh J, Nanri Y, Yamamura T. Rapid identi ﬁcation of 14-3-3-binding proteins by protein microarray analysis.J Neurosci Methods 2006; 152:278-88; PMID:16260042; http://dx.doi.org/10.1016/j.jneumeth.2005.09.015 [77] Kim S, Wong P, Coulombe PA. A keratin cytoskeletal protein regulates protein synthesis and epithelial cellgrowth.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Nature 2006; 441:362-5; PMID:16710422;http://dx.doi.org/10.1038/nature04659 [78] Liffers ST, Maghnouj A, Munding JB, Jackstadt R, Herbrand U, Schulenborg T, Marcus K, Klein-ScoryS, Schmiegel W, Schwarte-Waldhoff I, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"BMC Cancer 2011; 11:137;PMID:21492476; http://dx.do i.org/10.1186/1471-2407 -11-137 [79] Obsil T, Obsilova V. Structural basis of 14-3-3 protein functions.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Semin Cell Dev Biol 2011; 22:663-72;PMID:21920446; http://dx.doi.org/10.1016/j.semcdb.2011.09.001 [80] Ku NO, Fu H, Omary MB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2004;166:479-85; PMID:15314064; http://dx.doi.org/10.1083/jcb.200402051 [81] Yano S, Komine M, Fujimoto M, Okochi H, Tamaki K. Mechanical stretching in vitro regulates signal transduction pathways and cellular proliferation inhuman epidermal keratinocytes.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2004; 122:783-90; PMID:15086566; http://dx.doi.org/ 10.1111/j.0022-202X.2004.22328.x [82] Wang J, Zhang Y, Zhang N, Wang C, Herrler T, Li Q.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Cell Mol Life Sci 2015; 72:2091-106;PMID:25681865; http://dx.doi.org/10.1007/s00018-015-1853-y [83] Sivaramakrishnan S, Schneider JL, Sitikov A, Goldman RD, Ridge KM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell2009; 20:2755-65; PMID:19357195; http://dx.doi.org/10.1091/mbc.E08-10-1028 [84] Walko G, Castanon MJ, Wiche G. Molecular architec- ture and function of the hemidesmosome.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
Cell Tissue Res 2015; 360:529-44; PMID:26017636; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Annu Rev Pathol2016; PMID:26907530; http://dx.doi.org/10.1146/annurev-pathol-012615-044313 [86] Nitoiu D, Etheridge SL, Kelsell DP.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Cell Commun Adhes 2014; 21:129-40; PMID:24738885; http://dx.doi.org/ 10.3109/15419061.2014.908854 [87] Koss-Harnes D, Hoyheim B, Anton-Lamprecht I, Gjesti A, Jorgensen RS, Jahnsen FL, Olaisen B, Wiche G,Gedde-Dahl T, Jr. A site-speci ﬁc plectin mutation causes dominant epidermolysis bullosa simplex Ogna:two identical de novo mutations.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol2002; 118:87-93; PMID:11851880; http://dx.doi.org/ 10.1046/j.0022-202x.2001.01591.x [88] Baribault H, Oshima RG.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 1991; 115:1675-84; PMID:1721911;http://dx.doi.org/10.1083/jcb.115.6.1675 [89] Magin TM, Schroder R, Leitgeb S, Wanninger F, Zatlou- kal K, Grund C, Melton DW.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 1998; 140:1441-51; PMID:9508776; http://dx.doi.org/10.1083/jcb.140.6.1441 [90] Seltmann K, Fritsch AW, Kas JA, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"JCell Sci 2012; 125:1750-8; PMID:22375063; http://dx.doi.org/10.1242/jcs.097139 [92] Loschke F, Homberg M, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2016; 136:202-13; PMID:26763440; http://dx.doi.org/10.1038/JID.2015.403 [93] Koch S, Nusrat A.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Annu Rev Pathol 2012; 7:35-60; PMID:21838548; http://dx.doi.org/10.1146/annurev-pathol-011811-120905 [94] Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and in ﬂammation in keratin 8- deﬁcient FVB/N mice.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Genes Dev 1994; 8:2964-73; http://dx.doi.org/10.1101/gad.8.24.2964 [95] Asghar MN, Silvander JS, Helenius TO, Lahdeniemi IA, Alam C, Fortelius LE, Holmsten RO, ToivolaDM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One 2015; 10:e0127436; PMID:26000979; http://dx.doi.org/10.1371/journal.pone.0127436 [96] Habtezion A, Toivola DM, Butcher EC, Omary MB.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci2005; 118:1971-80; PMID:15840656; http://dx.doi.org/ 10.1242/jcs.02316 [97] Toivola DM, Krishnan S, Binder HJ, Singh SK, Omary MB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2004;164:911-21; PMID:15007064; http://dx.doi.org/10.1083/jcb.200308103 [98] Zupancic T, Stojan J, Lane EB, Komel R, Bedina-Zavec A, Liovic M. Intestinal cell barrier function in vitro isseverely compromised by keratin 8 and 18 mutationsidenti ﬁed in patients with in ﬂammatory bowel disease.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One 2014; 9:e99398; PMID:24915158; http://dx.doi.org/10.1371/journal.pone.0099398 [99] Lessard JC, Pina-Paz S, Rotty JD, Hickerson RP, Kaspar RL, Balmain A, Coulombe PA. Keratin 16 regulates innate immunity in response to epidermal barrier breach.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
J BiolChem 2003; 278:13422-30; PMID:12566451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Par-complex aPKC and Par3 cross-talk withinnate immunity NF-kappaB pathway in epithelial cells.Biol Open 2013; 2:1264-9; PMID:24244864; http://dx.doi.org/10.1242/bio.20135918 [102] Wald FA, Forteza R, Diwadkar-Watkins R, Mashukova A, Duncan R, Abreu MT, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Virch Arch 2011; 459:331-8; http://dx.doi.org/10.1007/s00428-011-1102-1 [103] Zhong B, Zhou Q, Toivola DM, Tao GZ, Resurrec- c i o nE Z ,O m a r yM B .O r g a n - s p e c i ﬁc stress induces mouse pancreatic keratin overexpression in associa-tion with NF-kappaB activation.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2004; 117:1709-19; PMID:15075232; http://dx.doi.org/ 10.1242/jcs.01016 [104] Corfe BM, Majumdar D, Assadsangabi A, Marsh AM, Cross SS, Connolly JB, Evans CA, Lobo AJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"BMJ Open Gastroenterol 2015;2:e000024; PMID:26462276; http://dx.doi.org/10.1136/ bmjgast-2014-000024 [105] Papathanasiou S, Rickelt S, Soriano ME, Schips TG, Maier HJ, Davos CH, Varela A, Kaklamanis L, Mann DL, Capetanaki Y. Tumor necrosis factor- aconfers car- dioprotection through ectopic expression of keratins K8and K18.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Nat Med 2015; 21:1076-84; PMID:26280121;http://dx.doi.org/10.1038/nm.3925 [106] Hobbs RP, DePianto DJ, Jacob JT, Han MC, Chung BM, Batazzi AS, Poll BG, Guo Y, Han J, Ong S, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Nat Genet 2015; 47:933-8; PMID:26168014; http://dx.doi.org/10.1038/ng.3355 [107] Roth W, Kumar V, Beer HD, Richter M, Wohlenberg C, Reuter U, Thiering S, Staratschek-Jox A, Hofmann A,Kreusch F, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Sci 2012; 125:5269-79; PMID:23132931; http://dx.doi.org/10.1242/jcs.116574 [108] Lu H, Chen J, Planko L, Zigrino P, Klein-Hitpass L, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Invest Dermatol 2007;127:2781-9; PMID:17581617; http://dx.doi.org/10.1038/sj.jid.5700918 [109] Obarzanek-Fojt M, Favre B, Huber M, Ryser S, Moodycliffe A M ,W i p f fP J ,H i n zB ,H o h lD .I n d u c t i o no fp 3 8 ,t u m o u r necrosis factor- aand RANTES by mechanical stretching of keratinocytes expressing mutant keratin 10R156H.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Br JDermatol 2011; 164:125-34; PMID:20804491; http://dx.doi.org/10.1111/j.1365-2133.2010.10013.x [110] Oriolo AS, Wald FA, Ramsauer VP, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Exp Cell Res 2007; 313:2255-64; PMID:17425955; http://dx.doi.org/ 10.1016/j.yexcr.2007.02.030 [111] Stutzmann J, Bellissent-Waydelich A, Fontao L, Launay JF, Simon-Assmann P. Adhesion complexes implicatedin intestinal epithelial cell-matrix interactions.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"MicroscRes Tech 2000; 51:179-90; PMID:11054868; http://dx.doi.org/10.1002/1097-0029(20001015)51:2 <179::AID- JEMT9>3.0.CO;2-4 [112] Seltmann K, Cheng F, Wiche G, Eriksson JE, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2009; 187:175-84;PMID:19841136; http://dx.doi.org/10.1083/jcb.200906094 [114] Bryant DM, Datta A, Rodriguez-Fraticelli AE, Peranen J, Martin-Belmonte F, Mostov KE.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"A molecular networkfor de novo generation of the apical surface and lumen.Nat Cell Biol 2010; 12:1035-45; PMID:20890297; http://dx.doi.org/10.1038/ncb2106 [115] Hein Z, Schmidt S, Zimmer KP, Naim HY.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2008; 183:19-28;PMID:18838552; http://dx.doi.org/10.1083/jcb.200803133 [117] Duan Y, Sun Y, Zhang F, Zhang WK, Wang D, Wang Y, Cao X, Hu W, Xie C, Cuppoletti J, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Biol Chem 2012;287:40547-59; PMID:23045527; http://dx.doi.org/10.1074/jbc.M112.403584 [118] Homolya L, Fu D, Sengupta P, Jarnik M, Gillet JP, Vitale-Cross L, Gutkind JS, Lippincott-Schwartz J, AriasIM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"PloS One 2014; 9: e91921; PMID:24643070; http://dx.doi.org/10.1371/journal.pone.0091921 [119] Bosch RR, Bazuine M, Span PN, Willems PH, Olthaar AJ, van Rennes H, Maassen JA, Tack CJ, Hermus AR,Sweep CG.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Bio Chem J 2004; 384:349-55; PMID:15307820; http://dx.doi.org/10.1042/BJ20040797 [120] Stretton C, Evans A, Hundal HS.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell2009; 20:2549-62; PMID:19321664; http://dx.doi.org/10.1091/mbc.E08-10-1030 [122] Oriolo AS, Wald FA, Canessa G, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Oncotarget 2013; 4:2010-20;PMID:24243820; http://dx.doi.org/10.18632/oncotarget.1451 [124] Ivanov AI, Parkos CA, Nusrat A. Cytoskeletal regulation of epithelial barrier function during in ﬂammation.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Am J Path 2010; 177:512-24; PMID:20581053; http://dx.doi.org/10.2353/ajpath.2010.100168 [125] Ivanov AI, Young C, Den Beste K, Capaldo CT, Humbert PO, Brennwald P, Parkos CA, Nusrat A.Tumor suppressor scribble regulates assembly oftight junctions in the intestinal epithelium.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"doi.org/10.2353/ajpath.2010.090220 [126] Karabinos A, Zimek A, Weber K. The genome of the early chordate Ciona intestinalis encodes only ﬁve cytoplasmic intermediate ﬁlament proteins including a single type I and type II keratin and a unique IF-annexin fusion protein.Gene 2004; 326:123-9; PMID:14729270; http://dx.doi.org/10.1016/j.gene.2003.10.019 [127] Mashukova A, Forteza R, Salas PJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Methods Enzymol 2016; 569:139-54; PMID:26778557;http://dx.doi.org/10.1016/bs.mie.2015.08.019 [128] Cheung KJ, Gabrielson E, Werb Z, Ewald AJ.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
Cell 2013; 155:1639-51; PMID:24332913;http://dx.doi.org/10.1016/j.cell.2013.11.029 [129] Omary MB.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Clin Invest 2009; 119:1756-62; PMID:19587450; http://dx.doi.org/10.1172/JCI39894 [130] Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratinsin human disease.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Clin Invest 2009; 119:1794-805;PMID:19587454; http://dx.doi.org/10.1172/JCI37762 [131] Calnek D, Quaroni A.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Differential localization by in situ hybridization of distinct keratin mRNA species duringintestinal epithelial cell development and differentiation.Differentiation Res Biol Diversity 1993; 53:95-104;PMID:7689500; http://dx.doi.org/10.1111/j.1432-0436.1993.tb00649.x [132] Pujal J, Huch M, Jose A, Abasolo I, Rodolosse A, Duch A, S /C19anchez-Palaz /C19on L, Smith FJ, McLean WH, Fillat C, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"FASEB J 2009;23:1366-75; PMID:19124560; http://dx.doi.org/10.1096/fj.08-115576 [133] Ju JH, Yang W, Lee KM, Oh S, Nam K, Shim S, Shin SY, Gye MC, Chu IS, Shin I.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Clin Can- cer Res 2013; 19:4335-46; PMID:23833298; http://dx.doi.org/10.1158/1078-0432.CCR-12-3295 [134] Ju JH, Oh S, Lee KM, Yang W, Nam KS, Moon HG, Noh DY, Kim CG, Park G, Park JB, et al.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Cell Death Diff 2015; 22:665-76; http://dx.doi.org/10.1038/cdd.2014.155 [135] Russell D, Ross H, Lane EB.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"ERK involvement in resis- tance to apoptosis in keratinocytes with mutant keratin.J Invest Dermatol 2010; 130:671-81; PMID:19847192;http://dx.doi.org/10.1038/jid.2009.327 [136] Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick SL.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Cel Biol 2013; 33:4448-60; http://dx.doi.org/10.1128/MCB.00241-13 [137] Kumar V, Pedroza LA, Mace EM, Seeholzer S, Cot- sarelis G, Condino-Neto A, Payne AS, Orange JS.The autoimmune regulator (AIRE), which is defec- tive in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients, is expressed inhuman epidermal and follicular keratinocytes andassociates with the intermediate ﬁlament protein cytokeratin 17.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
Am J Path 2011; 178:983-8;PMID:21356351; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"T JBiol Chem 2012; 287:7573-81; http://dx.doi.org/10.1074/jbc.M111.301549 [139] Alam H, Sehgal L, Kundu ST, Dalal SN, Vaidya MM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Mol Biol Cell v 2011; 22:4068-78; http://dx.doi.org/10.1091/mbc.E10-08-0703 [140] Gilbert S, Ruel A, Loranger A, Marceau N. Switch in Fas-activated death signaling pathway as result of kera-tin 8/18-intermediate ﬁlament loss.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Apoptosis 2008; 13:1479-93; PMID:19002587; http://dx.doi.org/10.1007/s10495-008-0274-x [141] Lee J, Jang KH, Kim H, Lim Y, Kim S, Yoon HN, Chung IK, Roth J, Ku NO.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"Biol Open 2013;2:695-702; PMID:23862017; http://dx.doi.org/10.1242/bio.20134606 [142] Fortier AM, Asselin E, Cadrin M. Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Biol Chem 2013; 288:11555-71; PMID:23449973; http://dx.doi.org/10.1074/jbc.M112.428920 [143] Meng Y, Wu Z, Yin X, Zhao Y, Chen M, Si Y, Yang J, Fu X, Han W. Keratin 18 attenuates estrogenreceptor a-mediated signaling by sequestering LRP16 in cytoplasm.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"BMC Cell Biol 2009; 10:96;PMID:20035625; http://dx.doi.org/10.1186/1471- 2121-10-96 [144] Kroger C, Loschke F, Schwarz N, Windoffer R, Leube RE, Magin TM.",OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"J Cell Biol 2013; 201:681-92; PMID:23690176;http://dx.doi.org/10.1083/jcb.201208162 [145] Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
Nat Genet 2010; 42:910-4; PMID:20871598; http://dx.doi.org/10.1038/ng.665TISSUE BARRIERS e1178368-17,Non-OADS,/arxiv_data1/oa_pdf/fa/48/ktib-04-03-1178368.PMC4993576.pdf
"4, e1208317 (11 pages)http://dx.doi.org/10.1080/2159256X.2016.1208317",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Microbiol Mol BiolRev 2010; 74:434-52; PMID:20805406; http://dx.doi.org/10.1128/MMBR.00020-10 [2] Garcillan-Barcia MP, Alvarado A, de la Cruz F. Identi ﬁ- cation of bacterial plasmids based on mobility and plas- mid population biology.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"35:936-56; PMID:21711366; http://dx.doi.org/10.1111/ j.1574-6976.2011.00291.x [3] Shearer JE, Wireman J, Hostetler J, Forberger H, Borman J, Gill J, Sanchez S, Mankin A, Lamarre J, Lindsay JA,et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"BMC Microbiol 2012; 12:104; PMID:22691167; http://dx.doi.org/10.1186/1471-2180-12-104 [5] Chua KY, Seemann T, Harrison PF, Monagle S, Korman TM, Johnson PD, Coombs GW, Howden BO, Davies JK, Howden BP, et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"PLoS One 2011; 6:e25887; PMID:21991381; http://dx.doi.org/10.1371/journal.pone.0025887 [6] Lee CA, Thomas J, Grossman AD.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Bacteriol 2012; 194:3165-72; PMID:22505685; http://dx.doi.org/10.1128/ JB.00301-12 [7] O ’Brien FG, Ramsay JP, Monecke S, Coombs GW, Rob- inson OJ, Htet Z, Alshaikh FA, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Antimicrob Chemother 2015; 70:649-52;PMID:25411186; http://dx.doi.org/10.1093/jac/dku454 [8] O ’Brien FG, Yui Eto K, Murphy RJ, Fairhurst HM, Coombs GW, Grubb WB, Ramsay JP.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Nucleic Acids Res 2015; 43:7971-83; PMID:26243776;http://dx.doi.org/10.1093/nar/gkv755 [9] Goessweiner-Mohr N, Arends K, Keller W, Grohmann E. Conjugation in gram-positive bacteria.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Bacteriol 2006; 188:2207-13; PMID:16513750; http://dx.doi.org/10.1128/JB.188.6.2207-2213.2006 [11] Wisniewski JA, Traore DA, Bannam TL, Lyras D, Whis- stock JC, Rood JI.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Mol Microbiol 2016; 99:884-96; PMID:26560080; http://dx.doi.org/10.1111/mmi.13270 [12] Llosa M, Gomis-Ruth FX, Coll M, de la Cruz Fd F. Bacte- rial conjugation: a two-step mechanism for DNA trans-port.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Mol Microbiol 2002; 45:1-8; PMID:12100543;http://dx.doi.org/10.1046/j.1365-2958.2002.03014.x [13] Archer GL, Johnston JL.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides.Antimicrob Agents Chemother 1983; 24:70-7; PMID:6625557; http://dx.doi.org/10.1128/AAC.24.1.70 [14] Townsend DE, Bolton S, Ashdown N, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Med Microbiol 1985; 20:169-85;PMID:2931527; http://dx.doi.org/10.1099/00222615-20-2-169 [15] Goering RV, Ruff EA.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Antimicrob Agents Chemother 1983; 24:450-2; PMID:6639004; http://dx.doi.org/10.1128/AAC.24.3.450 [16] Liu MA, Kwong SM, Jensen SO, Brzoska AJ, Firth N. Biol- ogy of the staphylococcal conjugative multiresistance plas-mid pSK41.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Science 2003; 302:1569-71; PMID:14645850; http://dx.doi.org/ 10.1126/science.1090956 [20] Grohmann E, Muth G, Espinosa M. Conjugative plasmid transfer in gram-positive bacteria.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Microbiol Mol BiolRev 2003; 67:277-301, table of contents; PMID:12794193;http://dx.doi.org/10.1128/MMBR.67.2.277-301.2003 [21] Climo MW, Sharma VK, Archer GL.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Bacteriol 2004; 186:3363-73; PMID:15150221;http://dx.doi.org/10.1128/JB.186.11.3363-3373.2004 [25] Apisiridej S, Leelaporn A, Scaramuzzi CD, Skurray RA, Firth N. Molecular analysis of a mobilizable theta-modeMOBILE GENETIC ELEMENTS e1208317-9",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Plasmid 1997; 38:13-24; PMID:9281492;http://dx.doi.org/10.1006/plas.1997.1292 [26] Caryl JA, Thomas CD.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Mol Microbiol2006; 60:1302-18; PMID:16689804; http://dx.doi.org/10.1111/j.1365-2958.2006.05188.x [27] Gennaro ML, Kornblum J, Novick RP.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Mol Gen Genet 1999; 261:707-15; PMID:10394908; http://dx.doi.org/10.1007/s004380050014 [30] Lorenzo-Diaz F, Fernandez-Lopez C, Garcillan-Barcia MP, Espinosa M. Bringing them together: plasmid pMV158 roll-ing circle replication and conjugation under an evolutionary perspective.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Plasmid 2014; 74:15-31; PMID:24942190; http://dx.doi.org/10.1016 /j.plasmid.2014.05.004 [31] O ’Brien FG, Coombs GW, Pearman JW, Gracey M, Moss F, Christiansen KJ, Grubb WB.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Antimicrob Chemother 2009; 64:684-93; PMID:19713400; http://dx.doi.org/10.1093/jac/dkp285 [32] Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, Narechania A, Xing G, Di Gioia TS, Doi A, et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"N Engl J Med 2014; 370:1524-31; PMID:24738669;http://dx.doi.org/10.1056/NEJMoa1303359 [33] Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, ReyesJ, et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Emerg Infect Dis 2015; 21:1844-8; PMID:26402569; http://dx.doi.org/10.3201/eid2110.141914 [34] Udo E, Townsend DE, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"FEMSMicrobiol Lett 1987; 40:279-83; http://dx.doi.org/10.1111/j.1574-6968.1987.tb02039.x [35] Udo EE, Grubb WB.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Eur J Epidemiol 1996; 12:637-41;PMID:8982625; http://dx.doi.org/10.1007/BF00499464 [36] Udo EE, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Med Microbiol1990; 33:227-34; PMID:2175358; http://dx.doi.org/10.1099/00222615-33-4-227 [37] Udo EE, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Med Microbiol 1990; 31:207-12; PMID:2156076; http://dx.doi.org/10.1099/00222615- 31-3-207 [38] Udo EE, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"FEMS Microbiol Lett 1991; 62:33-6; PMID:2032622; http://dx.doi.org/10.1111/j.1574-6968.1991.tb04412.x [39] Udo EE, Grubb WB.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"FEMS Microbiol Lett 1990; 60:183-7; PMID:2126516; http://dx.doi.org/10.1111/j.1574-6968.1990.tb03886.x [40] Townsend DE, Ashdown N, Annear DI, Grubb WB.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Aust J Exp Biol Med Sci 1985; 63 (Pt 5):573-86; PMID:4091763; http://dx.doi.org/ 10.1038/icb.1985.61 [41] Townsend DE, Bolton S, Ashdown N, Annear DI, Grubb WB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Conjugative, staphylococcal plasmids carryinghitch-hiking transposons similar to Tn 554: intra- and interspecies dissemination of erythromycin resistance.Aust J Exp Biol Med Sci 1986; 64 (Pt 4):367-79;PMID:3024610; http://dx.doi.org/10.1038/icb.1986.39 [42] Townsend DE, Grubb WB, Annear DI.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Aust J Exp Biol Med Sci 1985; 63(Pt 4):463-72;PMID:4084142; http://dx.doi.org/10.1038/icb.1985.51 [43] Udo EE, Wei MQ, Grubb WB.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"FEMS Microbiol Lett 1992; 76:243-8; PMID:1427013; http://dx.doi.org/10.1111/j.1574-6968.1992.tb05470.x [44] Shore AC, Lazaris A, Kinnevey PM, Brennan OM, Brennan GI, O ’Connell B, Feßler AT, Schwarz S, Cole- man DC.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Antimicrob Agents Chemother 2016; 60:3007-15; PMID:26953212; http://dx.doi.org/10.1128/AAC.02949-15 [45] Neron B, Menager H, Maufrais C, Joly N, Maupetit J, Letort S, Carrere S, Tuffery P, Letondal C. Mobyle: a newfull web bioinformatics framework.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Bioinformatics 2009;25:3005-11; PMID:19689959; http://dx.doi.org/10.1093/bioinformatics/btp493 [46] Kraushaar B, Appel B, Lanka E, Strauch E. Entry exclu- sion and oriT of a conjugative system encoded by the cryptic plasmid p29930 of Yersinia enterocolitica .",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Plas- mid 2010; 64:79-84; PMID:20470820; http://dx.doi.org/ 10.1016/j.plasmid.2010.05.001 [47] Nunez B, De La Cruz F. Two atypical mobilization pro- teins are involved in plasmid CloDF13 relaxation.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"MolMicrobiol 2001; 39:1088-99; PMID:11251827; http://dx.doi.org/10.1046/j.1365-2958.2001.02308.x [48] Zou X, Cau ﬁeld PW, Li Y, Qi F. Complete nucleotide sequence and characterization of pUA140, a cryptic plasmid from Streptococcus mutans .",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"46:77-85; PMID:11591133; http://dx.doi.org/10.1006/ plas.2001.1539 [49] Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"AntimicrobAgents Chemother 2008; 52:2244-6; PMID:18391032; http://dx.doi.org/10.1128/AAC.00231-08 [50] Mendes RE, Deshpande LM, Bonilla HF, Schwarz S, Huband MD, Jones RN, Quinn JP.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Antimicrob AgentsChemother 2013; 57:2923-8; PMID:23571552; http://dx.doi.org/10.1128/AAC.00071-13 [51] Chen H, Wu W, Ni M, Liu Y, Zhang J, Xia F, He W, Wang Q, Wang Z, Cao B, et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Int J Antimicrob Agents2013; 42:317-21; PMID:23880167; http://dx.doi.org/10.1016/j.ijantimicag.2013.06.008 [52] Pollet RM, Ingle JD, Hymes JP, Eakes TC, Eto KY, Kwong SM, Ramsay JP, Firth N, Redinbo MR.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Bacteriol 2016;198:888-97; PMID:26728193; http://dx.doi.org/10.1128/JB.00832-15 [53] Roberts AP, Mullany P. Tn 916-like genetic elements: a diverse group of modular mobile elements conferringantibiotic resistance.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"FEMS Microbiol Rev 2011; 35:856- 71; PMID:21658082; http://dx.doi.org/10.1111/j.1574- 6976.2011.00283.x [54] Dacco rd A, Ceccarelli D, Burrus V. Integrating conju- gative elements of the SXT/R391 family trigger theexcision and drive the mobilization of a new class ofVibrio genomic islands.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Mol Mi crobiol 2010; 78:576- 88; PMID:20807202; http://dx.doi.org/10.1111/j.1365-2958.2010.07364.x[55] Jaworski DD, Clewell DB.",Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Bacteriol 2009; 191:1574-80; PMID:19074386;http://dx.doi.org/10.1128/JB.01137-08 [57] Strahinic I, Kojic M, Tolinacki M, Fira D, Topisirovic L. Molecular characterization of plasmids pS7a and pS7bfrom Lactococcus lactis subsp.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"J Appl Microbiol 2009; 106:78-88; PMID:19040703;http://dx.doi.org/10.1111/j.1365-2672.2008.03977.x [58] Fernandez-Lopez C, Bravo A, Ruiz-Cruz S, Solano-Col- lado V, Garsin DA, Lorenzo-Diaz F, Espinosa M. Mobi- lizable rolling-circle replicating plasmids from gram- positive bacteria: a low-cost conjugative transfer.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Pathology 1983; 15:169-74; PMID:6310471; http://dx.doi.org/10.3109/00313028309084707 [60] Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. Scaffolding pre-assembled contigs using SSPACE.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Bioin- formatics 2011; 27:578-9; PMID:21149342; http://dx.doi.org/10.1093/bioinformatics/btq683 [61] Nurk S, Bankevich A, Antipov D, Gurevich AA, Koro- beynikov A, Lapidus A, Prjibelski AD, Pyshkin A, Sirot-kin A, Sirotkin Y, et al.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
"Bioinformatics 2014; 30:2068-9; PMID:24642063;http://dx.doi.org/10.1093/bioinformatics/btu153 [63] Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA.",OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
BMC Genomics 2011; 12:402; PMID:21824423;http://dx.doi.org/10.1186/1471-2164-12-402MOBILE GENETIC ELEMENTS e1208317-11,Non-OADS,/arxiv_data1/oa_pdf/7b/3c/kmge-06-04-1208317.PMC4993578.pdf
Available from:http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.,Non-OADS,/arxiv_data1/oa_pdf/d9/bf/520_2016_Article_3275.PMC4993798.pdf
"JAMA 306:1447 –14534102 Support Care Cancer (2016) 24:4097 –4103 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium,provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f6/61/520_2016_Article_3223.PMC4993803.pdf
"Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/ ,b a s e d on November 2013 SEER data submission, posted to the SEER web site, April 2014 3.",Non-OADS,/arxiv_data1/oa_pdf/57/9d/520_2016_Article_3250.PMC4993804.pdf
[J Adv Prosthodont 2016;8:251-8] KEYWORDS: Dimethyl sulfoxide; Push-out bond strength; Etch-and-rinse adhesive; Durabilityhttp://dx.doi.org/10.4047/jap.2016.8.4.251 http://jap.or.kr J Adv Prosthodont 2016;8:251-8 INTRODUCTION Adhesively cemented fiber-reinforced composite posts (so- called fiber posts) are commonly used to provide retention and support along with aesthetic appearance for restora-tions of  endodontically treated teeth.,Non-OADS,/arxiv_data1/oa_pdf/0d/04/jap-8-251.PMC4993837.pdf
"+987136263193 4: e-mail, memarpour@sums.ac.ir Received November 13, 2015 / Last Revision March 5, 2016 / Accepted  May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/04/jap-8-251.PMC4993837.pdf
ORCID Mahtab Memarpour  http://orcid.org/0000-0003-1910-5913   REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/0d/04/jap-8-251.PMC4993837.pdf
"[J Adv Prosthodont 2016;8:259-66] KEYWORDS: Surface treatment; Shear bond strength; Resin ceramic hybridshttp://dx.doi.org/10.4047/jap.2016.8.4.259 http://jap.or.kr J Adv Prosthodont 2016;8:259-66 INTRODUCTION The esthetic expectation resulted in an increase in metal-free  tooth colored materials.1 Although all-ceramic restorations  generally meet these esthetic expectations, a major drawback is their brittleness, which resulted from the low tensile stress and fracture toughness of  the material.",Non-OADS,/arxiv_data1/oa_pdf/64/14/jap-8-259.PMC4993838.pdf
"+903122034196: e-mail, secilkarakoca@yahoo.comReceived November 17, 2015 / Last Revision April 5, 2016 / Accepted  May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/14/jap-8-259.PMC4993838.pdf
The Journal of Advanced Prosthodontics     265ORCID Seçil Karakoca Nemli  http://orcid.org/0000-0001-8836-0673 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/64/14/jap-8-259.PMC4993838.pdf
"[J Adv Prosthodont 2016;8:267-74] KEYWORDS: Zirconia; Composite resin; Shear strength; Scanning electron microscopy; Surface propertieshttp://dx.doi.org/10.4047/jap.2016.8.4.267 http://jap.or.kr J Adv Prosthodont 2016;8:267-74 INTRODUCTION Use of indirect dental restorations, the yttria-stabilized  tetragonal polycrystalline zirconia (Y-TZP) ceramics, used for decades in biomedicine has been increasing because of  esthetics, mechanical properties, and chemical inertia.",Non-OADS,/arxiv_data1/oa_pdf/36/eb/jap-8-267.PMC4993839.pdf
"+903423609600: e-mail, acarasli@hotmail.comReceived February 3, 2016 / Last Revision April 27, 2016 / Accepted May  30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/eb/jap-8-267.PMC4993839.pdf
ORCID Fatih Sari  http://orcid.org/0000-0002-4818-8562Asli Secilmis  http://orcid.org/0000-0002-1065-3262Irfan Simsek  http://orcid.org/0000-0002-4524-1129Semih Ozsevik  http://orcid.org/0000-0001-9818-4853 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/36/eb/jap-8-267.PMC4993839.pdf
[J Adv Prosthodont 2016;8:275-84] KEYWORDS: Ceramics; Computer-Aided Design-Computer-Aided Manufacturing (CAD-CAM); Morphologic analysis; Surface treatment; Tensile bond strengthhttp://dx.doi.org/10.4047/jap.2016.8.4.275 http://jap.or.kr J Adv Prosthodont 2016;8:275-84 INTRODUCTION Technological developments in materials and devices pro- vide dentists with new and advanced options for indirect prosthetic treatments.,Non-OADS,/arxiv_data1/oa_pdf/b6/51/jap-8-275.PMC4993840.pdf
"+82415501979: e-mail, yu0324@hanmail.netReceived May 23, 2016 / Last Revision August 1, 2016 / Accepted August  10, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/51/jap-8-275.PMC4993840.pdf
ORCID Yu-Sung Choi  http://orcid.org/0000-0003-0053-7441 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/b6/51/jap-8-275.PMC4993840.pdf
Available at: http://multimedia.3m.com/mws/media/  781394O/lava-ultimate-technical-product-profile golbal.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/b6/51/jap-8-275.PMC4993840.pdf
"[J Adv Prosthodont 2016;285-9] KEYWORDS: Denture base; Denture teeth; Methyl acetate; Methyl formate; Auto-polymerized acrylic; Tensile  bond strengthhttp://dx.doi.org/10.4047/jap.2016.8.4.285 http://jap.or.kr J Adv Prosthodont 2016;8:285-9 INTRODUCTION The most common type of  acrylic denture failure is debond-ing or fracture of  the denture teeth, accounting for approxi- mately 33% of failures.1 This failure usually occurs in the  anterior region of the denture.",Non-OADS,/arxiv_data1/oa_pdf/bf/81/jap-8-285.PMC4993841.pdf
"+66815717031: e-mail, chairat.w@chula.ac.thReceived October 27, 2015 / Last Revision April 27, 2016 / Accepted  May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/81/jap-8-285.PMC4993841.pdf
ORCID Ticha Thongrakard  http://orcid.org/0000-0002-0651-8965 Chairat Wiwatwarrapan  http://orcid.org/0000-0001-6410-3605  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/bf/81/jap-8-285.PMC4993841.pdf
[J Adv Prosthodont 2016;8:290-5] KEYWORDS: Resilient liner; Ozone; Peracetic acidhttp://dx.doi.org/10.4047/jap.2016.8.4.290 http://jap.or.kr J Adv Prosthodont 2016;8:290-5 INTRODUCTION Tissue-born partial and full dentures may need relining with  silicone based resilient tissue liners for enhancing patient comfort.,Non-OADS,/arxiv_data1/oa_pdf/d2/c8/jap-8-290.PMC4993842.pdf
"+905337175954: e-mail, oekren@cu.edu.trReceived December 2, 2015 / Last Revision April 11, 2016 / Accepted  May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/c8/jap-8-290.PMC4993842.pdf
ORCID Orhun Ekren  http://orcid.org/0000-0002-3237-8003Ahmet Ozkomur  http://orcid.org/0000-0003-4900-3731 REFERENCES 	1.,Non-OADS,/arxiv_data1/oa_pdf/d2/c8/jap-8-290.PMC4993842.pdf
"[J Adv  Prosthodont 2016;8:296-303] KEYWORDS: Dimensional deformation; Denture base; 3D surface matching software; Dry storage; Denture storage methodhttp://dx.doi.org/10.4047/jap.2016.8.4.296 http://jap.or.kr J Adv Prosthodont 2016;8:296-303 INTRODUCTION Polymethyl methacrylate (PMMA) as denture base material  has many advantages including adequate mechanical strength, esthetics, low toxicity, easiness of  repair, and can be cured by simple procedures, therefore, PMMA has been the most commonly used for fabricating denture base since it was developed in the mid-1945.",Non-OADS,/arxiv_data1/oa_pdf/62/a0/jap-8-296.PMC4993843.pdf
"+82415501865: e-mail, joon322@dankook.ac.kr Received January 28, 2016 / Last Revision May 24, 2016 / Accepted May  30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/a0/jap-8-296.PMC4993843.pdf
Most  dimensional deformation presented within the first 2 weeks  in all groups.ORCID  Seo-Ryeon Lim  http://orcid.org/0000-0002-5817-9299Joon-Seok Lee  http://orcid.org/0000-0003-2962-1380 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/62/a0/jap-8-296.PMC4993843.pdf
"[J Adv  Prosthodont 2016;8:304-12] KEYWORDS: Bone level; Finite element analysis; Implant diameter; Short implanthttp://dx.doi.org/10.4047/jap.2016.8.4.304 http://jap.or.kr J Adv Prosthodont 2016;8:304-12 INTRODUCTION The maxillary posterior area contains cancellous bones with  low bone density and thin cortical bones, the quantity and quality of which are lower than those of the mandibular bone.",Non-OADS,/arxiv_data1/oa_pdf/48/0b/jap-8-304.PMC4993844.pdf
"+82336403153: e-mail, lila@gwnu.ac.kr Received December 23, 2015 / Last Revision March 14, 2016 / Accepted   May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/0b/jap-8-304.PMC4993844.pdf
ORCID Ho-Yong Song  http://orcid.org/0000-0002-5527-7635Yoon-Hyuk Huh  http://orcid.org/0000-0003-4072-5199Chan-Jin Park  http://orcid.org/0000-0003-4734-214XLee-Ra Cho  http://orcid.org/0000-0003-3989-2870 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/48/0b/jap-8-304.PMC4993844.pdf
[J Adv Prosthodont 2016;8:313-20] KEYWORDS: Implant overdenture; Edentulous mandible; Locator implant attachment; Locator bar attachment; Clinical complicationhttp://dx.doi.org/10.4047/jap.2016.8.4.313 http://jap.or.kr J Adv Prosthodont 2016;8:313-20 INTRODUCTION Implant overdentures increase the masticatory function and  improve satisfaction by making up for insufficient retention and stability of a conventional dentures.,Non-OADS,/arxiv_data1/oa_pdf/8c/5a/jap-8-313.PMC4993845.pdf
"+82553605146: e-mail, huhjb@pusan.ac.kr Received March 11, 2016 / Last Revision May 30, 2016 / Accepted July  12, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/5a/jap-8-313.PMC4993845.pdf
ORCID Mi-Jung Yun  http://orcid.org/0000-0003-3093-8406Jung-Bo Huh  http://orcid.org/0000-0001-7578-1989 REFERENCES  1. van Waas MA.,Non-OADS,/arxiv_data1/oa_pdf/8c/5a/jap-8-313.PMC4993845.pdf
Available  at http://www.zestanchors.com/media/wysiwyg/pdf/loca- tor/L8003-TM_REV_G_03-14_tech_manual_only.pdf [ac - cessed on 9 December 2015] 13.,Non-OADS,/arxiv_data1/oa_pdf/8c/5a/jap-8-313.PMC4993845.pdf
"[J Adv Prosthodont 2016;  8:321-8] KEYWORDS: Liver disease; Long-term care; Tooth losshttp://dx.doi.org/10.4047/jap.2016.8.4.321 http://jap.or.kr J Adv Prosthodont 2016;8:321-8 INTRODUCTION Nowadays, it is not difficult to find patients with systemic  disease who need dental treatment.",Non-OADS,/arxiv_data1/oa_pdf/3d/fe/jap-8-321.PMC4993846.pdf
ORCID Da-Le Yoon  http:/ /orcid.org/0000-0003-4415-8689 Yong-Gun Kim  http:/ /orcid.org/0000-0002-2793-7667Jin-Hyun Cho  http:/ /orcid.org/0000-0002-2453-9372Sang-Kyu Lee  http://orcid.org/0000-0001-5343-701XJae-Mok Lee  http:/ /orcid.org/0000-0002-0291-6114Long-term evaluation of teeth and implants during the periodic maintenance in patients with viral liver disease,Non-OADS,/arxiv_data1/oa_pdf/3d/fe/jap-8-321.PMC4993846.pdf
"[J Adv Prosthodont 2016;8:329-32] KEYWORDS: Computer-aided design/computer-assisted manufacturing (CAD/CAM); Monolithic zirconia crown; Retrofitting; Surveyed crown; Replicationhttp://dx.doi.org/10.4047/jap.2016.8.4.329 http://jap.or.kr J Adv Prosthodont 2016;8:329-32 INTRODUCTION Dental caries are commonly found under existing fixed par - tial dentures, and the occurrence of  recurrent carries neces- sitates installation of  a new crown.",Non-OADS,/arxiv_data1/oa_pdf/c3/e5/jap-8-329.PMC4993847.pdf
"+8229589340: e-mail, odontopia@khu.ac.krReceived September 14, 2015 / Last Revision May 23, 2016 / Accepted  May 30, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/e5/jap-8-329.PMC4993847.pdf
ORCID Janghyun Paek  http://orcid.org/0000-0002-1286-3140 Kwantae Noh  http://orcid.org/0000-0003-3480-7737Ahran Pae  http://orcid.org/0000-0001-8758-0754Hyeonjong Lee  http://orcid.org/0000-0002-5660-9515 Hyeong-Seob Kim  http://orcid.org/0000-0002-0964-0288 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/c3/e5/jap-8-329.PMC4993847.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC4993850.pdf
"Speci ﬁcations Table Subject area Psychology More speci ﬁc sub- ject areaSocial Cognition Type of data Table How data was acquiredPC with Dell Optiplex series ,Intel Pentium Processor (Dual Core ),Windows 7 Professional ,4GB Memory ,500GB Ha ,rd Drive ,and 220’CRT displayer Data format Raw Experimental factorsThree factors :personal association, matching ,and perspective takingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.06.062 2352-3409/ &2016 Published by Elsevier Inc.",Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC4993850.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.cognition.2016.04.015 nCorresponding author at: Department of Psychology, Tsinghua University, Beijing 100084, PR China.",Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC4993850.pdf
Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC4993850.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC4993850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pseudomonas moraviensisDraft genome sequenceDetailed analysisStudent Initiated Microbial Discovery (SIMD)projectMetabolic versatility 1.,Non-OADS,/arxiv_data1/oa_pdf/52/e0/main.PMC4993851.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.004 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/e0/main.PMC4993851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/e0/main.PMC4993851.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Heart development Cardiac regenerationCardiomyocyte proliferationMitochondrial dysfunctionCellular stress response Speci ﬁcations Organism/cell line/tissueMus musculus (129Sv/C57Bl6 mixed genetic background)/embryonic hearts (13.5 days post coitum) Sex femaleSequencer or array typeAffymetrix GeneChip Mouse Genome 430 2.0 arrays Data format Raw and processed Experimental factorsHeterozygous heart conditional Hccs (Holocytochrome c synthase) knockout ( cHccs +/−) versus littermate control female embryos Experimental featuresTotal RNA was isolated from whole 13.5 dpc embryonic hearts and processed for hybridization to Affymetrix arrays.,Non-OADS,/arxiv_data1/oa_pdf/8a/c2/main.PMC4993854.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE720542.,OADS,/arxiv_data1/oa_pdf/8a/c2/main.PMC4993854.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.009 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/c2/main.PMC4993854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/c2/main.PMC4993854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Micrococcus luteusDraft genomeDetailed annotationStudent Initiated Microbial Discovery (SIMD) project Metabolic versatility 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/10/main.PMC4993860.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.006 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/10/main.PMC4993860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/10/main.PMC4993860.pdf
http://www.who.int/men-tal_health/management/depression/definition/en/idex1.html (access:  2012 October).,Non-OADS,/arxiv_data1/oa_pdf/39/9e/MR-15-27977.PMC4993979.pdf
http://www.fac.org.ar/revista/99v28n4/derosa/derosa.htm.,Non-OADS,/arxiv_data1/oa_pdf/4a/cd/MR-15-27979.PMC4993981.pdf
"Ovarian cancers due to their histopatho-logical structures are divided into: serous, mucinous, endometrioid, clear cell, mixed and undifferentiated  carcinoma (source: WHO; http://webcache.googleuser - content.com/search?q=cache:sxun1BsGqPMJ:https:// www.seap.es/documents/228448/528821/01_Prat.pdf+&cd=1&hl=pl&ct=clnk&gl=pl).",Non-OADS,/arxiv_data1/oa_pdf/be/39/MR-15-27980.PMC4993982.pdf
Menopause Review/Przegląd Menopauzalny 15(2) 2016 88cer is 46% (source: http://www.cancerresearchuk.org/ cancerinfo/cancerstats/types/ovary/survival/ovarian-cancer survival statistics).,Non-OADS,/arxiv_data1/oa_pdf/be/39/MR-15-27980.PMC4993982.pdf
http://www.who.int/reproductivehealth/topics/sexual_health/sh_definitions/en/ Pobrano: 07.12.1014.,Non-OADS,/arxiv_data1/oa_pdf/6a/7d/MR-15-27984.PMC4993986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Oncogene (2016) 35,4422 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/1c/ff/onc201627a.PMC4994013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)SFRP2 assists WNT16B to promote cancer resistance Y Sun et al 4334 Oncogene (2016) 4321 –4334 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/d3/1e/onc2015494a.PMC4994019.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/57/3c/bmjqir-u206099-w2510.PMC4994090.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/6d/bmjqir-u212545-w4986.PMC4994091.pdf
Surveillance manual; 2012. http://ngha.med.sa/English/MedicalCities/AlRiyadh/MedicalServices/Documents/SurveillanceManual2012.pdf [accessed 24.04.16].,Non-OADS,/arxiv_data1/oa_pdf/c3/6d/bmjqir-u212545-w4986.PMC4994091.pdf
"Accessed April 24, 2016.http://www.ihi.org/knowledge/Pages/Changes/ImplementtheCentralLineBundle.aspx.",OADS,/arxiv_data1/oa_pdf/c3/6d/bmjqir-u212545-w4986.PMC4994091.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcodeREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
https://www.stepsforward.org/modules/pre-visit-planning.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
https://improvecarenow.org/care-providers/physician-global-assessment.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
https://d3n8a8pro7vhmx.cloudfront.net/improvecarenow/pages/283/attachments/original/1464375801/Model_IBD_Care_Guideline_2016.pdf?1464375801 16.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
https://www.stepsforward.org/modules/intensive-primary-care.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
http://www.aafp.org/practice-management/transformation/pcmh/ advanced/rscm.html?cmpid=_van_596.,Non-OADS,/arxiv_data1/oa_pdf/13/cb/bmjqir-u211063-w4361.PMC4994092.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/c8/bmjqir-u208961-w3675.PMC4994093.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/d6/bmjqir-u209855-w3501.PMC4994094.pdf
Available at: http://cdn.auntminnie.com/user/documents/content_documents/X-Ray_Patient_Positioning_Manual_080402.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/50/d6/bmjqir-u209855-w3501.PMC4994094.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/61/2f/bmjqir-u210300-w4189.PMC4994095.pdf
"HQIP and The Royal College of Psychiatrists 2012.http://www.rcpsych.ac.uk/pdf/NAS%20National%20report%20FINAL.pdf 6 Abdallah N, et al.BMJ Quality Improvement Reports 2016; 5:u210300.w4189.",Non-OADS,/arxiv_data1/oa_pdf/61/2f/bmjqir-u210300-w4189.PMC4994095.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/ac/bmjqir-u212969-w5150.PMC4994096.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/63/57/bmjqir-u210921-w4741.PMC4994097.pdf
Available from: http://www.npsa.nhs.uk/corporate/news/essential-care-after-an-inpatient-fall/(accessed 21 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/57/bmjqir-u210921-w4741.PMC4994097.pdf
Available from: https://www.nice.org.uk/news/article/older-patients-at-high-risk-of-hospital-falls [Accessed 16 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/63/57/bmjqir-u210921-w4741.PMC4994097.pdf
Available from: http://www.herg.gatech.edu/Files/ulrich_role_physical.pdf (accessed 24 May 2016).,OADS,/arxiv_data1/oa_pdf/63/57/bmjqir-u210921-w4741.PMC4994097.pdf
Department of Health (2004) The NHS Knowledge and Skills Framework (NHS KSF) and the development review process.Available from: http://www.msg.scot.nhs.uk/wp-content/uploads/KSF-Handbook.pdf (accessed 21 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/57/bmjqir-u210921-w4741.PMC4994097.pdf
"Rs7077361 (T vs. C, contig position 15509544, assembly GRCh38.p2) is an intronic SNP in ITGA8 (intron 28-29) and it has been linked to an expression quantitative trait loci (eQTL) in brain tissue in the caudate of the basal ganglia using the GTExPortal (http://www.gtexportal.org/home/).",Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"As controls we included spouses of PD patients and individuals without neurological disease visiting the neurology-clinic (=219), blood donors (n=95), and individuals from  the  SNAC-K  (Swedish  National  Study  on  Aging  and  Care  in  Kungsholmen)  project  (n=285) (http://www.snac-k.se ).",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"With our sample size and  an  estimated  minor  allele  frequency  of  0.14  in  individuals  with  European  descent (http://www.ncbi.nlm.nih.gov/SNP ),  we  have  80%  power  to  detect  an  association  with  0.579  <  OR  >  1.572.",Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
The  allele  and  genotype  frequencies  reported  herein  corresponds  to  the frequencies  observed  in  individuals  of  European  descent  in  publically  available  databases (http://www.ncbi.nlm.nih.gov/projects/SNP ).,Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/j.matbio.2004.08.005 ] [PMID: 15579315 ] [2] Schnapp LM, Breuss JM, Ramos DM, Sheppard D, Pytela R. Sequence and tissue distribution of the human integrin alpha 8 subunit: a beta 1- associated alpha subunit expressed in smooth muscle cells.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1091/mbc.6.4.433 ] [PMID: 7626807 ] [4] Zargham  R,  Thibault  G.  Alpha  8  integrin  expression  is  required  for  maintenance  of  the  smooth  muscle  cell  differentiated  phenotype.",Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/http://dx.doi.org/10.1016/j.cardiores.2006.03.003 ] [PMID: 16603140 ] [5] Benoit YD, Lussier C, Ducharme PA, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1042/BC20090060 ] [PMID: 19527220 ] [6] Lill CM, Roehr JT, McQueen MB, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1371/journal.pgen.1002548 ] [PMID: 22438815 ] [7] Foo JN, Tan LC, Liany H, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
[http://dx.doi.org/10.1093/hmg/ddu086 ] [PMID: 24565865 ] [8] Parkinson J.,OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1176/jnp.14.2.223 ] [PMID: 11983801 ] [9] Daniel SE, Lees AJ.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/http://dx.doi.org/10.2147/JPRLS.S38954 ] [11] Supriyanto I, Watanabe Y, Mouri K, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2012.11.002 ] [PMID: 23153507 ] [12] Varnum-Finney B, Venstrom K, Muller U, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/0896-6273(95)90268-6 ] [PMID: 7541634 ] [13] Bossy B, Bossy-Wetzel E, Reichardt LF.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
[http://dx.doi.org/http://dx.doi.org/10.1111/j.1601-183X.2010.00569.x. ],Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/j.ajhg.2013.12.017 ] [16] Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/http://dx.doi.org/10.1016/S0092-8674(00)81903-0 ] [PMID: 9054500 ] [17] Ness D, Ren Z, Gardai S, et al.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1371/journal.pone.0066164 ] [PMID: 23799078 ] [18] Wang M, Wang L, Jiang N, Jia T, Luo Z.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"ITGA8 and Parkinson’s Disease in Sweden The Open Neurology Journal, 2016, Volume 10    29 [http://dx.doi.org/10.1186/1471-2164-14-88 ] [PMID: 23394771 ] [19] Dupont WD, Plummer WD Jr. Power and sample size calculations.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/0197-2456(90)90005-M ] [PMID: 2161310 ] [20] Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"[http://dx.doi.org/10.1016/S0197-2456(98)00037-3 ] [PMID: 9875838 ] [21] Rodriguez S, Gaunt TR, Day IN.",OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
[http://dx.doi.org/http://dx.doi.org/10.1093/aje/kwn359 ] [PMID: 19126586 ] © Ran et al.,OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/32/TONEUJ-10-25.PMC4994103.pdf
http://orthoinfo.aaos.org.,Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
[http://dx.doi.org/10.5301/HIP.2011.8678 ] [PMID: 21960451 ] [2] Sierra RJ.,OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1016/j.ocl.2012.05.011 ] [PMID: 22819162 ] [4] Giori NJ, Trousdale RT.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1177/0363546513488861 ] [PMID: 23669751 ] [6] Friend L, Kelly BT.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1097/MOP.0b013e328320a945 ] [PMID: 19253465 ] [7] Saadat E, Martin SD, Thornhill TS, et al.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s12178-013-9170-2 ] [PMID: 23728614 ] [9] Nassif  NA,  Schoenecker  PL,  Thorsness  R,  Clohisy  JC.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.2106/JBJS.K.01038 ] [PMID: 23138238 ] [10] Peters  CL,  Anderson  LA,  Erickson  JA,  Anderson  AE,  Weiss  JA.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1016/j.arthro.2011.05.018 ] [PMID: 21862276 ] [12] Dippmann C, Thorborg K, Kraemer O, Winge S, Palm H, Hölmich P. Hip arthroscopy with labral repair for femoroacetabular impingement: short-term outcomes.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s00167-014-2885-9 ] [PMID: 24497058 ] [13] Ganz R, Parvizi J, Beck M, Leunig M, Nötzli H, Siebenrock KA.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s12178-013-9172-0 ] [PMID: 23743861 ] [15] Steppacher SD, Tannast M, Ganz R, Siebenrock KA.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s11999-008-0242-3 ] [PMID: 18449617 ] [16] Nwachukwu BU, Rebolledo BJ, McCormick F, Rosas S, Harris JD, Kelly BT.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
[http://dx.doi.org/10.1177/0363546515587719 ] [PMID: 26059179 ] [17] Anders Troelsen M. Assessment of adult hip dysplasia and the outcome of surgical treatment.,Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"Treatment Algorithm for Patients The Open Orthopaedics Journal, 2016, Volume 10    411 [http://dx.doi.org/10.2214/AJR.06.0921 ] [PMID: 17515374 ] [19] Jamali AA, Mladenov K, Meyer DC, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1002/jor.20380 ] [PMID: 17343286 ] [20] Reynolds D, Lucas J, Klaue K. Retroversion of the acetabulum.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1302/0301-620X.81B2.8291 ] [PMID: 10204935 ] [21] Giori NJ, Trousdale RT.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
[http://dx.doi.org/10.1007/s11999-007-0058-6 ] [PMID: 18264856 ] [23] Harris WH.,Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s00256-012-1420-7 ] [PMID: 22584462 ] [27] Leunig M, Ganz R. Evolution of technique and indications for the Bernese periacetabular osteotomy.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1097/BPO.0b013e31828114af ] [PMID: 23764789 ] [29] Pun SY, O’Donnell JM, Kim YJ.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1016/j.rdc.2012.11.004 ] [PMID: 23312416 ] [30] Tibor LM, Leunig M. The pathoanatomy and arthroscopic management of femoroacetabular impingement.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1302/2046-3758.110.2000105 ] [PMID: 23610655 ] [31] Millis MB, Kain M, Sierra R, et al.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1007/s11999-009-0824-8 ] [PMID: 19421831 ] [32] Philippon  MJ,  Wolff  AB,  Briggs  KK,  Zehms  CT,  Kuppersmith  DA.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
[http://dx.doi.org/10.1016/j.arthro.2009.11.003 ] [PMID: 20511033 ] [33] Larson CM.,OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1097/JSA.0b013e3181dc652e ] [PMID: 20473128 ] [34] Harris JD, McCormick FM, Abrams GD, et al.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1016/j.arthro.2012.11.003 ] [PMID: 23544691 ] [35] Ganz R, Klaue K, Vinh TS, Mast JW.",OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1097/00003086-200401000-00002 ] [PMID: 15052994 ] [36] Sierra RJ, Trousdale RT, Ganz R, Leunig M. Hip disease in the young, active patient: evaluation and nonarthroplasty surgical options.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.5435/00124635-200812000-00002 ] [PMID: 19056918 ] [37] Larson CM, Giveans MR, Stone RM.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
[http://dx.doi.org/10.1177/0363546511434578 ] [PMID: 22307078 ] © Jørgensen et al.,Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/TOORTHJ-10-404.PMC4994105.pdf
"[http://dx.doi.org/10.1002/ardp.200900092 ] [PMID: 19753564 ] [3] Pinto,  E.;  Queiroz,  M.J.;  Vale-Silva,  L.A.;  Oliveira,  J.F.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/j.bmc.2008.07.042 ] [PMID: 18678498 ] [4] Daniel, V.P.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/j.saa.2007.11.003 ] [PMID: 18165148 ] [5] Ghorab, M.M.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1080/10426500802505440 ] [6] Darwish, E.S.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/molecules13051066 ] [PMID: 18560329 ] [7] Queiroz, M.J.; Ferreira, I.C.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/j.bmc.2006.06.035 ] [PMID: 16843669 ] [8] Carrillo-Muñoz, A.J.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1586/14787210.3.3.333 ] [PMID: 15954850 ] [9] Chambhare, R.V.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/S0223-5234(02)01442-3 ] [PMID: 12593919 ] [10] El-Sharief,  S.A.;  Micky,  J.A.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1080/10426500307912 ] [11] El-Sherbeny, M.A.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/0223-5234(96)88255-9 ] [12] El-Agrody, A.; El-Latif, A.M.; El-Hady, N.; Fakery, A.; Bedair, A. Heteroaromatization with 4-hydroxycoumarin part II: synthesis of some",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/60600519 ] [13] Rositca, D.N.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/70500420 ] [14] Al-Amiery, A.A.; Al-Bayati, R.; Saour, K.; Radi, M. Cytotoxicity, antioxidant and antimicrobial activities of novel 2-quinolone derivatives derived from coumarins.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1007/s11164-011-0371-2 ] [15] Al-Amiery, A.A.; Musa, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/molecules16086833 ] [PMID: 21832973 ] [16] Kadhum, A.A.; Al-Amiery, A.A.; Musa, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/ijms12095747 ] [PMID: 22016624 ] [17] Kadhum, A.H.; Al-Amiery, A.A.; Sikara, M.; Mohamad, A. Synthesis, structure elucidation and DFT studies of new thiadiazoles.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/0165-1110(82)90015-X ] [PMID: 7043261 ] [20] Chhowala, T.N.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/0162-0134(88)80036-9 ] [PMID: 3137314 ] [24] Makhsumov, A.G.; Normatov, F.A.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1007/BF00777419 ] [25] Ibrahim, S.A.; el-Gahami, M.A.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/0162-0134(91)84063-F ] [PMID: 1940898 ] [26] Jarrahpour, A.A.; Motamedifar, M.; Pakshir, K.; Hadi, N.; Zarei, M. Synthesis of novel azo Schiff bases and their antibacterial and antifungal activities.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.3390/91000815 ] [PMID: 18007481 ] [27] Samadhiya, S.; Halve, H. Synthetic utility of Schiff bases as potential herbicidal agents.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1002/ange.19610730307 ] [29] Gewald, K. Heterocyclen aus CH-aciden nitrilen, VII.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1002/cber.19650981120 ] [30] Ried,  W.;  Nyiondi,  B.E.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1002/jlac.197319730119 ] [31] (a) Fondjo, S.E.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/j.tet.2006.04.037 ] (b) Fondjo, S.E.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
[http://dx.doi.org/10.1002/jhet.757 ],Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1016/j.foodchem.2005.02.033 ] [40] Kumar, K.C.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1111/j.1439-0507.2011.02089.x ] [PMID: 21831103 ] [42] Metwally, M.A.",OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/53/TOMCJ-10-21.PMC4994106.pdf
"[http://dx.doi.org/10.1038/nm0702-673] [PMID: 12091904] [2] Moir S, Chun TW, Fauci AS.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1146/annurev-pathol-011110-130254] [PMID: 21034222] [3] UNAIDS.,OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
Available  from:  http://www.unaids.org/sites/default/files/media_asset/ 20150714_FS_MDG6_Report_en.pdf.,OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/313849] [PMID: 10860902] [5] Hall HI, Li J, McKenna MT.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1111/j.1748-0361.2005.tb00090.x] [PMID: 16092299] [6] Gray KM, Cohen SM, Hu X, Li J, Mermin J, Hall HI.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAI.0000000000000028] [PMID: 24121761] [7] Cohen MS, Chen YQ, McCauley M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1056/NEJMoa1105243] [PMID: 21767103] [8] Lingappa JR, Hughes JP, Wang RS, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1371/journal.pone.0012598] [PMID: 20856886] [9] Khunnawat C, Mukerji S, Havlichek D Jr, Touma R, Abela GS.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2008.04.035] [PMID: 18721528] [10] Autran B, Gorin I, Leibowitch M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0140-6736(83)92058-5] [PMID: 6188005] [11] Barbaro G, Lipshultz SE.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.2001.tb03903.x] [PMID: 11762996] [12] Fisher SD, Lipshultz SE.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1111/j.1749-6632.2001.tb03900.x] [PMID: 11762981] [13] CDC.,Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/313849] [PMID: 10860902] [15] Corallo S, Mutinelli MR, Moroni M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0735-1097(89)90256-8] [PMID: 2926051] [17] De Castro S, Migliau G, Silvestri A, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-9149(94)90501-0] [PMID: 8017317] [19] Heidenreich PA, Eisenberg MJ, Kee LL, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1161/01.CIR.92.11.3229] [PMID: 7586308] [20] Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0735-1097(10)80134-2] [PMID: 1826690] [22] Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0002-8703(99)70500-4] [PMID: 10047635] [23] Flum DR, McGinn JT Jr, Tyras DH.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1378/chest.107.6.1522] [PMID: 7781340] [24] Decker CF, Tuazon CU.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1378/chest.105.2.615] [PMID: 8306779] [25] Karve MM, Murali MR, Shah HM, Phelps KR.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1378/chest.101.5.1461] [PMID: 1582323],Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1001/jama.1986.03380030064029] [PMID: 3723722] [27] Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.7326/0003-4819-104-2-234] [PMID: 3946951] [28] Boulanger E, Gérard L, Gabarre J, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1200/JCO.2005.07.084] [PMID: 15994147] [29] Sanna P, Bertoni F, Zucca E, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1007/s002770050416] [PMID: 9760158] [30] Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1056/NEJM199101313240503] [PMID: 1898769] [31] Maisch B, Seferović PM, Ristić AD, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1016/j.ehj.2004.02.002] [PMID: 15120056] [32] Lewis W. Cardiomyopathy in AIDS: a pathophysiological perspective.,Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1053/pcad.2000.9031] [PMID: 11014331] [33] Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/eurheartj/ehr398] [PMID: 22048682] [34] Guha S, Pande A, Mookerjee S, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-9149(90)90589-S] [PMID: 2371952] [37] Barbaro G, Fisher SD, Lipshultz SE.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S1473-3099(01)00067-6] [PMID: 11871462] [38] Goldblum N, Daefler S, Llana T, Ablashi D, Josephs S, Salahuddin Z. Susceptibility to HIV-1 infection of a human B-lymphoblastoid cell line, DG75, transfected with subgenomic DNA fragments of Epstein-Barr virus.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0735-1097(94)90865-6] [PMID: 7930193] [40] Gopal M, Bhaskaran A, Khalife WI, Barbagelata A.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.2174/157340309788166705] [PMID: 20436855] [41] Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.ahj.2005.07.030] [PMID: 16781213] [42] Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical- pathological study.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1089/aid.1998.14.1071] [PMID: 9718123] [43] Anderson DW, Virmani R, Reilly JM, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0735-1097(88)90213-6] [PMID: 3351145] [44] Kaul S, Fishbein MC, Siegel RJ.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1016/0002-8703(91)91013-D] [PMID: 1858638] [45] Prendergast BD.,OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1136/heart.89.7.793] [PMID: 12807864],Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1056/NEJMra1410150] [PMID: 26222561] [47] Barbaro G, Di Lorenzo G, Soldini M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-200005050-00009] [PMID: 10839591] [48] Pozzan G, Pagliari C, Tuon FF, Takakura CF, Kauffman MR, Duarte MI.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2007.10.057] [PMID: 18222550] [49] Barbaro G, Di Lorenzo G, Soldini M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1161/01.CIR.100.9.933] [PMID: 10468523] [50] Yunis NA, Stone VE.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00042560-199806010-00006] [PMID: 9637579] [51] Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett JD.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.7326/0003-4819-116-4-311] [PMID: 1733387] [52] Bristow MR, Mason JW, Billingham ME, Daniels JR. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.7326/0003-4819-88-2-168] [PMID: 626445] [53] Brown DL, Sather S, Cheitlin MD.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-8703(93)91023-8] [PMID: 8386905] [54] Arsura EL, Ismail Y, Freedman S, Karunakar AR.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-9343(94)90353-0] [PMID: 7985716] [55] Muga R, Sanvisens A, Egea JM, Tor J, Rey-Joly C. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1086/377550] [PMID: 14648455] [56] Sani MU.,Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1007/s00508-008-0935-3] [PMID: 18322768] [57] Yu Q, Larson DF, Watson RR.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0024-3205(03)00260-1] [PMID: 12738029] [58] Liang H, Wang X, Chen H, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.2353/ajpath.2008.070971] [PMID: 18458095] [59] Jacob AJ, Fell GS, Boon NA.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1177/0148607189013006644] [61] Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1001/archinte.160.5.602] [PMID: 10724045] [62] Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1086/505977] [PMID: 16838245] [64] Barbaro G. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.,Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.2174/1568006054553444] [PMID: 16101566] [65] Chastain DB, Henderson H, Stover KR.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.2174/1874613601509010023] [PMID: 25866592] [66] Mesa RA, Edell ES, Dunn WF, Edwards WD.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1016/S0025-6196(11)63616-1] [PMID: 9443676],OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1164/ajrccm.155.3.9117037] [PMID: 9117037] [68] Limsukon A, Saeed AI, Ramasamy V, Nalamati J, Dhuper S. HIV-related pulmonary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1161/01.CIR.89.6.2722] [PMID: 8205687] [70] Zuber JP, Calmy A, Evison JM, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/383037] [PMID: 15095226] [71] Ghofrani  HA,  Friese  G,  Discher  T,  et  al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1183/09031936.03.00057703] [PMID: 14979511] [72] Nunes H, Humbert M, Sitbon O, et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1164/rccm.200204-330OC] [PMID: 12615632] [73] Sitbon  O,  Gressin  V,  Speich  R,  et  al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1164/rccm.200404-445OC] [PMID: 15317666] [74] Schumacher YO, Zdebik A, Huonker M, Kreisel W. Sildenafil in HIV-related pulmonary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-200109070-00026] [PMID: 11546958] [75] Silver MA, Macher AM, Reichert CM, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-9149(84)90554-X] [PMID: 6702667] [76] Vijay V, Aloor RK, Yalla SM, Bebawi M, Kashan F. Pericardial tamponade from Kaposi’s sarcoma: role of early pericardial window.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0002-8703(96)90332-4] [PMID: 8831387] [77] Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0140-6736(91)92513-2] [PMID: 1672911] [78] Duong M, Dubois C, Buisson M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1002/clc.4960200519] [PMID: 9134285] [79] Constantino A, West TE, Gupta M, Loghmanee F. Primary cardiac lymphoma in a patient with acquired immune deficiency syndrome.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1002/1097-0142(19871201)60:11<2801::AID-CNCR2820601134>3.0.CO;2-W] [PMID: 3677014] [80] Little  RF,  Gutierrez  M,  Jaffe  ES,  Pau  A,  Horne  M,  Wilson  W.  HIV-associated  non-Hodgkin  lymphoma:  incidence,  presentation,  and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1001/jama.285.14.1880] [PMID: 11308402] [81] Goldfarb A, King CL, Rosenzweig BP, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/0002-8703(89)90030-6] [PMID: 2686386] [82] Kelsey RC, Saker A, Morgan M. Cardiac lymphoma in a patient with AIDS.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.7326/0003-4819-115-5-370] [PMID: 1863027] [83] Vishnu P, Aboulafia DM.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1200/JCO.2011.41.4193] [PMID: 23045581] [85] Ratner L, Lee J, Tang S, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/eurheartj/16.suppl_O.50] [PMID: 8682102] [87] Lopez JA, Ross RS, Fishbein MC, Siegel RJ.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1016/0002-8703(87)90719-8] [PMID: 3548296],OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0025-7125(05)70500-9] [PMID: 8941233] [89] Currie PF, Sutherland GR, Jacob AJ, Bell JE, Brettle RP, Boon NA.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/eurheartj/16.suppl_B.15] [PMID: 7671917] [90] Cicalini S, Forcina G, De Rosa FG.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1053/jinf.2001.0812] [PMID: 11545570] [91] Nahass RG, Weinstein MP, Bartels J, Gocke DJ.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/infdis/162.4.967] [PMID: 2401795] [92] Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/01.qai.0000243120.67529.78] [PMID: 17099314] [93] Rivera Del Rio JR, Flores R, Meléndez J, Gómez MA, Vila S, Hunter R. Profile of HIV patients with and without bacterial endocarditis.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1056/NEJMoa062744] [PMID: 17460226] [95] Hazenberg MD, Stuart JW, Otto SA, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/338572] [PMID: 11865397] [97] Park  IW,  Wang  JF,  Groopman  JE.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1182/blood.V97.2.352] [PMID: 11154208] [98] Armah KA, McGinnis K, Baker J, et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/cid/cis406] [PMID: 22534147] [99] Farrugia PM, Lucariello R, Coppola JT.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/CRD.0b013e3181b151a3] [PMID: 19690471] [100] Calza L, Pocaterra D, Pavoni M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e31819a292c] [PMID: 19322038] [101] Wang T, Yi R, Green LA, Chelvanambi S, Seimetz M, Clauss M. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.carpath.2015.07.001] [PMID: 26233281] [102] Paladugu R, Fu W, Conklin BS, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0741-5214(03)00770-5] [PMID: 12947275] [103] Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.4049/jimmunol.170.4.1716] [PMID: 12574335] [105] Hsue PY, Deeks SG, Hunt PW.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/infdis/jis200] [PMID: 22577211] [106] Kaplan RC, Sinclair E, Landay AL, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/infdis/jiq071] [PMID: 21220772] [107] Kaplan RC, Sinclair E, Landay AL, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"Cardiovascular Disease in Untreated HIV The Open AIDS Journal, 2016, Volume 10   125 [http://dx.doi.org/10.1016/j.atherosclerosis.2011.03.011] [PMID: 21492857] [108] Kaplan RC, Kingsley LA, Gange SJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e328300581d] [PMID: 18670221] [109] Neuhaus J, Jacobs DR Jr, Baker JV, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/652749] [PMID: 20446848] [110] Calza L, Manfredi R, Verucchi G. Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e328337afdf] [PMID: 20224307] [111] Riddler SA, Smit E, Cole SR, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1001/jama.289.22.2978] [PMID: 12799406] [112] Mujawar Z, Rose H, Morrow MP, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1371/journal.pbio.0040365] [PMID: 17076584] [113] Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1093/cid/cit757] [PMID: 24343580] [114] Third Report of the National Cholesterol Education Program (NCEP).,Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.jacc.2013.11.002] [PMID: 24239923] [116] Friis-Møller N, Weber R, Reiss P, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-200305230-00010] [PMID: 12819520] [117] Behrens G, Dejam A, Schmidt H, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-199907090-00001] [PMID: 10416516] [118] Fontas E, van Leth F, Sabin CA, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1086/381783] [PMID: 14999610] [119] Carr A, Samaras K, Burton S, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-199807000-00003] [PMID: 9619798] [120] Walli R, Herfort O, Michl GM, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-199815000-00001] [PMID: 9814858] [121] Fellay J, Boubaker K, Ledergerber B, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S0140-6736(01)06413-3] [PMID: 11684213] [122] Lu CL, Lin YH, Wong WW, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.jmii.2010.08.003] [PMID: 21524961] [123] Overton ET, Arathoon E, Baraldi E, Tomaka F. Effect of darunavir on lipid profile in HIV-infected patients.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1310/hct1305-256] [PMID: 23134626] [124] Galli M, Ridolfo AL, Adorni F, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00042560-200201010-00003] [PMID: 11782586] [125] Crane HM, Grunfeld C, Willig JH, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e328341f925] [PMID: 21150555] [126] Tungsiripat M, Kitch D, Glesby MJ, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32833ad8b4] [PMID: 20495438] [127] van der Valk M, Kastelein JJ, Murphy RL, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-200112070-00008] [PMID: 11740191] [128] Lee FJ, Carr A. Tolerability of HIV integrase inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/COH.0b013e328356682a] [PMID: 22886031] [129] Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/S1474-4422(12)70205-3] [PMID: 22995692] [130] de Gaetano Donati K, Rabagliati R, Tumbarello M, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1097/00002030-200303280-00020] [PMID: 12646805] [131] Elkind MS, Luna JM, Moon YP, et al.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.109.571299] [PMID: 20075350] [132] Tinkle BT, Ngo L, Luciw PA, Maciag T, Jay G. Human immunodeficiency virus-associated vasculopathy in transgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1371/journal.pone.0008170] [PMID: 19997643] [134] Lo J, Plutzky J.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1093/infdis/jis201] [PMID: 22577210] [135] Ovbiagele B, Nath A.",OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
[http://dx.doi.org/10.1212/WNL.0b013e31820a0cfc] [PMID: 21248273] © Chastain et al.,OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/29/TOAIDJ-10-113.PMC4994107.pdf
"[http://dx.doi.org/10.1016/j.juro.2007.08.089 ] [PMID: 18006012 ] [2] S.C. Campbell, V. Krishnamurthi, G. Chow, J. Hale, J. Myles, and A.C. Novick, ""Renal cryosurgery: experimental evaluation of treatment parameters"", Urology , vol.",Non-OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/S0090-4295(98)00169-1 ] [PMID: 9671865 ] [3] J.L.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.2214/AJR.07.3706 ] [PMID: 18806159 ] [4] C.C.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/S0011-2240(02)00125-6 ] [PMID: 12482382 ] [5] T.D.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
"[http://dx.doi.org/10.1016/j.juro.2010.06.003 ] [PMID: 20719341 ] [6] B. J. Donnelly, J. C. Saliken, P. M. Brasher, S. D. Ernst, J. C. Rewcastle, and H. Lau, ""A randomized trial of external beam radiotherapy versus  cryoablation in patients with localized prostate cancer"", Cancer.",OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1002/cncr.24779 ] [7] J.L.,Non-OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1053/j.tvir.2007.08.005 ] [PMID: 17980318 ] [8] J.S.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
"[http://dx.doi.org/10.1016/j.juro.2008.04.027 ] [PMID: 18550117 ] [9] H. Wang, P.J.",OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
"[http://dx.doi.org/10.1148/radiol.2351030747 ] [PMID: 15798173 ] [10] A. Zemlyak, W.H.",OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/j.jamcollsurg.2010.03.020 ] [PMID: 20610251 ] [11] P.E.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/j.urology.2006.03.066 ] [PMID: 16857453 ] [12] P.J.,Non-OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
"[http://dx.doi.org/10.1016/j.jvir.2009.05.038 ] [PMID: 19695903 ] [13] J.K. Seifert, C.D.",OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/j.cryobiol.2003.10.007 ] [PMID: 14697733 ] [14] B.K.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1089/end.2006.20.1101 ] [PMID: 17206911 ],Non-OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1007/s10147-006-0654-6 ] [PMID: 17443274 ] [16] J.L.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
[http://dx.doi.org/10.1016/j.juro.2009.09.072 ] [PMID: 20022060 ] © Rau et al.,OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/46/TOBEJ-10-62.PMC4994113.pdf
Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/83/srep16614.PMC4994120.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/3d/83/srep16614.PMC4994120.pdf
[http://dx.doi.org/10.1001/jama.1958.02990220027008 ] [PMID: 13538738 ],Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
[http://dx.doi.org/10.1055/s-2007-1013899 ] [PMID: 2522252 ] [3] Cooley DA.,OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1111/j.1540-8191.1989.tb00282.x ] [PMID: 2535278 ] [4] Mickleborough LL, Carson S, Ivanov J.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1067/mtc.2001.112633 ] [PMID: 11279407 ] [5] Mickleborough LL, Maruyama H, Liu P, Mohamed S. Results of left ventricular aneurysmectomy with a tailored scar excision and primary closure technique.",Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/j.ejheart.2006.12.003 ] [PMID: 17257894 ] [7] Jones RH, White H, Velazquez EJ, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/j.jacc.2009.11.102 ] [PMID: 20670760 ] [8] Marui A, Nishina T, Saji Y, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1097/00005344-200309000-00008 ] [PMID: 12960682 ] [10] Massoudy P, Zahler S, Freyholdt T, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/S0022-5223(00)70138-3 ] [PMID: 10694618 ] [11] Marui A, Nishina T, Saji Y, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1093/bja/81.2.147 ] [PMID: 9813513 ] [14] Tritapepe L, De Santis V, Vitale D, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1093/bja/aen367 ] [PMID: 19151048 ] [15] Ikonomidis I, Parissis JT, Paraskevaidis I, et al.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/j.ejheart.2007.10.002 ] [PMID: 18062901 ] [16] Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass.",Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2010.01.031 ] [PMID: 20381078 ] [20] Burkhoff D, Wechsler AS.",OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2006.04.045 ] [PMID: 16935094 ] [21] Artrip JH, Oz MC, Burkhoff D. Left ventricular volume reduction surgery for heart failure: a physiologic perspective.",Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
[http://dx.doi.org/10.1067/mtc.2001.116208 ] [PMID: 11581612 ],Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
[http://dx.doi.org/10.1016/j.jtcvs.2007.01.088 ] [PMID: 17662762 ] © Temizturk et al.,OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/27/TOCMJ-10-138.PMC4994121.pdf
"There are many ways to determine colorectal cancer such as the gemokult test, immunoassay, colonoscopy, computed  tomography  (CT),  magnetic  resonance  imaging  (MRI),  and  positron  emission  tomography  (PET) (http://www.globality-health.com/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
"Before signing the  consent  form,  the  participant  could  refuse  to  take  part  in  the  study” (https://bioethicsarchive.georgetown.edu/nbac/clinical/Chap3.htm ).",Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
"The Kolmogorov-Smirnov test, Student t-test,  Mann-Whitney  U-test,  ROC-analysis,  discriminant  analysis  and  binary  logistic  regression  were  used (http://itl.nist.gov/div898/handbook/index.htm ).",OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
Available from: http://www.worldgastroenterology.org/guidelines/global-guidelines/colorectal- cancer-screening/colorectal-cancer-screening-english [3] K.G.,Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
[http://dx.doi.org/10.1089/107555302317371442 ] [PMID: 12006123 ] [19] D.A.,Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
[http://dx.doi.org/10.1063/1.1360700 ] [20] K.G.,Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
[http://dx.doi.org/10.1016/S0140-6736(96)03430-7 ] [PMID: 8942774 ] [29] E.I.,OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/2f/TOBEJ-10-72.PMC4994194.pdf
"[http://dx.doi.org/10.1016/j.arth.2004.06.033 ] [PMID: 16376259 ] [7] Chen CE, Wang JW, Juhn RJ.",OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"[http://dx.doi.org/10.1007/s00264-007-0366-1 ] [PMID: 17483946 ] [8] Beaulé PE, Matta JM, Mast JW.",OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
[http://dx.doi.org/10.5435/00124635-200207000-00003 ] [PMID: 15089074 ] [9] El-Mowafi H. Outcome of pelvic support osteotomy with the Ilizarov method in the treatment of the unstable hip joint.,Non-OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"[http://dx.doi.org/10.1016/j.injury.2010.06.016 ] [PMID: 20638660 ] [11] Singh S, Lahiri A, Iqbal M. The results of limb lengthening by callus distraction using an extending intramedullary nail (Fitbone) in non- traumatic disorders.",OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"[http://dx.doi.org/10.1302/0301-620X.88B7.17618 ] [PMID: 16799000 ] [12] García-Cimbrelo  E,  Curto  de  la  Mano  A,  García-Rey  E,  Cordero  J,  Marti-Ciruelos  R.  The  intramedullary  elongation  nail  for  femoral lengthening.",Non-OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"[http://dx.doi.org/10.1302/0301-620X.84B7.12984 ] [PMID: 12358388 ] [13] Götz J, Schellman WD.",OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/44/TOORTHJ-10-232.PMC4994195.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ae/a1/10.1177_2325967116663185.PMC4994398.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/43/e7/10.1177_2325967116662251.PMC4994399.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/de/ac/10.1177_2058460116645831.PMC4994404.pdf
"Area under visual gradingcharacteristics curves (17) were used to evaluate qualitative image quality, using OR-DBM MRMC2.5 software (available from http://perception.radiology.",OADS,/arxiv_data1/oa_pdf/de/ac/10.1177_2058460116645831.PMC4994404.pdf
Available at: http://static1.squarespace.,Non-OADS,/arxiv_data1/oa_pdf/de/ac/10.1177_2058460116645831.PMC4994404.pdf
EUR 16262 2004 Available at: http://www.msct.eu/CT_Quality_Criteria.htm#Download% 20the%202004%20CT%20Quality%20Criteria (accessed January 2016).,Non-OADS,/arxiv_data1/oa_pdf/de/ac/10.1177_2058460116645831.PMC4994404.pdf
"Ageing and lifecourse, http://www.who.int/age - ing/en/ Yuan P , Raz N (2014) Prefrontal cortex and executive functions in healthy  adults: a meta-analysis of structural neuroimaging studies.",OADS,/arxiv_data1/oa_pdf/7a/9f/NRR-11-1067.PMC4994441.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/5a/rjw140.PMC4994511.pdf
Camilleri M. Acute Colonic Pseudo-Obstruction (Ogilvie ’s Syndrome) http://www.uptodate.com (updated 26 March 2015; 31 March 2016 date last accessed).2.,Non-OADS,/arxiv_data1/oa_pdf/68/5a/rjw140.PMC4994511.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/de/rjw143.PMC4994514.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/3f/de/rjw143.PMC4994514.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/04/rjw139.PMC4994521.pdf
http://www.ndc.scot.nhs.,Non-OADS,/arxiv_data1/oa_pdf/0d/97/10.1177_0269216315627122.PMC4994701.pdf
"End of life  care local authority profiles – indicators metadata guide,  http://www.endoflifecare-intelligence.org.uk/view?rid=511  13.",Non-OADS,/arxiv_data1/oa_pdf/0d/97/10.1177_0269216315627122.PMC4994701.pdf
"BMC Neurol 2014; 14: 59, http://www.biomedcen- tral.com/1471-2377/14/59 (accessed 4 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/97/10.1177_0269216315627122.PMC4994701.pdf
Baseline Study and Regional Economic Profile for Dumfries  and Galloway Regional Economic Strategy 2014–2020 http://crichtonobservatory.org.uk/index.php/component/content/article/98-data-themes/995-baseline-study-and- regional-economic-profile-for-dumfries-and-galloway- regional-economic-strategy-2014-2020  16.,Non-OADS,/arxiv_data1/oa_pdf/0d/97/10.1177_0269216315627122.PMC4994701.pdf
"Percentage of end of life spent at home or in a community  setting, http://www.isdscotland.org/Health-Topics/Health-and-Social-Community-Care/Publications/data-tables.asp?id=1462#1462  18.",Non-OADS,/arxiv_data1/oa_pdf/0d/97/10.1177_0269216315627122.PMC4994701.pdf
Available at: http://www.fda.gov/.,Non-OADS,/arxiv_data1/oa_pdf/3a/97/10.1177_1757177416657162.PMC4994702.pdf
223 https://www.gov.uk/drug-device-alerts/medical-device-alert-all-med- ical-devices-and-medicinal-products-containing-chlorhexidine-risk-of-anaphylactic-reaction-due-to-chlorhexidine-allergy (accessed 17 February 2016).,Non-OADS,/arxiv_data1/oa_pdf/3a/97/10.1177_1757177416657162.PMC4994702.pdf
Available at: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-medical-technologies/Medical-technologies-evaluation-programme-methods-guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/97/10.1177_1757177416657162.PMC4994702.pdf
Available at: https://www.nice.org.uk/guidance/cg139.,Non-OADS,/arxiv_data1/oa_pdf/3a/97/10.1177_1757177416657162.PMC4994702.pdf
Available at: https://www.nice.org.uk/guidance/mtg25.,Non-OADS,/arxiv_data1/oa_pdf/3a/97/10.1177_1757177416657162.PMC4994702.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/d3/evv015.PMC4994717.pdf
Supplementary Material Supplementary ﬁgures S1–S3 andtables S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/02/d3/evv015.PMC4994717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/evv016.PMC4994718.pdf
"8, 2064 –2074 http://dx.doi.org/10.1080/21645515.2016.1165908",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis 1979; 140:48-53; PMID:458200; http://dx.doi.org/10.1093/infdis/140.1.48 [2] Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, P €a€akk€o PK, Gilardi P, Stratford-Perricaudet LD, Perri- caudet M. Adenovirus-mediated transfer of a recombinant a1-anti- trypsin gene to the lung epithelium in vivo.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Science 1991; 252:431-4;PMID:2017680; http://dx.doi.org/10.1126/science.2017680 [3] Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nat Med 2000; 6:879-85; PMID:10932224; http://dx.doi.org/10.1038/78638 [4] Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Science 1996; 274:373-6; PMID:8832876; http://dx.doi.org/10.1126/science.274.5286.373 [5] Lasaro MO, Ertl HC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Therapy 2009; 17:1333-9; http://dx.doi.org/10.1038/ mt.2009.130 [6] Tatsis N, Ertl HC.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Therapy 2004; 10:616-29; http://dx.doi.org/10.1016/j.ymthe.2004.07.013 [7] Walsh MP, Seto J, Liu EB, Dehghan S, Hudson NR, Lukashev AN, Ivanova O, Chodosh J, Dyer DW, Jones MS, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Clin Microbiol 2011; 49:3482-90; PMID:21849694; http://dx.doi.org/10.1128/JCM.00156-11 [8] Wang X, Xing M, Zhang C, Yang Y, Chi Y, Tang X, Zhang H, Xiong S, Yu L, Zhou D. Neutralizing antibody r esponses to enterovirus and ade- novirus in healthy adults in China.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Emerg Microbes Infect 2014; 3:e30; PMID:26038738; http://dx.doi.org/10.1038/emi.2014.30 [9] Hendrix RM, Lindner JL, Benton FR, Monteith SC, Tuchscherer MA, Gray GC, Gaydos JC.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in US army trainees.Emerging Infect Dis 1999; 5:798-801; PMID:10603214; http://dx.doi.org/10.3201/eid0506.990609 [10] Xia D, Henry LJ, Gerard RD, Deisenhofer J.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Structure 1994; 2:1259-70; PMID:7704534; http://dx.doi.org/10.1016/S0969-2126(94)00126-X [11] Saban SD, Silvestry M, Nemerow GR, Stewart PL.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2006; 80:12049-59; PMID:17005667; http://dx.doi.org/ 10.1128/JVI.01652-06 [12] Liu H, Jin L, Koh SB, Atanasov I, Schein S, Wu L, Zhou ZH.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Biol Chem 2001; 276:45120-7; PMID:11571294; http://dx.doi.org/10.1074/jbc.M106386200 [14] Ugai H, Dobbins GC, Wang M, Le LP, Matthews DA, Curiel DT.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Virology 2012; 432:283-95; PMID:22717133; http://dx.doi.org/10.1016/j.virol.2012.05.028 [15] Matthews DA.,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2001; 75:1031-8; PMID:11134316; http://dx.do i.org/10.1128/JVI.75.2.1031-1038.2001 [16] Johnson JS, Osheim YN, Xue Y, Emanuel MR, Lewis PW, Banko- vich A, Beyer AL, Engel DA.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2004; 78:6459-68; PMID:15163739; http://dx.doi.org/10.1128/JVI.78.12.6459-6468.2004 [17] Xue Y, Johnson JS, Ornelles DA, Lieberman J, Engel DA.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2005; 79:2474-83; PMID:15681448;http://dx.doi.org/10.1128/JVI.79.4.2474-2483.2005[18] Karen KA, Hearing P. Adenovirus core protein VII protects the viral genome from a DNA damage response at early times afterinfection.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2011; 85:4135-42; PMID:21345950; http://dx.doi.org/10.1128/JVI.02540-10 [19] Anderson CW, Young ME, Flint SJ.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Virology 1989; 172:506-12;PMID:2800334; http://dx.doi.org/10.1016/0042-6822(89)90193-1 [20] Crawford-Miksza L, Schnurr DP.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2007;81:1680-9; PMID:17108028; http://dx.doi.org/10.1128/JVI.02023-06 [22] Zhang C, Yang Y, Chi Y, Yin J, Yan L, Ku Z, Liu Q, Huang Z, Zhou D. Hexon-modi ﬁed recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2015; 33:5087-94; PMID:26296491; http://dx.doi.org/ 10.1016/j.vaccine.2015.08.016 [23] Zhou D, Wu TL, Emmer KL, Kurupati R, Tuyishime S, Li Y, Giles- Davis W, Zhou X, Xiang Z, Liu Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J MolBiol 2008; 383:923-34; PMID:18786542; http://dx.doi.org/10.1016/j.jmb.2008.08.054 [27] Wodrich H, Henaff D, Jammart B, Segura-Morales C, Seelmeir S, Coux O, Ruzsics Z, Wiethoff CM, Kremer EJ.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PLoS Pathogens 2010; 6:e1000808; PMID:20333243; http://dx.doi.org/10.1371/journal.ppat.1000808 [28] Fabry CM, Rosa-Calatrava M, Conway JF, Zubieta C, Cusack S, Ruigrok RW, Schoehn G. A quasi-atomic model of human adenovi-rus type 5 capsid.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"EMBO J 2005; 24:1645-54; PMID:15861131; http://dx.doi.org/10.1038/sj.emboj.7600653 [29] Colby WW, Shenk T. Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Virol 2011; 410:192-200; http://dx.doi.org/10.1016/j.virol.2010.10.040 [31] Havenga MJ, Holterman L, Melis I, Smits S, Kaspers J, Heemskerk E, van der Vlugt R, Koldijk M, Schouten GJ, Hateboer G, et al.Serum-free transient protein production system based on adenovi- ral vector and PER.C6 technology: high yield and preserved bioac- tivity.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Biotechnol Bioengineering 2008; 100:273-83; http://dx.doi.org/10.1002/bit.21757 [32] Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithi- vas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Science 1997; 275:1320-3; PMID:9036860; http://dx.doi.org/ 10.1126/science.275.5304.1320 [33] Kirby I, Lord R, Davison E, Wickham TJ, Roelvink PW, Kovesdi I, Sutton BJ, Santis G. Adenovirus type 9 ﬁber knob binds to the cox- sackie B virus-adenovirus receptor (CAR) with lower af ﬁnity than ﬁber knobs of other CAR-binding adenovirus serotypes.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
J Virol 2001; 75:7210-4; PMID:11435605; http://dx.doi.org/10.1128/JVI.75.15.7210-7214.20012070 C. ZHANG AND D. ZHOU,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Urology 2002; 60:531-6; PMID:12350512; http://dx.doi.org/10.1016/S0090-4295(02)01748-X [36] Fuxe J, Liu L, Malin S, Philipson L, Collins VP, Pettersson RF.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Int J Cancer J Int Du Cancer2003; 103:723-9; http://dx.doi.org/10.1002/ijc.10891 [37] Nalbantoglu J, Pari G, Karpati G, Holland PC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Hum Gene Therapy 1999;10:1009-19; http://dx.doi.org/10.1089/10430349950018409 [38] Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, Ornelles DA, Gooding LR.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"JVirol 2009; 83:2417-28; PMID:19109384; http://dx.doi.org/10.1128/ JVI.02392-08 [39] Smith TA, Idamakanti N, Marshall-Neff J, Rollence ML, Wright P, Kaloss M, King L, Mech C, Dinges L, Iverson WO, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Human Gene Therapy 2003; 14:1595-604; PMID:14633402; http://dx.doi.org/10.1089/104303403322542248 [40] Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular r eceptor for group B adenoviruses.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nat Med 2003; 9:1408-12; PMID:14566335; http://dx.doi.org/10.1038/nm952 [41] Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nat Med 2011; 17:96-104;PMID:21151137; http://dx.doi.org/10.1038/nm.2270 [42] Nilsson EC, Storm RJ, Bauer J, Johansson SM, Lookene A, Angstrom J, Hedenstr €om M, Eriksson TL, Fr €a n g s m y rL ,R i n a l d iS ,e ta l .T h eG D 1 a glycan is a cellular receptor for adenoviruses causing epidemic kerato-conjunctivitis.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Nat Med 2011; 17: 105-9; PMID:21151139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Trends Pharmacological Sci 2012; 33:442-8; http://dx.doi.org/10.1016/j.tips.2012.04.005 [46] Davison E, Diaz RM, Hart IR, Santis G, Marshall JF.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Gene Med 2001; 3:550-9; PMID:11778901; http://dx.doi.org/10.1002/jgm.223 [48] Colin M, Mailly L, Rogee S, D ’Halluin JC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Therapy 2005; 11:224-36;http://dx.doi.org/10.1016/j.ymthe.2004.10.007 [49] Choi JW, Lee JS, Kim SW, Yun CO. Evolution of oncolytic adenovi- rus for cancer treatment.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Adv Drug Delivery Rev 2012; 64:720-9; http://dx.doi.org/10.1016/j.addr.2011.12.011[50] Ura T, Okuda K, Shimada M. Developments in Viral Vector-Based Vaccines.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccines 2014; 2:624-41; PMID:26344749; http://dx.doi.org/10.3390/vaccines2030624 [51] Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet 2008; 372:1881-93; PMID:19012954; http://dx.doi.org/ 10.1016/S0140-6736(08)61591-3 [52] Janes H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloS One 2012; 7:e43396; http://dx.doi.org/10.1371/journal.pone.0043396 [53] Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis 2013;207:240-7; PMID:23125444; http://dx.doi.org/10.1093/infdis/jis670 [55] Keefer MC, Gilmour J, Hayes P, Gill D, Kopycinski J, Cheeseman H, Cashin-Cox M, Naarding M, Clark L, Fernandez N, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloS One 2012; 7:e41936; PMID:22870265; http://dx.doi.org/10.1371/journal.pone.0041936 [56] Gray G, Buchbinder S, Duerr A. Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efﬁcacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vac- cine.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Curr Opinion HIV AIDS 2010; 5:357-61; http://dx.doi.org/10.1097/COH.0b013e32833d2d2b [57] Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Clin Invest2012; 122:359-67; PMID:22201684; http://dx.doi.org/10.1172/ JCI60202 [58] Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2005; 23:1029-36; PMID:15620476; http://dx.doi.org/10.1016/j.vaccine.2004.07.043 [60] Peters W, Brandl JR, Lindbloom JD, Martinez CJ, Scallan CD, Trager GR, Tingley DW, Kabongo ML, Tucker SN.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2013; 31:1752-8; PMID:23357198; http://dx.doi.or g/10.1016/j.vaccine.2013.01.023 [61] Gurwith M, Lock M, Taylor EM, Ishioka G, Alexander J, Mayall T, Ervin JE, Greenberg RN, Strout C, Treanor JJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet Infect Dis 2013; 13:238-50; PMID:23369412; http://dx.doi.org/10.1016/S1473-3099(12)70345-6 [62] Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Rob- bins PD, Swayne DE, Donis RO, Katz JM, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis1990; 161:27-30; PMID:2295855; http://dx.doi.org/10.1093/infdis/161.1.27 [64] Vos A, Neubert A, Pommerening E, Muller T, Dohner L, Neubert L, Hughes K. Immunogenicity of an E1-deleted recombinant humanadenovirus against rabies by different routes of administration.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J General Virol 2001; 82:2191-7; http://dx.doi.org/10.1099/0022- 1317-82-9-2191 [65] Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, Dubois E, Thiery R, Br /C19eard E, Tordo N, Richardson J, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine2011; 29:1304-10; PMID:21134446; http://dx.doi.org/10.1016/j.vaccine.2010.11.068 [66] Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Virol 2014; 450-451:243-9; http://dx.doi.org/10.1016/j.virol.2013.12.029 [67] Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Worara- tanadharm J, Chen L, Hayes C, Dong JY, Porter K, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2008; 82:6927-34; PMID:18480438; http://dx.doi.org/10.1128/JVI.02724-07 [68] Jaiswal S, Khanna N, Swaminathan S. Replication-defective adeno- viral vaccine vector for the induction of immune responses to den- gue virus type 2.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2003; 77:12907-13; PMID:14610213; http://dx.doi.org/10.1128/JVI.77.23.12907-12913.2003 [69] Khanam S, Pilankatta R, Khanna N, Swaminathan S. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetra- valent antigen elicits immune responses against all four dengueviruses in the presence of prior AdV5 immunity.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Vaccine 2009; 27:6011-21; PMID:19665609; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Immunol 2015; 145:476-84; http://dx.doi.org/10.1111/imm.12462 [71] Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A. Immunoge-nicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2014; 32:5975-82; PMID:25192975; http://dx.doi.org/10.1016/j.vaccine.2014.08.058 [72] Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchi- kov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2010; 29:304-13;PMID:21034824; http://dx.doi.org/10.1016/j.vaccine.2010.10.037 [73] Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nat Med 2011; 17:1128-31;PMID:21857654; http://dx.doi.org/10.1038/nm.2447 [74] Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2011; 85:4222-33; PMID:21325402; http://dx.doi.org/10.1128/JVI.02407-10 [75] Wong G, Richardson JS, Cutts T, Qiu X, Kobinger GP.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Anti Viral Res2015; 116:17-9; http://dx.doi.org/10.1016/j.antiviral.2015.01.001 [76] Wong G, Richardson JS, Pillet S, Racine T, Patel A, Soule G, Ennis J, Turner J, Qiu X, Kobinger GP.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis 2015; 212 Suppl 2:S379-83; PMID:25957963; http://dx.doi.org/10.1093/infdis/jiv102 [77] Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet Infect dis 2015; 16:31-42; PMID:26546548; http://dx.doi.org/10.1016/S1473-3099(15)00362-X [78] Choi JH, Schafer SC, Zhang L, Kobinger GP, Juelich T, Freiberg AN, Croyle MA.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Pharmaceutics 2012; 9:156-67; http://dx.doi.org/10.1021/mp200392g [79] Li W, Li M, Deng G, Zhao L, Liu X, Wang Y. Prime-boost vaccina- tion with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacte-rium tuberculosis induces robust antigen-speci ﬁc immune responses in mice.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Med 2012; 18:647-58; PMID:22396020;http://dx.doi.org/10.2119/molmed.2011.00222 [81] Hoft DF, Blazevic A, Stanley J, Landry B, Sizemore D, Kpamegan E, Gearhart J, Scott A, Kik S, Pau MG, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Vaccine 2012; 30:2098-108;PMID:22296955; http://dx.doi.org/10.1016/j.vaccine.2012.01.048 [82] Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige-Don N, Zganiacz A, Yin C, Heriazon A, Damjanovic D, Puri L, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Sci Translational Med 2013; 5:205ra134; http://dx.doi.org/10.1126/scitranslmed.3006843 [83] Tamminga C, Sedegah M, Maiolatesi S, Fedders C, Reyes S, Reyes A, Vasquez C, Alcorta Y, Chuang I, Spring M, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Hum Vaccines Immunotherapeutics 2013; 9:2165-77; http://dx.doi.org/10.4161/hv.24941 [84] Schwenk R, Banania G, Epstein J, Kim Y, Peters B, Belmonte M, Ganeshan H, Huang J, Reyes S, Stryhn A, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Malaria J 2013; 12:376; http://dx.doi.org/10.1186/1475-2875-12-376 [85] Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tam- minga C, Patterson N, Guerrero M, Bennett JW, McGrath S, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloS One 2013; 8:e55571; PMID:23457473; http://dx.doi.org/10.1371/journal.pone.0055571 [86] Ouedraogo A, Tiono AB, Kargougou D, Yaro JB, Ouedraogo E, Kabore Y ,K a n g o y eD ,B o u g o u m aE C ,G a n s a n eA ,H e n r iN ,e ta l .Ap h a s e1 b randomized, controlled, double-blind ed dosage-escalation trial to evalu- ate the safety, reactogenicity and i mmunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults18 to 45 years of age.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Infect Immunity 2015; 83:268-75; http://dx.doi.org/10.1128/IAI.02626-142072 C. ZHANG AND D. ZHOU,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Mol Therapy 2012; 20:2355-68; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Adv Virus Res 1999; 54:1-13; PMID:10547672; http://dx.doi.org/10.1016/S0065- 3527(08)60363-2 [90] Kochanek S. High-capacity adenoviral vectors for gene transfer and somatic gene therapy.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Hum Mol Genet-ics 2003; 12:1287-99; http://dx.doi.org/10.1093/hmg/ddg141 [94] Dicks MD, Guzman E, Spencer AJ, Gilbert SC, Charleston B, Hill AV, Cottingham MG.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Vaccine 2015; 33:1121-8; PMID:25629523; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2013; 87:1359-72; PMID:23175355; http://dx.doi.org/10.1128/ JVI.02055-12 [96] Teigler JE, Iampietro MJ, Barouch DH.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Virol 2012; 86:9590-8; PMID:22787208; http://dx.doi.org/10.1128/JVI.00740-12 [97] Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
J Virol 2003; 77:10780-9; PMID:14512528; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet Infect Dis 2015; 15:1041-8; PMID:26333337; http://dx.doi.org/10.1016/S1473-3099(15)00266-2 [99] Richert L, Lhomme E, Fagard C, Levy Y, Chene G, Thiebaut R. Recent developments in clinical trial designs for HIV vaccine research.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Hum Vaccines Immunotherapeutics 2015; 11:1022-9;http://dx.doi.org/10.1080/21645515.2015.1011974 [100] Perreau M, Pantaleo G, Kremer EJ.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Exp Med 2008; 205:2717-25; PMID:18981239; http://dx.doi.org/10.1084/jem.20081786 [101] Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, Hayes P, Lieber A, Athanasopoulos T, Bachy V, Csomor E, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"N Eng J Med 2013; 369:2083-92; http://dx.doi.org/10.1056/NEJMoa1310566 [104] Cheng C, Wang L, Ko SY, Kong WP, Schmidt SD, Gall JG, Colloca S, Seder RA, Mascola JR, Nabel GJ.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Combination recombinant sim- ian or chimpanzee adenoviral vectors for vaccine development.Vaccine 2015; 33:7344-51; PMID:26514419; http://dx.doi.org/10.1016/j.vaccine.2015.10.023 [105] Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA, Jr, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis 2015; 211:518-28; PMID:25165165; http://dx.doi.org/ 10.1093/infdis/jiu485 [106] Baden LR, Liu JY, Li HL, Johnson JA, Walsh SR, Kleinjan JA, Engel- son BA, Peter L, Abbink P, Milner DA, Jr, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J Infect Dis 2015; 211:518-28; PMID:25165165 http://dx.doi.org/ 10.1093/infdis/jiu485 [107] Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"J AIDS Clin Res 2015; 6:23; http://dx.doi.org/10.4172/2155-6113.1000461 [108] Van Kampen KR, Shi ZK, Gao P, Zhang JF, Foster KW, Chen DT, Marks D, Elmets CA, Tang DC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Vaccine 2005; 23:1029-36; PMID:15620476; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloS One 2013; 8; http://dx.doi.org/10.1371/ journal.pone.0062496 [110] Webby RJ, Weaver EA.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloS One 2015; 10:e0115476; PMID: 25629161; http://dx.doi.org/10.1371/journal.pone.0115476 [112] Zhang H, Tang X, Zhu C, Song Y, Yin J, Xu J, Ertl HC, Zhou D. Adenovirus-mediated arti ﬁcial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal in ﬂuenza virus chal- lenge.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nat Rev Immunol 2003; 3:677-85; PMID:12974482; http://dx.doi.org/10.1038/nri1154 [114] Feldmann H, Geisbert TW.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet 2011; 377:849-62; PMID:21084112; http://dx.doi.org/10.1016/S0140-6736 (10)60667-8 [115] Sacks JA, Zehe E, Redick C, Bah A, Cowger K, Camara M, Diallo A, Gigo AN, Dhillon RS, Liu A.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Global Health Sci Practice 2015; 3:646-59; http://dx.doi.org/ 10.9745/GHSP-D-15-00207 [116] Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Nature 2000; 408:605-9; PMID:11117750; http://dx.doi.org/ 10.1038/35046108HUMAN VACCINES & IMMUNOTHERAPEUTICS 2073,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Nature2003; 424:681-4; PMID:12904795; http://dx.doi.org/10.1038/ nature01876 [118] Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"N Eng J Med 2014; PMID: 25426834; http://dx.doi.org/10.1056/NEJMoa1410863 [119] Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Gynecologic Oncol 2004; 94:442-8; http://dx.doi.org/10.1016/j.ygyno.2004.05.041 [121] Wu J, Zhu Y, Xu C, Xu H, Zhou X, Yang J, Xie Y, Tao M. Adenovi- rus-mediated p53 and ING4 gene cotransfer elicits synergistic anti-tumor effects through enhancement of p53 acetylation in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Head Neck 2011; 33:131-4; PMID:20222046; http://dx.doi.org/10.1002/hed.21364 [123] Nie B, Shen Z, Wen JB, Wong OG, Hsueh WD, Huo LF, Kung HF, Jiang B, Lin MC.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"M ol Cancer Therapeutics 2008; 7:2855- 65; http://dx.doi.org/10.1158/1535-7163.MCT-08-0366 [124] Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C, Hamm J, Yoo G, Baselga J, Murphy BA, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Lancet Oncol 2013; 14:823-33;PMID:23850491; http://dx.doi.org/10.1016/S1470-2045(13)70274-2 [126] Xie J, Guo X, Liu F, Luo J, Duan F, Tao X.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Cell Immunol 2015; 297:46-52; PMID:26140980; http://dx.doi.org/10.1016/j.cellimm.2015.06.003 [127] Liikanen I, Ahtiainen L, Hirvinen ML, Bramante S, Cerullo V, Nokisalmi P, Hemminki O, Diaconu I, Pesonen S, Koski A, et al.Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Therapy 2013; 21:1212-23; http://dx.doi.org/10.1038/mt.2013.51 [128] Ariyoshi Y, Watanabe M, Eikawa S, Yamazaki C, Sadahira T, Hirata T, Araki M, Ebara S, Nasu Y, Udono H, et al.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Gene Therapy 2016; PMID:26836118; http://dx.doi.org/10.1038/gt.2016.7 [129] Yao C, Sasaki HM, Ueda T, Tomari Y, Tadakuma H. Single-Molecule Analysis of the Target Cleavage Reaction by the Drosophila RNAiEnzyme Complex.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Therapy 2007; 15:295-302; http://dx.doi.org/10.1038/sj.mt.6300023 [131] Chi Y, Wang X, Yang Y, Zhang C, Ertl HC, Zhou D. Survivin-tar- geting Arti ﬁcial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Mol Ther-apy Nucleic Acids 2014; 3:e208; PMID:25368912; http://dx.doi.org/10.1038/mtna.2014.59 [132] MacLeod SH, Elgadi MM, Bossi G, Sankar U, Pisio A, Agopsowicz K, Sharon D, Graham FL, Hitt MM.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Cancer Gene Therapy 2012; 19:888-98; PMID:23099884; http://dx.doi.org/ 10.1038/cgt.2012.79 [133] Zhan Y, Yu B, Wang Z, Zhang Y, Zhang HH, Wu H, Feng X, Geng RS, Kong W, Yu XH.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Int J Clin Exp Pathol 2014; 7:2850-60; PMID:25031704 [134] Takagi-Kimura M, Yamano T, Tamamoto A, Okamura N, Oka- mura H, Hashimoto-Tamaoki T, Tagawa M, Kasahara N, Kubo S. Enhanced antitumor ef ﬁcacy of ﬁber-modi ﬁed, midkine promoter- regulated oncolytic adenovirus in human malignant mesothelioma.Cancer Sci 2013; 104:1433-9; PMID:23962292; http://dx.doi.org/ 10.1111/cas.12267 [135] Rux JJ, Burnett RM.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Hum Gene Therapy 2004; 15:1167-76; http://dx.doi.org/10.1089/hum.2004.15.1167 [136] Nemerow GR, Pache L, Reddy V, Stewart PL.",OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Virology 2009; 384:380-8; PMID:19019405; http://dx.doi.org/10.1016/j.virol.2008.10.016 [137] Tian X, Su X, Li X, Li H, Li T, Zhou Z, Zhong T, Zhou R. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"Plos One 2012; 7:e41381;PMID:22848478; http://dx.doi.org/10.1371/journal.pone.0041381 [138] Sharma A, Krause A, Xu Y, Sung B, Wu W, Worgall S. Adenovirus- based vaccine with epitopes incorporated in novel ﬁber sites to induce protective immunity against Pseudomonas aeruginosa.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"PloSOne 2013; 8:e56996; PMID:23437292; http://dx.doi.org/10.1371/journal.pone.0056996 [139] Krause A, Joh JH, Hackett NR, Roelvink PW, Bruder JT, Wickham TJ, Kovesdi I, Crystal RG, Worgall S. Epitopes expressed in differentadenovirus capsid proteins induce different levels of epitope-speci ﬁc immunity.",Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
J Virol 2006; 80:5523-30; PMID:16699033; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
J Virol 2002; 76:6893-9; PMID:12072490; http://dx.doi.org/10.1128/JVI.76.14.6893-6899.2002 [142] Parks RJ.,Non-OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
Mol Ther- apy 2005; 11:19-25; http://dx.doi.org/10.1016/j.ymthe.2004.09.0182074 C. ZHANG AND D. ZHOU,OADS,/arxiv_data1/oa_pdf/74/8f/khvi-12-08-1165908.PMC4994731.pdf
"8, 2162 –2168 http://dx.doi.org/10.1080/21645515.2016.1163455",Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Expert Rev Anti Infect Ther 2011; 9:761-74; PMID:21905785;http://dx.doi.org/10.1586/eri.11.89.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Pediatr Infect Dis J 2008; 27:193-9; PMID:18277925; http://dx.doi.org/ 10.1097/INF.0b013e31815c1b3a.,OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Pediatr Infect Dis J 2011; 30:e41-8; PMID:21200360; http://dx.doi.org/10.1097/ INF.0b013e3182054ab9.,OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
"Pediatr Infect Dis J 2011; 30:e56-62; PMID:21278617; http://dx.doi.org/10.1097/INF.0b013e31820e6e02 [13] Knuf M, Pantazi-Chatzikonstantinou A, P ﬂetschinger U, Tichmann- Schumann I, Maurer H, Maurer L, Fischbach T, Zinke H, Pankow- Culot H, Papaevangelou V, et al.",OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Vac- cine 2011; 29:4264-73; PMID:21420417; http://dx.doi.org/10.1016/j.vaccine.2011.03.009.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Hum Vac- cin Immunother 2012; 8:881-7; PMID:22485048; http://dx.doi.org/10.4161/hv.20212.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Drugs Aging 2013; 30:309-19; PMID:23494214; http://dx.doi.org/10.1007/ s40266-013-0065-0.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Curr Opin Pediatr 2013; 25:397-406; PMID:23652687; http://dx.doi.org/10.1097/MOP.0b013e328360dc63.,OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Hum Vaccin Immunother 2013; 9:162-71; PMID:23108355; http://dx.doi.org/10.4161/hv.22302.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
BMC Infectious Diseases 2013; 13:116; PMID:23510357; http://dx.doi.org/10.1186/1471-2334-13-116.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
Hum Vaccin Immunother 2012; 8:866-72; PMID:22485049; http://dx.doi.org/10.4161/hv.20229.,Non-OADS,/arxiv_data1/oa_pdf/87/ab/khvi-12-08-1163455.PMC4994734.pdf
"8, 2197 –2203 http://dx.doi.org/10.1080/21645515.2016.1164362",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
J Diabetes Sci Technol 2012; 6:858-66; PMID:22920812; http://dx.doi.org/10.1177/193229681200600417 [2] Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
J Diabetes Sci Technol 2009; 3:283-88; http://dx.doi.org/10.1177/193229680900300208 [4] CDC DVH - Viral Hepatitis Outbreak Information - Outbreaks Related to Healthcare 2008 –2013 [article online].,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Available from: http://www.cdc.gov/hepatitis/Outbreaks/HealthcareHepOutbreakTable.htm [Accessed 8 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Epidemiol Infect 2011; 139:327-35; http://dx.doi.org/10.1017/S0950268810001007 [6] De Schrijver K, Eurosurveillance editorial team.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"BMC Med 2009; 7:15; http://dx.doi.org/10.1186/1741-7015-7-15 [8] Farkas K, Jermendy G. Transmission of hepatitis B infection during home blood glucose monitoring.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Diabet Med 1997; 14(3):263; http://dx.doi.org/10.1002/(SICI)1096-9136(199703)14:3%3c263::AID- DIA342%3e3.0.CO;2-R [9] Czech Vaccinology Society [article online].,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Available from: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-hepb-eng.php [Accessed 20 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Available from: http://www.health.belgium.be/ ﬁle store/4930389_FR/ ﬁche_de_vaccination_h /C19epatite_B_06032013.pdf [Accessed 30 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Ali ment Pharmacol Ther 2011; 33:815-21; PMID:21281319; http://dx.doi.org/10.1111/j.1365-2036.2011.04589.x [14] Alavian S-M, Tabatabaei SV.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Vaccine 2010; 28:3773-77; PMID:20371390; http://dx.doi.org/10.1016/j.vaccine.2010.03.038 [15] Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective ef ﬁcacy against hepati- tis B.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Drugs 2003; 63:1021-51; PMID:12699402; http://dx.doi.org/10.2165/00003495-200363100-00006 [16] Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Clin Infect Dis 2008; 46:1078-84;PMID:18444828; http://dx.doi.org/10.1086/529197 [17] Gruver AL, Hudson LL, Sempowski GD.",OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"J Pathol 2007; 211:144-56; PMID:17200946; http://dx.doi.org/10.1002/path.2104 [18] Goodwin K, Viboud C, Simonsen L. Antibody response to in ﬂuenza vaccination in the elderly: a quantitative review.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Vaccine 2006; 24:1159-69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105 [19] Hoel T, Wolter JM, Schuerman LM.",OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Eur J Emerg Med 2006; 13:67-71; PMID:16525231; http://dx.doi.org/10.1097/01.mej.0000184993.51799.ad [20] Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
J Infect Dis 1999; 179:489-92; PMID:9878036; http://dx.doi.org/10.1086/314578 [21] Plotkin SA.,OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"J Clin Virol 2013; 58:262-4; PMID:23895931; http://dx.doi.org/10.1016/j.jcv.2013.07.003 [23] Shaw FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm RR Jr, Talley WS, Hadler SC.",OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Vaccine 1989; 7:425-30; PMID:2530717; http://dx.doi.org/10.1016/0264-410X(89)90157-6 [24] Diagnosis and classi ﬁcation of diabetes mellitus.,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"Ann Intern Med 2009; 150:604-12; PMID:19414839; http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006 [27] Thome RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, Drobeniuc J, Hu DJ, Turner C, Wafeeg T, et al.",OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
StatMed 1998; 17:873-90; PMID:9595617; http://dx.doi.org/10.1002/ (SICI)1097-0258(19980430)17:8%3c873::AID-SIM779%3e3.0.,OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"J Pae- diatr Child Health 1997; 33:67-70; PMID:9069048; http://dx.doi.org/10.1111/j.1440-1754.1997.tb00994.x [30] Cui W, Sun C-M, Deng B-C, Liu P. Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a m eta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
Gene 2013; 525:35-40; PMID:23651591; http://dx.doi.org/10.1016/j.gene.2013.04.065HUMAN VACCINES & IMMUNOTHERAPEUTICS 2203,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/khvi-12-08-1164362.PMC4994745.pdf
"8, 2148 –2161 http://dx.doi.org/10.1080/21645515.2016.1160177",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Pharmacoeconomics 2013; 31(7):563- 76; PMID:23673904; http://dx.doi.org/10.1007/s40273-013-0057-2 [2] Davis KL, Misurski D, Miller J, Karve S. Cost impact of complica- tions in meningococcal disease: evidence from a United States man- aged care population.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Hum Vaccin 2011; 7(4):458-65; PMID:21795848; http://dx.doi.org/10.4161/hv.7.4.14434 [3] Harrison LH, Trotter CL, Ramsay ME.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 2009; 27 Suppl 2:B51-63; PMID:19477562; http://dx.doi.org/10.1016/j.vaccine.2009.04.063 [4] Gasparini R, Panatto D. Meningococcal glycoconjugate vaccines.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Hum Vaccin 2011; 7:170-82; PMID:21178398; http://dx.doi.org/10.4161/hv.7.2.13717 [5] Panatto D, Amicizia D, Lai PL, Gasparini R. Neisseria meningitidis B vaccines.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Expert Rev Vaccines 2011; 10:1337-51;PMID:21919622; http://dx.doi.org/10.1586/erv.11.103 [6] European Centre for Disease Prevention and Control: Surveillance of invasive bacterial diseases in Europe 2008/2009.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.ecdc.europa.eu.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.simi.iss.it/ dati.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.epicentro.iss.it/temi/vaccinazioni/pdf/Istruttoria %20MENINGOCOCCO%20B.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet 1983; 2:355-57;PMID:6135869; http://dx.doi.org/10.1016/S0140-6736(83)90340-9 [10] Bjune G, Høiby EA, Grønnesby JK, Arnesen O, Fredriksen JH, Hal- stensen A, Holten E, Lindbak AK, Nøkleby H, Rosenqvist E, et al.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet 1991; 338:1093-96;PMID:1682541; http://dx.doi.org/10.1016/0140-6736(91)91961-S [11] Sierra GV, Campa HC, Varcacel NM, Garcia IL, Izquierdo PL, Soto- longo PF, Casanueva GV, Rico CO, Rodriguez CR, Terry MH.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet 1992; 340:1074-78; PMID:1357461; http://dx.doi.org/10.1016/0140-6736(92)93086-3[13] Boslego J, Garcia J, Cruz C, Zollinger W, Brandt B, Ruiz S, Martinez M, Arthur J, Underwood P, Silva W. Ef ﬁcacy, safety, and immuno- genicity of a meningococcal group B (15:P1.3) outer membraneprotein vaccine in Iquique, Chile.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 1995; 13:821-29; PMID:7483804; http://dx.doi.org/10.1016/0264-410X(94)00037-N [14] Oster P, Lennon D, O ’Hallahan J, Mulholland K, Reid S, Martin D. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 2005; 23(17 –18):2191-96; PMID:15755593; http://dx.doi.org/10.1016/j.vaccine.2005.01.063 [15] Panatto D, Amicizia D, Lai PL, Cristina ML, Domnich A, Gasparini R. New versus old meningococcal group B vaccines: how the new ones may bene ﬁt infants & toddlers.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.hc-sc.gc.ca/dhp-mps/prod pharma/sbd-smd/drug-med/sbd_smd_2014_bexsero_147275-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
ARTG ID 190718. http://search-au.funnelback.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Vaccine 2014; 32:1187-91; PMID:24120548; http://dx.doi.org/10.1016/j.vaccine.2013.09.055 [21] WHO: Principles and considerations for adding a vaccine to a national immunization programme From decision to implementa-tion and monitoring.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"http://www.who.int/immunization/program mes_systems/policies_strategies/vaccine_intro_resources/nvi_guide lines/en/Accessed Oct 2014 [22] Anderson RM, Nokes DJ: Mathematical models of transmission and control.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.who.int/csr/resources/publications/men ingitis/WHO_CDS_CSR_EDC_99_7_EN/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.vaccinarsi.org/assets/uploads/news/report_situazione_meningiti_veneto/report_%202007_2012_ssm-simi-mib.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Plos One 2015; 10(4):e0123383; PMID:25874805; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 2014; 32(42):5436-46; PMID:25131732; http://dx.doi.org/10.1016/j.vaccine.2014.07.096 [27] Christensen H, Hickman M, Edmunds WJ, Trotter CL.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vac-cine 2013; 31:2638-46; PMID:23566946; http://dx.doi.org/10.1016/j.vaccine.2013.03.034 [28] Pouwels KB, Hak E, van der Ende A, Christensen H, van den Dob- belsteen GP, Postma MJ.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Hum Vaccin Immunother 2013; 9:1129-38; PMID:23406816; http://dx.doi.org/10.4161/hv.23888 [29] Christensen H, Trotter CL, Hickman M, Edmuds WJ.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.who.int/ choice/publications/p_2003_generalised_cea.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet Infect Dis2013; 13:416-25; PMID:23414709; http://dx.doi.org/10.1016/S1473-3099(13)70006-9 [33] Frosi G, Biolchi A, Lo Sapio M, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, et al.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 2013; 31:4968-74;PMID:23954380; http://dx.doi.org/10.1016/j.vaccine.2013.08.006 [34] McQuaid F, Snape MD.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Expert Rev Vaccines 2014; 13(3):313-5; PMID:24451002; http://dx.doi.org/10.1586/14760584.2014.878654 [35] Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D. Neisseria meningitidis B vaccines: recent advances and possible immuniza- tion policies.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Expert Rev Vaccines 2014; 13:345-64; PMID:24476428; http://dx.doi.org/10.1586/14760584.2014.880341 [36] Roed C, Omland LH, Engsig FN, Skinhoj P, Obel N. Long-term mortality in patients diagnosed with meningococcal disease: a Dan- ish nationwide cohort study.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"PloS One 2012; 5:e9662; http://dx.doi.org/10.1371/journal.pone.0009662 [37] Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJ, Pollard AJ, Turner DP, et al.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet 2014; 384:2123-31; PMID:25145775; http://dx.doi.org/10.1016/ S0140-6736(14)60842-4 [38] Trotter CL, Maiden M. Meningococcal vaccines and herd immu- nity: lessons learned from serogroup C conjugate vaccination pro- grams.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Expert Rev Vaccines 2009; 8(7):851-61; PMID:19538112;http://dx.doi.org/10.1586/erv.09.48 [39] Gasparini R, Comanducci M, Amicizia D, Ansaldi F, Canepa P, Orsi A, Icardi G, Rizzitelli E, De Angelis G, Bambini S, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"J ClinMicrobiol 2014; 52:1901-10; PMID:24648565; http://dx.doi.org/ 10.1128/JCM.03584-13 [40] Muzzi A, Mora M, Pizza M, Rappuoli R, Donati C. Conservation of meningococcal antigens in the genus Neisseria.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Microb Biotechnol 2011; 4(1):20-31; PMID:21255369; http://dx.doi.org/10.1111/j.1751-7915.2010.00178.x [42] Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, Findlow J, Ramsay ME, Borrow R. Effectiveness ofMeningococcal B Vaccine agains t Endemic Hypervirulent Neis- seria meningitidis W Strain, E ngland.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Emerg Infect Dis 2016; 22(2):309-11; PMID:26811872; http://dx.doi.org/10.3201/ eid2202.150369 [43] Istituto Nazionale di Statistica (ISTAT): Demogra ﬁa in cifre.,OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Pediatr Infect Dis 2010; 29:e71 –9; http://dx.doi.org/10.1097/ INF.0b013e3181faa6be [45] Rivaluta: Rivalutazioni e documentazione su prezzi, costi e retribu- zioni contrattuali.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://rivaluta.istat.it.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.simi.iss.it/meningite_ batterica.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"http://www.ecdc.it Accessed July 2014 [51] Edmond K, Clark A, Korczak VS, Sanderson C, Grif ﬁths UK, Rudan I.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet Infect Dis 2010; 10(5):317-28; PMID:20417414; http://dx.doi.org/10.1016/S1473-3099(10)70048-7 [52] Wang B, Haji Ali Afzali H, Marshall H. The inpatient costs and hospital service use associat ed with invasive meningococ- cal disease in South Australian children.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Vaccine 2014;32(37):4791-8; PMID:24998605; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Pediatrics 2005; 115(5):1220- 32; PMID:15867028; http://dx.doi.org/10.1542/peds.2004-2514 [54] Healy CM, Butler KM, Smith E, Hensey OP, Bate T, Moloney AC, MacMahon P, Cosgrove J, Cafferkey MT.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Clin InfectDis 2002; 34(10):1323-30; PMID:11981727; http://dx.doi.org/10.1086/340050 [55] Gottfredsson M, Reynisson IK, Ingvarsson RF, Kristjansdottir H, Nardini MV, Sigurdsson JF, Schneerson R, Robbins JB, Miller MA.Comparative Long-term adverse effects elicited by invasive group B and C meningococcal infections.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
CID 2011; 53:e117; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Lancet Neurol 2012; 11:774-83;PMID:22863608; http://dx.doi.org/10.1016/S1474-4422(12)70180-1 [57] van de Beek D. The burden of serogroup B meningococcal disease.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Lancet Neurol 2012; 11:743-5; PMID:22863607; http://dx.doi.org/ 10.1016/S1474-4422(12)70184-9 [58] Woods CR.,OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"J Clin Epidemiol 2002; 55:791-99; PMID:12384194; http://dx.doi.org/10.1016/S0895-4356(02)00448-1 [61] Xu R, Insinga RP, Golden W, Hu XH.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Qual Life Res 2011; 20:601- 08; PMID:21063786; http://dx.doi.org/10.1007/s11136-010-9783-5 [62] Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, L€onnqvist J.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Br J Psychiatry 2007; 190:326-32; PMID:17401039; http://dx.doi.org/10.1192/bjp.bp.106.025106 [63] Caban-Martinez AJ, Lee DJ, Fleming LE, Tancredi DJ, Arheart KL, LeBlanc WG, McCollister KE, Christ SL, Louie GH, Muennig PA. Arthritis, occupational class, and the aging US workforce.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
2011; 101:1729-34; PMID:21778483; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.moh.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Br J Ophthalmol2001; 85(3):327-31; PMID:11222340; http://dx.doi.org/10.1136/bjo.85.3.327 [66] Donev D, Zalatel-Kragelj, Bjegovic V, Burazeri G. Measuring the burden of disease: Disability Adjusted Life Year (DALY).",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.mf.uni-lj.si/dokumenti/6b695fc9385e3e2ab8fb41ec7d34660d.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Plos Med 2012; 9(9):e1001307;PMID:22984353; http://dx.doi.org/10.1371/journal.pmed.1001307 [70] Findlow J, Borrow R, Snape MD, Dawson T, Holland A, John TM, et al.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Clin Infect Dis 2010; 51(5):1127-37; PMID:20954968; http://dx.doi.org/10.1086/656741 [71] Giuliani MM, Adu-Bobie J, Comanducci M, AricR B, Savino S, San- tini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"J Clin Microbiol 2009; 47:3577-85; PMID:19759227; http://dx.doi.org/10.1128/JCM.00936-09 [73] Nolan T, O ’Ryan M, Wassil J, Abitbol V, Dull P. Vaccination with a multicomponent meningo coccal B vaccine in prevention of disease in adolescents and young adults.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Vaccine 2015; 33(36):4437-45; PMID:26187261; http://dx.doi.org/10.1016/j.vaccine.2015.06.011 [74] Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A, EU Meningococcal B Infant Vaccine Studygroup.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Lancet 2013;381(9869):825-35; PMID:23324563; http://dx.doi.org/10.1016/ S0140-6736(12)61961-8 [75] Santolaya ME, O ’Ryan ML, Valenzuela MT, Prado V, Vergara R, Mu~noz A, Toneatto D, Gra ~na G, Wang H, Clemens R, Dull PM, V72P10 Meningococcal B Adolescent Vaccine Study group.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Immu- nogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: aphase 2b/3 randomised, observer-blind, placebo-controlled study.Lancet 2012; 379(9816):617; PMID:22260988; http://dx.doi.org/ 10.1016/S0140-6736(11)61713-3 [76] Atkinson W, Wolfe S, Hamborsky J.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Pediatr Infect Dis J 2014; 33:760-66; PMID:24722351; http://dx.doi.org/10.1097/INF.0000000000000327 [78] AGENAS.,OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Gennaio 2010. http://www.quotidianosanita.it/allegati/allegato5477154.pdf Accessed July 2014 [79] ISTAT: retribuzioni.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.istat.it/it/archivio/retribuzioni.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Eur Neuropsychopharmacol 2011; 21:718-79; PMID:21924589; http://dx.doi.org/10.1016/j.euroneuro .2011.08.008 [81] Oxford Economic: The economic costs of arthritis for the UK econ- omy.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Final Report March 2010. http://www.oxfordeconomics.com/ publication/download/222531.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Pharmaco Economics Italian Res 2007; 9(1):1-8; http://dx.doi.org/10.1007/BF03320565 [83] Olesen J, Gustavsson A, Svensson M, Wittchen HU, J €onsson B. CDBE2010 study group; European Brain Council.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Eur J Neurol 2012; 19(1):155-62; PMID:22175760; http://dx.doi.org/10.1111/j.1468-1331.2011.03590.x [84] Frick KD, Walt JG, Chiang TH, Doyle JJ, Stern LS, Katz LM, Dol- gitser M, Hendlish SK.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Ophthalmology 2008; 115:11-7; PMID:17475331; http://dx.doi.org/10.1016/j.ophtha.2007.02.007 [85] Guerrini R, Battini R, Ferrari AR, Veggiotti P, Besana D, Gobbi G, Pezzani M, Berta E, Tetto A, Beghi E, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Epilepsia 2001; 42:641-46; PMID:11380572; http://dx.doi.org/10.1046/j.1528-1157.2001.27300.x [86] Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F. EPICOS Group.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Epilep-sia 2004; 45:171-8; PMID:14738425; http://dx.doi.org/10.1111/ j.0013-9580.2004.14103.x [87] Hepkema H, Pouwels KB, van der Ende A, Westra TA, Postma MJ.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"PLOS One 2013; 8:e65036; PMID:23741448; http://dx.doi.org/10.1371/ journal.pone.0065036 [88] Gopal I, Bhonagiri S, Ronco C, Bellomo R. Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous veno- venous hemo ﬁltration/hemodia ﬁltration.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Intensive Care Med 1997; 23:766-72; PMID:9290991; http://dx.doi.org/10.1007/s001340050407 [89] Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
J Headache Pain 2012; 13:361-78; PMID:22644214; http://dx.doi.org/10.1007/s10194-012-0460-7 [90] ISTAT: PIL Pro CaPite Italia.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://noi-italia.istat.itindex.php?,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.istat.it/it/archivio/ fecondit /C18a.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
http://www.istat.it/it/ archivio/mercatodellavoro.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"http://www.gazzettauf ﬁciale.it Accessed July 2014 [94] Landefeld JS, Seskin EP.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"Am J Public Health 1982; 72:555-66; PMID:6803602; http://dx.doi.org/10.2105/AJPH.72.6.555 [95] Cabellos C, Nolla JM, Verdaguer R, Pelegrin I, Ribera A, Ariza J, Viladrich PF.",Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Eur J Clin Mi crobiol Infect Dis 2012; 31:2661-66; PMID:22476361; http://dx.doi.org/10.1007/s10096-012-1610-1 [96] Bollettino Uf ﬁciale della Regione Basilicata N5 - 24-2-2014: Parte I. http://:www.basilicatanet.it.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Gynecol Oncol 2009; 112:370-6; PMID:19041125; http://dx.doi.org/ 10.1016/j.ygyno.2008.09.031[98] Tutto sui farmaci.,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"JAMA 2012; 307:573-82; PMID:22318278; http://dx.doi.org/ 10.1001/jama.2012.85 [100] Wu FC, Tsang YP.",OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Ecol Modell 2004; 177(3 –4):393-414; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
Health Econ 2004; 13 (5):405-15; PMID:15127421; http://dx.doi.org/10.1002/hec.903HUMAN VACCINES & IMMUNOTHERAPEUTICS 2161,Non-OADS,/arxiv_data1/oa_pdf/08/c9/khvi-12-08-1160177.PMC4994748.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/b8/evv203.PMC4994751.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"2013 ) were masked using the genome coordi- nates and Perl scripts supplied by the Drosophila Genome Nexus website ( http://johnpool.net/genomes.html , last accessed November 2015).",OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"DNA Sequence Statistics Calculation Codon usage statistics for each gene were estimated using the program CodonW ( http://sourceforge.net/projects/codonw/ , last accessed November 2015) for the frequency of optimal codon (F OP)(Ikemura 1981 ) and the effective number of codon (ENC) ( Wright 1990 ) statistics.",OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"Recombination rate (cM/Mb) for each gene was calcu- lated using the Perl scripts from D. melanogaster Recombination Rate Calculator version 2.3 ( http://petrov.stan- ford.edu/cgi-bin/recombination-rates_updateR5.pl , last accessed November 2015) ( Fiston-Lavier et al.",OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
DNA Sequence Polymorphism and Divergence Analysis The population genetic analysis software suite from K. Thornton ( https://github.com/molpopgen/analysis last accessed November 2015) and his libsequence package ( Thornton 2003 ) was used for DNA polymorphism analysis.,OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"Additionally, the CDS data for eight newly sequenced Drosophila genomes ( D. biarmipes, D. bipectinata, D. elegans, D. eugracilis, D. ﬁcusphila, D. kikkawai, D. takahashii, and D. rhopaloa ) were downloaded from the Drosophila modENCODE website ( ftp://ftp.hgsc.bcm.edu/DmodENC ODE/maker_annotation/ , last accessed November 2015).",OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"We conducted GO enrichment analysis (from the GO website: http://geneontology.org/ ,l a s t accessed November 2015) on our set of genes with signiﬁcantMK test result ( table 3 ) and found signiﬁcant enrichment for categories such as “germarium-derived female germ-line cystformation,” “cystoblast division,” and “female germ-line cyst formation” for the GSC genes; and “neurogenesis” for the NSC genes.",Non-OADS,/arxiv_data1/oa_pdf/d6/87/evv207.PMC4994752.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/55/evv201.PMC4994753.pdf
"psittaci were aligned against the previously sequenced C. abortus S26/3 , C. pecorum E58 and C. psittaci 6BC genomes, respectively, using abacus ( http://abacas.sourceforge.net/Manual.html , last accessed April, 2015) to create concatenated, ordered “pseudocontigs.” These pseudocontigs were considered as the bacterial chromosome for each strain and annotated using the Prokka bacterial genome annotation pipeline(Seemann 2014 ).",OADS,/arxiv_data1/oa_pdf/0c/55/evv201.PMC4994753.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtables S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/0c/55/evv201.PMC4994753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/omv017.PMC4994762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/47/jhc-3-001.PMC4994795.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Hepatocellular Carcinoma 2016:3 1–7Journal of Hepatocellular Carcinoma Dove press submit your manuscript | www.dovepress.co m Dove press  1Original researCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JHC.S6226 1Yttrium-90 resin microspheres as an adjunct to  sorafenib in patients with unresec table  hepatocellular carcinoma armeen Mahvash1 ravi Murthy1 Bruno C Odisio1 Kanwal Pratap raghav2 lauren girard2 sheree Cheung1 Van nguyen3 Joe ensor4 sameer gadani5 Khaled M elsayes6 reham abdel-Wahab1,7 Manal Hassan1 ahmed s shalaby1 James C Yao1 Michael J Wallace1 ahmed O Kaseb2 1Department of interventional radiology,   2Department of gastrointestinal Medical  Oncology,  3Department of Pharmacy,   4Department of statistics, The University  of T exas MD anderson Cancer Center,   Houston, TX,  5Department of radiology,   saint louis University Hospital, st louis,   MO, 6Department of Diagnostic radiology,   The University of Texas MD anderson  Cancer Center, Houston, TX, Usa;   7Department of Clinical Oncology, assiut  University Hospital, assiut, egypt Correspondence: armeen Mahvash   Department of interventional radiology,   Unit 1471, The University of Texas MD   anderson Cancer Center,  1515 Holcombe   Boulevard, Houston, TX  77030, Usa   Tel +1 713 563 7340  Fax +1 713 745 1163  email amahvash@mdanderson.or g    ahmed O Kaseb   Department of gastrointestinal Medical  Oncology, Unit  426, The University of Texas  MD anderson Cancer Center,  1515 Holcombe  Boulevard, Houston, TX  77030, Usa   Tel +1 713 792 2828  Fax +1 713 745 1163  email akaseb@mdanderson.or gPurpose:  The safety and efficacy of the combined use of sorafenib and yttrium-90 resin   microspheres (Y90 RMS) to treat advanced hepatocellular carcinoma (HCC) is not well  established.",Non-OADS,/arxiv_data1/oa_pdf/78/47/jhc-3-001.PMC4994795.pdf
"Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-hepatocellular-carcinoma-journa lThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina - tion and study of clinical, translational and basic research findings in  this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/78/47/jhc-3-001.PMC4994795.pdf
Visit http://www.dovepress.com/testimonialsph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/47/jhc-3-001.PMC4994795.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 337–340Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  337 SHORT REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S112148Blood pressure and fasting lipid changes after  24 weeks’ treatment with vildagliptin: a pooled  analysis in >2,000 previously drug-naïve patients  with type 2 diabetes mellitus Marc Evans1 Anja Schweizer2 James E Foley3 1Diabetes Resource Centre,   Llandough Hospital, Cardiff, UK;   2Medical Affairs Cardio Metabolic,   Novartis Pharma AG, Basel,   Switzerland; 3Medical Affairs Cardio- Metabolic, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAIntroduction: We have previously shown modest weight loss with vildagliptin treatment.",Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
"To address these questions, we employed a large (>2,000) vildagliptin pooled monotherapy database.Correspondence: Marc Evans Diabetes Resource Centre, Room 18 On-Call Landing, Llandough Hospital, Penlan Road, Penarth, CF64 2XX, Cardiff, UKTel +44 29 2071 6871Fax +44 29 2071 6844Email marclyndon1@hotmail.comJournal name: Vascular Health and Risk Management  Article Designation: SHORT REPORTY ear: 2016V olume: 12Running head verso: Evans et alRunning head recto: BP and fasting lipid changes with vildagliptinDOI: http://dx.doi.org/10.2147/VHRM.S112148",Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 340 Evans et al chosen to report the BP and fasting lipids results in a single  pool as we did previously with the weight.1 The BP and fasting lipids results are associated with  some caveats.,Non-OADS,/arxiv_data1/oa_pdf/6a/50/vhrm-12-337.PMC4994796.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1249–1260Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1249ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10809 4 The association between methylated CDKN2A   and cervical carcinogenesis, and its diagnostic  value in cervical cancer: a meta-analysis Jinyun li1,2,* Chongchang Zhou1,* haojie Zhou3,* Tianlian Bao1 T engjiao gao1 Xiangling Jiang1 Meng Ye1,2 1Department of Biochemistry and  Molecular Biology, school of Medicine,   ningbo University, 2Department of  Medical Oncology, affiliated hospital,   ningbo University, 3Department  of Molecular Diagnosis, ningbo  Diagnostic Pathology Center, ningbo,   Zhejiang, People’s Republic of China *These authors are co-first authors  of this workBackground:  Cervical cancer is the second deadliest gynecologic malignancy, characterized by  apparently precancerous lesions and cervical intraepithelial neoplasia (CIN), and having a long  course from the development of CIN to cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
"According to a report by the American Cancer Society, 12,990 new cervical cancers  and 4,120 new deaths are projected to occur in the US in 2016,1 although a substantially  increasing incidence of cervical cancer has been seen in developing countries, which  might be due to the inadequacy of the Pap screening test in these areas.2 The etiology of cervical cancer is related to interactions between host and envi - ronmental factors, such as contraceptive use,3 infection with certain types of human  papillomavirus (HPV),4 having sex at an early age, and having many sexual partners.5,6 Correspondence: Meng Ye The Affiliated Hospital, Renming Road,  ningbo, Zhejiang 315000, People’s  Republic of China Tel +86 574 135 6600 2088 Fax +86 574 8703 5866 email yemeng@nbu.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Li et al Running head recto: Association between methylated CDKN2A  and cervical carcinogenesis DOI: http://dx.doi.org/10.2147/TCRM.S108094",Non-OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
"The  Nfs was created using the Meta package in R (version 3.22,  http://www.r-project.org /).",OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/9d/tcrm-12-1249.PMC4994797.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/11/copd-11-1939.PMC4994798.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1939–1947International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1939OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10472 8 Efficacy of a self-management plan in  exacerbations for patients with advanced COPD Juan Miguel Sánchez- nieto1,2 Rubén Andújar-Espinosa3 Roberto Bernabeu-Mora1,2 Chunshao hu1 Beatriz Gálvez-Martínez1 Andrés Carrillo-Alcaraz1 Carlos Federico Álvarez- Miranda3 Olga Meca-Birlanga1 Eva Abad-Corpa4 1Division of Pneumology, Hospital  Morales Meseguer, 2University of  Murcia, 3Division of Pneumology,   hospital arrixaca, Murcia,   4Department of Professional  Development Unit, Murcia, spainBackground:  Self-management interventions improve different outcome variables in various  chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/d0/11/copd-11-1939.PMC4994798.pdf
"Keywords:  self-management, COPD, severe exacerbations Introduction COPD is a large and growing public health problem; it is now the most costly respira - tory disease in Europe.1 COPD is an irreversible and debilitating disease that progresses  through different stages and has a huge impact on patients’ functional performance  and quality of life.2 It is also characterized by episodes of acute exacerbation that are  a particular problem in the control of the disease because of the negative impact on  quality of life,3,4 prognosis, and costs.5,6 In addition to the severity of COPD, there  are other concomitant factors, such as comorbidities and unmet social/health needs  due to poor self-management of the disease, which can affect rates of hospital admis - sions and use of health care resources for these patients.7 In this context, different Correspondence: Roberto Bernabeu-Mora Division of Pneumology, Hospital Morales  Meseguer, Avda Marqués de los Vélez  s/n, 30008 Murcia, spain Tel +34 968 360 900  Fax +34 968 360 994 email rbernabeumora@hotmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Sánchez-Nieto et al Running head recto: Efficacy of a self-management plan in COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S104728",Non-OADS,/arxiv_data1/oa_pdf/d0/11/copd-11-1939.PMC4994798.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d0/11/copd-11-1939.PMC4994798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/11/copd-11-1939.PMC4994798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/copd-11-1921.PMC4994799.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1921–1928International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1921MethODO lOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S10966 1 Effects of roflumilast in COPD patients receiving  inhaled corticosteroid/long-acting β2-agonist  fixed-dose combination: RE2SPOND rationale  and study design Stephen I Rennard,1,2  Fernando J Martinez,3,4  Klaus F Rabe,5–7 Sanjay  Sethi,8 Emilio Pizzichini,9  Andrew McIvor,10 Shahid  Siddiqui,11 Antonio  Anzueto,12 haiyuan Zhu13 1Department of Internal Medicine,   University of Nebraska Medical  Center, Omaha, NE, USA;   2AstraZeneca, Cambridge, UK; 3Joan  and Sanford I Weill Department of  Medicine, Weill Cornell University,   New Y ork, NY, 4Department of  Internal Medicine, Michigan Health  System, Ann Arbor, MI, USA;   5LungenClinic Grosshansdorf,   Großhansdorf, 6Department of  Medicine, University Kiel, Kiel,   7Airway Research Center North,   German Center for Lung Research,   Großhansdorf, Germany; 8Department  of Medicine, University at Buffalo,   State University of New Y ork,   Buffalo, NY, USA; 9Department of  Medicine, Universidade Federal de  Santa Catarina, Santa Catarina, Brazil;   10Firestone Institute of Respiratory  Health, St Joseph’s Healthcare,   McMaster University, Hamilton, ON,   Canada; 11AstraZeneca, Gaithersburg,   MD, 12South texas Veterans health  Care System at San Antonio,   University of texas health Science  Center, San Antonio, TX, 13Allergan  plc, Jersey City, NJ, USABackground:  Roflumilast, a once-daily, selective phosphodiesterase-4 inhibitor, reduces the  risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis  and a history of exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/copd-11-1921.PMC4994799.pdf
"Keywords:  exacerbation, RE2SPOND, phosphodiesterase-4, ICS/LABA, methodology, study  design Introduction COPD is characterized by irreversible, progressive airflow limitation often associated  with pulmonary inflammation.1–3 In a recent study, $32 billion USD were attributed  to COPD-related medical costs, with a projected increase to $49 billion by 2020.4  Acute worsening of respiratory symptoms (exacerbations) contributes to morbidity  and mortality in patients with COPD, is associated with chronic and acutely worsened  airway inflammation,5 and further increases the cost of care.6 Patients with acute COPD Correspondence: Stephen I Rennard 985910 University of Nebraska Medical  Center, Omaha, NE 68198, USA tel +1 402 559 7313 Fax +1 402 559 4878 email stephen.rennard@astrazeneca.co m Journal name: International Journal of COPD Article Designation: Methodology Y ear: 2016 Volume: 11 Running head verso: Rennard et al Running head recto: Roflumilast and COPD: RE2SPOND study design DOI: http://dx.doi.org/10.2147/COPD.S109661",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/copd-11-1921.PMC4994799.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5e/a3/copd-11-1921.PMC4994799.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/a3/copd-11-1921.PMC4994799.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Hepatocellular Carcinoma 2016:3 9–18submit your manuscript | www.dovepress.co m Dove press  9 http: //dx.doi.org/10.2147/JHC.S10144 8Hepatocellular carcinoma in elderly patients:  challenges and solutions Angélique Brunot Samuel Le Sourd Marc Pracht Julien edeline Department of Medical Oncology,   Centre eugene Marquis, Rennes,   France Correspondence: Julien edeline   Department of Medical Oncology, Centre  eugene Marquis, Avenue de la Bataille  Flandres-Dunkerque, 35043 Rennes,  France   T el +33 2 9925 3196   email j.edeline@rennes.unicancer.f rAbstract:  Hepatocellular carcinoma (HCC) is the second most common cause of death by  cancer in the world.",Non-OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
"Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-hepatocellular-carcinoma-journa lThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina - tion and study of clinical, translational and basic research findings in  this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
Visit http://www.dovepress.com/testimonialsph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
Available from:  http://onlinelibrary.wiley.com.passerelle.univ-rennes1.fr/doi/10.1002/ hep.510300211/abstract?systemMessage =Wiley+Online+Library+wil l+have+intermittent +access+on+8th+August+2015+from+10%3A00- 16%3A00 +BST+%2F+05%3A00-11%3A00 +EDT+%2F+17%3A00- 23%3A00 +SGT+for+essential+maintenance.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/jhc-3-009.PMC4994800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/82/jhc-3-019.PMC4994801.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Hepatocellular Carcinoma 2016:3 19–24Journal of Hepatocellular Carcinoma Dove press submit your manuscript | www.dovepress.co m Dove press  19Original researCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JHC.S8670 8Clinical significance of vascular endothelial growth  factor in hepatitis C related hepatocellular  carcinoma in egyptian patients Mohamed Magdi El-Sadek  ali atta1,2 Hazem Mahmoud Atta3,4 Magdy Abdel-Mawgoud Gad2 Laila Ahmad Rashed4 ebada M said2 Sharaf El-Sayed Ali  Hassanien2 Ahmed O Kaseb5 1Department of Medicine, Rabigh  Faculty of Medicine, King Abdulaziz  University, Jeddah, Kingdom of Saudi  arabia;  2Department of Hepatology,   gastroenterology and infectious  Diseases, Faculty of Medicine, Benha  University, Benha, Egypt;  3Department  of Clinical Biochemistry, Rabigh  Faculty of Medicine, King Abdulaziz  University, Jeddah, Kingdom of Saudi  arabia;  4Department of Medical  Biochemistry and Molecular Biology,   Faculty of Medicine, Cairo University,   Cairo, egypt;  5Department of  gastrointestinal Medical Oncology,   The University of Texas MD Anderson  Cancer Center, Houston, TX, Usa Correspondence: Mohamed Magdi  El-Sadek Ali Atta   Department of Hepatology,  gastroenterology and infectious Diseases,  Faculty of Medicine, Benha University,   52 Taawon Street,   Ahram Road,    giza 12151, egypt   T el +20 100 537 0605  Fax +20 966 541 264352   email magdielsadek@yahoo.co.u kBackground and aims:  Several angiogenic factors are involved in the development and  progression of hepatocellular carcinoma (HCC), a hypervascular tumor.",Non-OADS,/arxiv_data1/oa_pdf/be/82/jhc-3-019.PMC4994801.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.,OADS,/arxiv_data1/oa_pdf/be/82/jhc-3-019.PMC4994801.pdf
"Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-hepatocellular-carcinoma-journa lThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina - tion and study of clinical, translational and basic research findings in  this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/be/82/jhc-3-019.PMC4994801.pdf
Visit http://www.dovepress.com/testimonialsph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/82/jhc-3-019.PMC4994801.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1929–1937International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1929OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10861 1 general practitioners’ perceptions of COPD  treatment: thematic analysis of qualitative  interviews Katrine rutkær Molin1 Ingrid egerod2 laura staun Valentiner1 Peter lange3 henning langberg1 1Copenrehab, section of social  Medicine, Department of Public  health, University of Copenhagen,  Copenhagen, Denmark; 2Department of  neuroanaesthesiology, rigshospitalet,  University of Copenhagen,  Copenhagen,  Denmark; 3section of  social Medicine, Department of Public  health, University of Copenhagen,  Copenhagen, DenmarkBackground:  In Denmark, the treatment of COPD is mainly managed by general practitioners  (GPs).",Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"Other  benefits of rehabilitation programs are related to relieving anxiety and depression  associated with COPD.1Correspondence: Katrine rutkær Molin Copen rehab, section of social  Medicine, Department of Public health,  University of Copenhagen, sund Vækst  huset, henrik  Pontoppidansvej 6, 2200  Copenhagen n, Denmark Tel +45 5135 2551 email katrine.rutkaer@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Molin et al Running head recto: General practitioners’ perceptions of COPD treatment DOI: http://dx.doi.org/10.2147/COPD.S108611 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
Or use: http://youtu.be/W890cs_7NQ UVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"Available from: http://www.lungemedicin.dk/fagligt/101-dansk-kol- retningslinje-2012/file.htm l. Accessed May 17, 2013.",OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
Available from: http://www.laeger.dk/ portal/pls/portal/!PORTAL.wwpob_page.show?_docname =8542883.,Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"Available from: http://www.dsam.dk/files/9/kol.pd f.  Accessed June 12, 2015.",OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
"2009. https://www.regionh.dk/Sundhedsaf - tale/bilag-og-download/Documents/RH_Program_KOL_rev_2015.pd f.  Accessed July 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/71/6b/copd-11-1929.PMC4994802.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 201–202Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 201 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S112746 Dengue infection severity score – improvised  disease management Syed Uzair Mahmood1 Maryam Jamil Syed1 Aisha Jamal1 Maria Shoaib2 1Sindh Medical College, Jinnah  Sindh Medical University, Karachi,   Pakistan; 2Dow Medical College, Dow  University of Health Sciences, Karachi,  PakistanDear editor We would like to add our views regarding the paper “Validation of Dengue infection  severity score” by Pongpan et al.1 As the paper outlines, the purpose of the Dengue  Severity Score is to classify individuals with dengue infection into three levels of severity with clinically acceptable underestimation or overestimation.",Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
"Correspondence: Syed Uzair Mahmood 43-8-D, Block 6, Pechs, Karachi, PakistanTel +92 331 846 1557Email uzair.hbb@gmail.com Journal name: Risk Management and Healthcare Policy Article Designation: LETTERY ear: 2016V olume: 9Running head verso: Mahmood et alRunning head recto: Dengue infection severity scoreDOI: http://dx.doi.org/10.2147/RMHP .S112746",Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 202 Mahmood et al We suggest that the scoring system should be made  widely applicable to effectively manage the ongoing  changes being currently observed in the virulence factors of dengue virus, for example, a fifth serotype DENV -5 recently discovered in 2015, has been shown to have caused frequent epidemics and life-threatening mortalities.",Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
Available at: http://www.cdc.gov/dengue/entomologyEcology/climate.html.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/rmhp-9-201.PMC4994803.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2016:3 25–29Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 25 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S50359 Transarterial radioembolization for hepatocellular  carcinoma: a review Rodolfo Sacco1  Caterina Conte2  Emanuele T umino1  Giuseppe Parisi1  Sara Marceglia3  Salvatore Metrangolo1  Roberto Eggenhoffner4  Giampaolo Bresci1  Giuseppe Cabibbo5  Luca Giacomelli4 1Department of Gastroenterology,   Cisanello Hospital, Pisa,   2Endocrinology and Metabolic  Diseases, Policlinico A. Gemelli,   Università Cattolica del Sacro Cuore,  Rome,  3Department of Engineering  and Architecture, University of Trieste, Trieste,  4Department of  Surgical Sciences and Integrated Diagnostics, School of Medicine,  Genova University, Genoa,  5Section of  Gastroenterology, DIBIMIS, University of Palermo, Palermo, ItalyAbstract:  Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is the  second cause of death due to malignancy in the world.",Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
"This review discusses Correspondence: Rodolfo Sacco   Department of Gastroenterology,  Cisanello Hospital, Via Paradisa 2, 56124 Pisa, Italy Tel +39 50 99 7411   Fax +39 50 99 7412   Email r.sacco@ao-pisa.toscana.itJournal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEWY ear: 2016V olume: 3Running head verso: Sacco et alRunning head recto: Transarterial radioembolization for hepatocellular carcinomaDOI: http://dx.doi.org/10.2147/JHC.S50359",Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
Available from: http://www.nccn.org/professionals/physician_gls/PDF/hepatobili-ary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
"Journal of Hepatocellular Carcinoma 2016:3submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 29 Transarterial radioembolization for hepatocellular carcinoma  41.,Non-OADS,/arxiv_data1/oa_pdf/9a/2b/jhc-3-025.PMC4994804.pdf
"19This increase was © Laura A Adamson-Small and Blanca Hay /C19e Ruiz-Ordaz *Correspondence to: Blanca Hayd /C19e Ruiz-Ordaz; Email: bhro@unam.mx Submitted: 01/06/2016; Accepted: 01/06/2016http://dx.doi.org/10.1080/21505594.2016.1141163 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
"http://dx.doi.org/10.1080/ 21505594 70 Volume 7 Issue 2 VirulenceVirulence 7:2, 70--71; February/March 2016; Published with license by Taylor & Francis Group, LLCEDITORIAL",Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Virulence 2015; 7(2); PMID:26632342; http://dx.doi.org/10.1080/21505594 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
N Engl J Med 2004; 350:586-596; PMID:14762186; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Autoim- munity Review 2003; 2(4): 218-223; http://dx.doi.org/10.1016/S1568-9972(03)00014-4 4.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Virus Res 2014; 190:8- 16; PMID:24998884; http://dx.doi.org/10.1016/j.virusres.2014.06.017 5.,OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Virology 1994; 203:106-15.; PMID:8030266; http://dx.doi.org/ 10.1006/viro.1994.1460 7.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
J Virol 2002; 76(11):5395-403; PMID:11991968; http://dx.doi.org/ 10.1128/JVI.76.11.5395-5403.2002 9.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Clin Exp Immunol 2006; 144(1): 152-7; PMID:16542377; http://dx.doi.org/10.1111/j.1365-2249.2006.03023.x 10.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
J Virol 2008; 82(16): 7942-52; PMID:18550668; http://dx.doi.org/ 10.1128/JVI.00891-08 11.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
J Virol 2002; 76(4):2014-8.; PMID:11799199; http://dx.doi.org/10.1128/ JVI.76.4.2014-2018.2002 12.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
PNAS 1998; 95(14): 8227-32; PMID:9653169; http://dx.doi.org/ 10.1073/pnas.95.14.8227 14.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Br J Cancer 2008; 98(3): 611-8; PMID:18212749; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Clin Microbiol Rev 2002; 15(3): 485-505; PMID:12097253;http://dx.doi.org/10.1128/CMR.15.3.485-505.2002 17.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
J Biomed Scie 2009; 16:14; http://dx.doi.org/10.1186/ 1423-0127-16-14 18.,OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
J Gen Virol 2001; 82: 3011-9; PMID:11714978;http://dx.doi.org/10.1099/0022-1317-82-12-3011 21.,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
Am J Gastroenterol 2007; 102(7): 1489-98; PMID:17459020; http://dx.doi.org/10.1111/j.1572-0241.2007.01240.x www.tandfonline.com 71 Virulence,Non-OADS,/arxiv_data1/oa_pdf/2a/7f/kvir-07-02-1141163.PMC4994827.pdf
"© Tan N Doan, David CM Kong, Caroline Marshall, Carl MJ Kirkpatrick, and Emma S McBryde *Correspondence to: Emma S McBryde; Email: emma.mcbryde@mh.org.au; David CM Kong; Email: david.kong@monash.eduSubmitted: 06/05/2015; Revised: 07/17/2015; Accepted: 07/21/2015 http://dx.doi.org/10.1080/21505594.2015.1076615 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Crit Care 2011; 26:453- 9; PMID:21439763; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clin Infect Dis 2008; 46:1254-63; PMID:18444865; http://dx.doi.org/10.1086/529198 3.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
PLoS One 2014; 9:e95476; PMID:24748167; http://dx.doi.org/10.1371/journal.pone.0095476 4.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
PLoS One 2015; 10: e0132037; PMID:26131722; http://dx.doi.org/10.1371/journal.pone.0132037 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
BMC Infect Dis 2010; 10:228; PMID:20670453; http://dx.doi.org/10.1186/1471-2334-10-228 6.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Hosp Infect 2011; 79:302-8;PMID:22033439; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Theor Biol 2007;245:470-81; PMID:17188714; http://dx.doi.org/ 10.1016/j.jtbi.2006.11.008 11.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
PLoS One 2011; 6:e20604; PMID:21750700;http://dx.doi.org/10.1371/journal.pone.0020604 14.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
264:645-56; PMID:20347850; http://dx.doi.org/ 10.1016/j.jtbi.2010.03.036 15.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Antimicrob Agents Chemother 2008; 52:2933- 6; PMID:18519718; http://dx.doi.org/10.1128/ AAC.00456-08 16.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Crit Care 2012; 16:R102; PMID:22694969; http://dx.doi.org/10.1186/cc11383 17.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Am J Infect Control 2010; 38:329- 31; PMID:20189683; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clos- tridium difﬁcile exposure as an insidious source of infec- tion in healthcare settings: an epidemiological model.BMC Infect Dis 2013; 13:376; PMID:23947736; http://dx.doi.org/10.1186/1471-2334-13-376 19.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Pharmacotherapy 1999; 19:1080-5; PMID:10610015; http://dx.doi.org/10.1592/phco.19.13.1080.31597 20.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infect Control Hosp Epidemiol 2010; 31:1087-9; PMID:20804376; http://dx.doi.org/10.1086/656378 21.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
PLoS One 2012; 7:e52452; PMID:23300673; http://dx.doi.org/ 10.1371/journal.pone.0052452 22.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Eur J Clin Microbiol Infect Dis 2007; 26:793-800; PMID:17701063; http://dx.doi.org/10.1007/s10096-007-0371-8 23.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infect Con- trol Hosp Epidemiol 2008; 29:203-11; PMID:18257689; http://dx.doi.org/10.1086/528810 24.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clin Infect Dis 2007; 44:664-70; PMID:17278056; http://dx.doi.org/10.1086/511640 25.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Curr Opin Crit Care 2011; 17:487-92; PMID:21900768; http://dx.doi.org/10.1097/MCC.0b013e32834a4bab 27.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Available at http://www.hha.org.au/LatestNationalData.aspx [accessed in April 2015].,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Hosp Infect 1999; 43:131-47; PMID:10549313; http://dx.doi.org/10.1053/jhin.1998.0647 29.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Am J Infect Control 2015; 43:292-4; PMID:25556049; http://dx.doi.org/ 10.1016/j.ajic.2014.11.009 32.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infect Control Hosp Epidemiol 2007; 28:713-9; PMID:17520546; http://dx.doi.org/ 10.1086/517954 34.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Intensive Care Med 2010; 25:343-8; PMID:20837632; http://dx.doi.org/10.1177/0885066610377975 35.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infection 1982; 10:168- 71; PMID:7107014; http://dx.doi.org/10.1007/ BF01640769 36.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infect Control Hosp Epidemiol 2008; 29:1080-3; PMID:18837670; http://dx.doi.org/10.1086/591456 37.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Br Med Bull 2009; 92:33-42;PMID:19855103; http://dx.doi.org/10.1093/bmb/ ldp038 38.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J R Soc Interface 2010; 7:873-85; PMID:19892718; http://dx.doi.org/10.1098/rsif.2009.0386 39.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Hosp Infect 2009;73:143-50; PMID:19716203; http://dx.doi.org/ 10.1016/j.jhin.2009.06.007 40.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Theor Biol 2008; 254:178-96; PMID:18572196; http://dx.doi.org/ 10.1016/j.jtbi.2008.04.011 41.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Infect Dis 2005;192:2004-11; PMID:16267774; http://dx.doi.org/ 10.1086/498041 42.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Infect Control Hosp Epidemiol 2004; 25:819-24; PMID:15518022; http://dx.doi.org/10.1086/502302 43.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
J Hosp Infect 2007; 65:204-11; PMID:17254667; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
JAMA 2009; 302:2323-9; PMID:19952319; http://dx.doi.org/10.1001/jama.2009.1754 45.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
ClinInfect Dis 2011; 52:1232-40; PMID:21507920; http://dx.doi.org/10.1093/cid/cir063 48.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Surg Infect 2007; 8:589-97; PMID:18171118; http://dx.doi.org/ 10.1089/sur.2006.021 49.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clin Microbiol Infect 2014; 20:82-8; PMID:23517432; http://dx.doi.org/10.1111/ 1469-0691.12191 50.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
World J Surg 2006; 30:1848-55; PMID:16983476; http://dx.doi.org/10.1007/s00268-005-0653-1 51.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clin Nutr 2005; 24:211-9; PMID:15784480; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Clin Infect Dis 2014; 58:164-9; PMID:24158412; http://dx.doi.org/10.1093/cid/cit688 53.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Emerg Microbes and Infect 2014; 3:e43; PMID:26038744; http://dx.doi.org/10.1038/emi.2014.43 54.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Crit Care Med 2011; 39:651-8; PMID:21242793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
Crit Care 2006; 10:R48; PMID:16563184; http://dx.doi.org/10.1186/cc4869 www.tandfonline.com 151 Virulence,Non-OADS,/arxiv_data1/oa_pdf/eb/10/kvir-07-02-1076615.PMC4994832.pdf
"Similarly, reports of EVD cases started to © Maria Kiskowski and Gerardo Chowell *Correspondence to: Maria Kiskowski; Email: abyrne@southalabama.eduSubmitted: 04/15/2015; Revised: 07/06/2015; Accepted: 07/21/2015 http://dx.doi.org/10.1080/21505594.2015.1076613 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
N Engl J Med 2014 Apr 16;371(15):1418-25; PMID:24738640; http://dx.doi.org/10.1056/NEJMoa1404505 2.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Available from:http://apps.who.int/ebola/current-situation/ebola-situation-report-1-july-2015 (accessed on 5 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2015 [cited; Available from: http://apps.who.int/ebola/en/current-situation/ebola-situation-report-6-may-2015 3.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2015 Jan;13(1):e1002057; PMID:25607595; http://dx.doi.org/10.1371/journal.pbio.1002057 4.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2014 Oct 10;12(1):196; PMID:25300956;http://dx.doi.org/10.1186/s12916-014-0196-0 5.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Science 2014 Nov 21;346(6212):991-5; PMID:25414312; http://dx.doi.org/10.1126/ science.1260612 6.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Emerg Infect Dis 2015 Mar;21(3):393-9; PMID:25694150; http://dx.doi.org/10.3201/eid2103.141892 10.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Lancet Infect Dis 2015 Feb;15(2):204-11; PMID:25575618; http://dx.doi.org/10.1016/S1473-3099(14)71074-6 11.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Lancet Infect Dis 2014 Dec;14(12):1189-95; http://dx.doi.org/10.1016/S1473-3099(14)70995-8 12.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Comput Math Methods Med 2015;2015:736507; PMID:25755674; http://dx.doi.org/10.1155/2015/736507 14.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2015 Jan;13(1):e1002056; PMID:25585384; http://dx.doi.org/10.1371/journal.pbio.1002056 15.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
New England J Med 2014 Sep 22;371(16):1481-95; PMID:25244186; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
J Infect Dis 1999 Feb;179 Suppl 1:S87-91; http://dx.doi.org/ 10.1086/514284 20.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
J Infect Dis 1999 Feb;179Suppl 1:S1-7; PMID:9988155; http://dx.doi.org/ 10.1086/514308 21.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2007 Sep;121(9):700-20; PMID:17544041; http://dx.doi.org/10.1016/j.puhe.2006.12.011 28.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2004 Jan 22;427(6972):344-7; PMID:14737166; http://dx.doi.org/10.1038/nature02225 29.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
"Grenfell BT, Bjornstad ON, Kappey J. Travelling waves and spatial hierarchies in measles epidemics.Nature 2001 Dec 13;414(6865):716-23; PMID:11742391; http://dx.doi.org/10.1038/414716a 30.",OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
J Theor Biol 2004 Jul7;229(1):119-26; PMID:15178190; http://dx.doi.org/ 10.1016/j.jtbi.2004.03.006 32.,OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Nature 1998 Jun 4;393(6684):440-2;http://dx.doi.org/10.1038/30918 35.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Phys Rev Lett 2001 Apr2;86(14):3200-3; http://dx.doi.org/10.1103/ PhysRevLett.86.3200 36.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Phys Rev E Stat Nonlin Soft Matter Phys 2006 Nov;74(5 Pt 2):056101; PMID:17279962; http://dx.doi.org/ 10.1103/PhysRevE.74.056101 37.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
1989 Jun;86 (12):4793-7; http://dx.doi.org/10.1073/ pnas.86.12.4793 42.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Lancet Infect Dis 2015 Mar;15(3):320-6; PMID:25619149; http://dx.doi.org/10.1016/S1473-3099(14)71075-8 45.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
2006 Jan;3(1):1-15; PMID:20361804; http://dx.doi.org/10.3934/mbe.2006.3.1 46.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
"Sattenspiel L, Dietz K. A structured epidemic model incorporating geographic mobility among regions.Math Biosci 1995 Jul-Aug;128(1-2):71-91; PMID:7606146; http://dx.doi.org/10.1016/0025- 5564(94)00068-B 47.",OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
Phys Rev E Stat Nonlin Soft Matter Phys 2002 Jul;66(1 Pt 2):016128; PMID:12241447; http://dx.doi.org/ 10.1103/PhysRevE.66.016128 www.tandfonline.com 173 Virulence,Non-OADS,/arxiv_data1/oa_pdf/95/1b/kvir-07-02-1076613.PMC4994833.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 81–88Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 81 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S109124Laboratory- and field-based testing as predictors  of skating performance in competitive-level  female ice hockey T ommy Henriksson1,2  Jason D Vescovi3  Anncristine Fjellman- Wiklund4  Kajsa Gilenstam1 1Sport Medicine Unit, Department  of Community Medicine and  Rehabilitation, 2The National  Graduate School of Gender Studies,  Umeå University, Umeå, Sweden;   3Faculty of Kinesiology and Physical  Education, University of T oronto,  T oronto, ON, Canada;  4Physiotherapy  Unit, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, SwedenObjectives:  The purpose of this study was to examine whether field-based and/or laboratory- based assessments are valid tools for predicting key performance characteristics of skating in  competitive-level female hockey players.",Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
"3–5 So far, most research regarding Correspondence: Tommy Henriksson Sports Medicine Unit, Department of Community Medicine and Rehabilitation, Umeå University, Gösta Skoglunds väg 3, Umeå SE-90187, Sweden Tel +46 90 786 66 11   Email tommy.henriksson@umu.seJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Henriksson et alRunning head recto: Laboratory- and field-based testingDOI: http://dx.doi.org/10.2147/OAJSM.S109124",Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
Available from: http://cdn.agili-tycms.com/hockey-canada/Hockey-Programs/Players/Skills-Testing/Downloads/nsst_handbook_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
Available from: http://www.scarboroughtrack.com/sprintingme-chanics.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/ae/oajsm-7-081.PMC4994876.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5123–5131OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10372 9 Comparison of the short-term efficacy between  docetaxel plus carboplatin and 5-fluorouracil  plus carboplatin in locoregionally advanced  nasopharyngeal carcinoma Xing lv1,2,* Wei-Xiong Xia1,2,* liang-ru Ke1,2 Jing Yang1,2 Wen-Zhe Qiu1,2 Ya-hui Yu1,2 hu liang1,2 Xin-Jun huang1,2 guo-Yin liu1,2 Qi Zeng1,2 Xiang guo1,2 Yan-Qun Xiang1,2 1Key Laboratory of Oncology  in south china, 2Department of  nasopharyngeal carcinoma, sun  Yat-sen University cancer center,   Guangzhou, People’s Republic of  china *These authors contributed equally  to this workObjective:  Platinum-based chemotherapy in combination with radiotherapy is a standard  treatment strategy for locoregionally advanced nasopharyngeal carcinoma (NPC).",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
"Keywords:  nasopharyngeal cancer, carboplatin, 5-fluorouracil, docetaxel, tolerability Introduction Nasopharyngeal carcinoma (NPC) is the most common malignancy of the head and  neck in southern part of the People’s Republic of China.1,2 Approximately 21.4/100,000  persons per year will develop NPC in the People’s Republic of China, which is higher  than the worldwide rate of incidence ( ,1/100,000 persons per year).1,2 The gold  standard of NPC treatment is a combination of radiotherapy and chemotherapy, com - monly involving 5-fluorouracil (5-FU) and cisplatin.3–6 Treatment failure for primary  NPC is common, with failure rates of 7%–13% for residual tumor and 15%–58% for  recurrent NPC.4,7 Treatment of recurrent or residual NPC is even more difficult with  an average 5-year survival rate of 20%.7correspondence: Xiang guo;   Yan-Qun Xiang Department of nasopharyngeal  carcinoma, sun Yat-sen University  cancer center, 651 Dongfeng road  east, guangzhou 510060, guangdong,  People’s Republic of China Tel +86 20 8734 3359 Fax +86 20 8734 3392 email guoxiang@sysucc.org.c n;   xiangyq@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lv et al Running head recto: Docetaxel plus carboplatin versus 5-FU plus carboplatin in NPC  DOI: http://dx.doi.org/10.2147/OTT.S103729",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
"Table S2  Dose adjustment of chemotherapy due to adverse events as defined by the National Cancer Institute Common Terminology  criteria for adverse events 3.0 Serious AE Dose adjustment Homological toxicity Fever due to agranulocytosis 75% of standard dose neutropenia (grade 3–4, temperature $38.5°C, or with concomitant bleeding) 75% of standard dose Gastrointestinal toxicity Vomiting/nausea (grade 3 following preventive or symptomatic treatment) 75% of standard dose Vomiting/nausea (grade 3 following preventive or symptomatic treatment) 50% of standard dose Kidney creatinine clearance – calculated value 35–49 ml/min 50% of standard dose, and the longest time interval to delayed   chemotherapy was 2 weeks creatinine clearance – measured value 45–59 ml/min Discontinuation of chemotherapy if toxicity was not resolved Liver grade 3 toxicity no adjustment grade 4 toxicity Discontinue chemotherapy Notes:  Data from the website of the National Cancer Institute ( http://www.cancer.gov ).",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ott-9-5123.PMC4994877.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/26/ott-9-5133.PMC4994878.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5133–5142OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5133Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11113 2 coexpression of periostin and egFr in patients  with esophageal squamous cell carcinoma  and their prognostic significance Wei Jia1 Wei Wang1 chu-shu Ji1 Jun-yang niu2 Ya-jing lv1 hang-cheng Zhou2 Bing hu1 1Department of Medical Oncology,   2Department of Pathology, anhui  Provincial hospital, anhui Medical  University, hefei, People’s republic  of chinaBackground:  Both periostin (PN) and epidermal growth factor receptor (EGFR) can predict the  prognosis of several carcinomas alone.",Non-OADS,/arxiv_data1/oa_pdf/be/26/ott-9-5133.PMC4994878.pdf
"Keywords:  esophageal squamous cell carcinoma, periostin, epidermal growth factor receptor,  prognosis Introduction Esophageal carcinoma, one of the virulent upper gastrointestinal tract malignant  tumors, is the eighth most common incident cancer and sixth in lethal globally.1  Esophageal adenocarcinoma is the most predominant type of esophageal cancer in  America and Europe, while more than 80% of patients with esophageal cancer in correspondence: Bing hu Department of Medical Oncology,  anhui Provincial hospital, anhui  Medical University, no 17 lujiang road,  hefei 230001, People’s republic of china Tel/fax +86 551 6228 3337 email hubing2013oncol@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jia et al Running head recto: Coexpression of periostin and EGFR in ESCC DOI: http://dx.doi.org/10.2147/OTT.S111132",Non-OADS,/arxiv_data1/oa_pdf/be/26/ott-9-5133.PMC4994878.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/be/26/ott-9-5133.PMC4994878.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/26/ott-9-5133.PMC4994878.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/85/ott-9-5143.PMC4994879.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5143–5152OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5143Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10859 9 Meta-analysis of the prognostic value of  abnormally expressed lncrnas in hepatocellular  carcinoma Zhen Qu1,* chun-hui Yuan2,* chang-Qing Yin1 Qing guan2 hao chen1 Fu-Bing Wang1 1Department of laboratory  Medicine and center for gene  Diagnosis, Zhongnan hospital of  Wuhan University, 2Department of  immunology, school of Basic Medical  sciences, Wuhan University, Wuhan,   People’s republic of china *These authors contributed equally  to this workAbstract:  Many long noncoding RNAs (lncRNAs) have been reported to be abnormally  expressed in hepatocellular carcinoma (HCC), and may have the potential to serve as prog - nostic markers.",Non-OADS,/arxiv_data1/oa_pdf/ef/85/ott-9-5143.PMC4994879.pdf
"As a classic biomarker for HCC diagnosis, alfa-fetoprotein correspondence: Fu-Bing Wang Department of laboratory Medicine  and center for gene Diagnosis,  Zhongnan hospital of Wuhan  University, no 169 Donghu road,  Wuchang District, Wuhan 430071,  People’s republic of china Tel +86 27 6781 3517 Fax +86 27 6781 3128 email wfb20042002@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qu et al Running head recto: Abnormal expression of lncRNAs in hepatocellular carcinoma DOI: http://dx.doi.org/10.2147/OTT.S108599",Non-OADS,/arxiv_data1/oa_pdf/ef/85/ott-9-5143.PMC4994879.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/85/ott-9-5143.PMC4994879.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/ott-9-5143.PMC4994879.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/2f/ppa-10-1591.PMC4994880.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1591–1600Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1591OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10842 2 “My cancer is not my deepest concern”:  life course disruption influencing patient pathways  and health care needs among persons living with  colorectal cancer Anita salamonsen1 Mona A Kiil2 Agnete Egilsdatter  Kristoffersen1 Trine stub1 gro r Berntsen1,3 1national research center in  complementary and Alternative  Medicine, Department of community  Medicine, UiT the Arctic University  of norway, Tromsø, norway;   2Department of clinical Medicine,   UiT the Arctic University of norway,   Tromsø, norway; 3Norwegian  Center  for e health research, University  hospital of northern n orway,   Tromsø, norwayBackground:  The concept of “patient pathways”  in cancer care is most commonly understood as  clinical pathways, operationalized as standardized packages of health care based on guidelines for  the condition in question.",Non-OADS,/arxiv_data1/oa_pdf/be/2f/ppa-10-1591.PMC4994880.pdf
"This includes living with a stoma, continuing fatigue, altered bowel correspondence: Anita salamonsen national research center in  complementary and Alternative  Medicine, Department of community  Medicine, Faculty of health sciences,  UiT – The Arctic University of norway,  PO Box 6050 Langnes, N-9037 Tromsø,  norway Tel +47 9712 5135 email anita.salamonsen@uit.n o Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Salamonsen et al Running head recto: Colorectal cancer patients’ pathways and health care needs DOI: http://dx.doi.org/10.2147/PPA.S108422",Non-OADS,/arxiv_data1/oa_pdf/be/2f/ppa-10-1591.PMC4994880.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/be/2f/ppa-10-1591.PMC4994880.pdf
"Avail - able from: http://www.cancer.ca/en/cancer-information/cancer-type/ colorectal/supportive-care/?region =on#ixzz3QB3mNmv l. Accessed  February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/be/2f/ppa-10-1591.PMC4994880.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/63/d1/NG2016002097.PMC4995058.pdf
Available at:http://www.fda.gov/Drugs/DrugSafety/ucm349538.htm.,Non-OADS,/arxiv_data1/oa_pdf/63/d1/NG2016002097.PMC4995058.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ucm372774.htm.,Non-OADS,/arxiv_data1/oa_pdf/63/d1/NG2016002097.PMC4995058.pdf
"Preprocessing of the structural images collected at both sites was performed using the open-source FreeSurfer pipeline (version 5.3, http://surfer.nmr.mgh.harvard.edu).",OADS,/arxiv_data1/oa_pdf/2b/3d/mp20164a.PMC4995163.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Hippocampal sub ﬁeld volumes in schizophrenia NF Ho et al 152 Molecular Psychiatry (2017), 142 –152",Non-OADS,/arxiv_data1/oa_pdf/2b/3d/mp20164a.PMC4995163.pdf
2011 (https://www.ncpg.org.sg/ en/pdf/2011_NCPG_Gambling_Participation_Survey_23_Feb_2012.pdf).,Non-OADS,/arxiv_data1/oa_pdf/00/6c/bjporcpsych002519.PMC4995164.pdf
2005 (http://www.hab.gov.hk/file_manager/en/docu- ments/whats_new/gambling/KeyStat_200514_e.pdf).,OADS,/arxiv_data1/oa_pdf/00/6c/bjporcpsych002519.PMC4995164.pdf
"Institute for the Study of Commercial Gaming, University of Macau, 2003 (http://www.umac.mo/iscg/Events/Seminar/S1_SummaryReport _ENG.pdf).",Non-OADS,/arxiv_data1/oa_pdf/00/6c/bjporcpsych002519.PMC4995164.pdf
"19The Public Gaming Act India , 1867 (http://www.sangrurpolice.in/wp-content/ themes/intrepidity/images/actrule/publicGamblingAct1867.pdf).",Non-OADS,/arxiv_data1/oa_pdf/00/6c/bjporcpsych002519.PMC4995164.pdf
"Wikipedia , 2012 (http://en.wikipedia.org/wiki/ List_of_social_networking_websites).",Non-OADS,/arxiv_data1/oa_pdf/4d/08/bjporcpsych002832.PMC4995166.pdf
"WHO, 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_ 2004update_full.pdf 2Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al.",OADS,/arxiv_data1/oa_pdf/76/eb/bjporcpsych002923.PMC4995167.pdf
fMRI analysis Statistical parametric mapping (SPM8; http://www.fil.ion.ucl.ac.,Non-OADS,/arxiv_data1/oa_pdf/56/3a/bjporcpsych002550.PMC4995168.pdf
"Plots of contrast estimates wereextracted using the plots tool in SPM8, and WFU Pick Atlas (http://www.fmri.wfubmc.edu/cms/software) was used to display neural activation, with error bars representing the standard errorof the mean.",OADS,/arxiv_data1/oa_pdf/56/3a/bjporcpsych002550.PMC4995168.pdf
"Bias correction was performed using N41TK, which is an improved MNI_N3 bias correction software package available at http://www.insight-journal.org/browse/publi cation/640package.",OADS,/arxiv_data1/oa_pdf/a9/27/bjporcpsych002493.PMC4995169.pdf
"Spatial registration of all the skull-stripped images to the Jakob template was performed using the Deformable Registration via Attribute Matching and Mutual-saliencing Matching registrationpackage (DRAMMS, version 1.1.0; http://www.cbica.upenn.edu/sbia/software/dramms/index.html).",OADS,/arxiv_data1/oa_pdf/a9/27/bjporcpsych002493.PMC4995169.pdf
"Birth: Registry of Births, Deaths and Marriages , 2015 (http://www.bdm.nsw.gov.au/Pages/births/births.aspx).",Non-OADS,/arxiv_data1/oa_pdf/d3/00/bjporcpsych002790.PMC4995171.pdf
"How Record Linkage Works , 2016 (http://www.cherel.org.au/how-record-linkage-works).",Non-OADS,/arxiv_data1/oa_pdf/d3/00/bjporcpsych002790.PMC4995171.pdf
(http://www-01.ibm.com/software/analytics/spss/).,OADS,/arxiv_data1/oa_pdf/d3/00/bjporcpsych002790.PMC4995171.pdf
(http://www.health.gov.,Non-OADS,/arxiv_data1/oa_pdf/d3/00/bjporcpsych002790.PMC4995171.pdf
The app Catch It (http://appstore.liv.ac.uk/catch-it/) is an innovative smartphone app which uses the basic principles of CBT and hasbeen developed jointly by the universities of Liverpool andManchester.,Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bjporcpsych002436.PMC4995173.pdf
"App overview and procedure The Catch It app ran on all Apple iOS or Google/Android smartphones and could be downloaded from the University ofLiverpool app store, the Apple App Store and Google Play Store (http://appstore.liv.ac.uk/catch-it/).",OADS,/arxiv_data1/oa_pdf/8d/7a/bjporcpsych002436.PMC4995173.pdf
"Health Apps Library , 2013 (http://apps.nhs.uk).",Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bjporcpsych002436.PMC4995173.pdf
(http://dx.doi.org/10.1038/mp.2016.4).,OADS,/arxiv_data1/oa_pdf/af/4f/bjporcpsych002857.PMC4995174.pdf
(http://dx.doi.org/10.3389/fpsyt.2012.00096).,OADS,/arxiv_data1/oa_pdf/af/4f/bjporcpsych002857.PMC4995174.pdf
(http://dx.doi.org/10.1192/bjpo.bp.115.002444).,OADS,/arxiv_data1/oa_pdf/af/4f/bjporcpsych002857.PMC4995174.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.The Effect of Regular Exercise on Insulin Sensitivity in  Type 2 Diabetes Mellitus: A Systematic Review and  Meta-Analysis Kimberley L. Way1,2,3, Daniel A. Hackett1, Michael K. Baker3,4, Nathan A. Johnson1,2,3 1University of Sydney Faculty of Health Sciences, Lidcombe,  2Charles Perkins Centre, University of Sydney, Camperdown,   3Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders, Sydney Medical School University of Sydney, Camperdown,  4Australian Catholic University School of Exercise Science, Strathfield, Australia The purpose of this study was to examine the effect of regular exercise training on insulin sensitivity in adults with type 2 diabe - tes mellitus (T2DM) using the pooled data available from randomised controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Keywords:  Aerobic training; Glucose tolerance test; Hyperinsulinaemic euglycaemic clamp; Insulin resistance; Resistance train - ing Corresponding authors: Kimberley L. Way    http://orcid.org/0000-0002-1999-2498 Charles Perkins Centre, University of Sydney, Camperdown, NSW 2006,  Australia E-mail: kway2744@uni.sydney.edu.au Nathan A. Johnson    http://orcid.org/0000-0002-3874-7092 Charles Perkins Centre, University of Sydney, Camperdown, NSW 2006,  Australia E-mail: nathan.johnson@sydney.edu.au Received: Mar.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"For instance, in a longi - tudinal study which monitored CVD in individuals with  T2DM, each unit increase in homeostasis model of insulin re - sistance was associated with a 31% greater risk of CVD (odds  ratio [OR], 1.48), and a 56% elevated risk of CVD in individu -Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2016.40.4.253 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:253-271 Copyright © 2016 Korean Diabetes Association http://e-dmj.org",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.254 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgals who were followed-up at 52 months (OR, 2.24) [4].",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Regular exercise and insulin sensitivity 255 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgClamps: euglycaemic clamp Glucose levels are clamped and titrated at a predetermined  level, in conjunction with continuous insulin infusion at a  fixed rate.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.256 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgAnalyses The within trial standardised mean difference, or effect size  (ES), and 95% confidence intervals (CIs) were calculated.",OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
Regular exercise and insulin sensitivity 257 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.258 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgTable 1.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
Regular exercise and insulin sensitivity 259 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.260 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgAuthor ModeNutritional  interventionFrequency IntensitySession  durationIntervention  duration Middle - brooke et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
Regular exercise and insulin sensitivity 261 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgAuthor ModeNutritional  interventionFrequency IntensitySession  durationIntervention  duration Wing et al.,Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.262 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgTable 3.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Regular exercise and insulin sensitivity 263 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgAuthor Mode, n MeasureTime post- intervention, hrPre, mean±SD Post, mean±SD Change score Ronnemaa et al.",OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.264 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgFig.",OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Regular exercise and insulin sensitivity 265 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgstudies [21,24,30] showed an ES favouring exercise therapy,  ranging from –1.428 to –0.155.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.266 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgreview highlights a relative lack of data available from high  quality studies (14 studies for the pooled analysis in our  study) to support this.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
Regular exercise and insulin sensitivity 267 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgrate this.,Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"Way KL, et al.268 Diabetes Metab J 2016;40:253-271 http://e-dmj.org15.",Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
Regular exercise and insulin sensitivity 269 Diabetes Metab J 2016;40:253-271 http://e-dmj.orgAzhar S. Effect of muscle glycogen depletion on in vivo insulin  action in man.,Non-OADS,/arxiv_data1/oa_pdf/5f/c5/dmj-40-253.PMC4995180.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgRoles of Reactive Oxygen Species on Insulin Resistance  in Adipose Tissue Chang Yeop Han Division of Metabolism, Endocrinology & Nutrition, Department of Medicine and Diabetes and Obesity Center of Excellence, University of Washington,  Seattle, W A, USA Obesity resulting from the delivery of an excess amount of energy to adipose tissue from glucose or free fatty acids is associated  with insulin resistance and adipose tissue inflammation.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"Keywords:  Adipocytes; Insulin resistance; Mitochondria; NADPH oxidase; Obesity; Reactive oxygen species Corresponding author: Chang Y eop Han    http://orcid.org/0000-0001-9201-7982 Division of Metabolism, Endocrinology & Nutrition, Department of  Medicine, University of Washington, Box 356426, Seattle,   W A 98195-6426, USA E-mail: hancy@u.washington.edu Received: May 9, 2016; Accepted: Jun.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"Treat - ment with the antioxidants, N-acetyl cysteine, catalase and  superoxide dismutase (SOD) repressed ROS generation and  NF-κB translocation stimulated by excess glucose and palmi -Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2016.40.4.272 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:272-279",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"ROS, insulin resistance, and adipose tissue inflammation273 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgtate, and decreased inflammatory gene expression [17].",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
Han CY274 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgwhether NOX4-derived ROS itself can promote the onset of  insulin resistance in adipocytes during the progression of obe - sity is unknown and needs to be investigated.,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"ROS, insulin resistance, and adipose tissue inflammation275 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgROS AND NOX2 IN THE INTERMEDIATE  STAGES OF OBESITY Another potentially important source of ROS in obesity is  from macrophages that are recruited and accumulate in obese  adipose tissue.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"Han CY276 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgof energy flux into β-oxidation could overwhelm the capacity  of mitochondria, leading to leakage of electrons (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"ROS, insulin resistance, and adipose tissue inflammation277 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgstoring insulin signaling.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
Han CY278 Diabetes Metab J 2016;40:272-279 http://e-dmj.orgadipocyte hypertrophy from inflammation.,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"ROS, insulin resistance, and adipose tissue inflammation279 Diabetes Metab J 2016;40:272-279 http://e-dmj.org43.",Non-OADS,/arxiv_data1/oa_pdf/3c/0b/dmj-40-272.PMC4995181.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgDietary Sodium Intake in Patients with Type 2 Diabetes  Mellitus Mi-Kyung Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea Corresponding author: Mi-Kyung Kim    http://orcid.org/0000-0003-1111-9122 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Keimyung University School of Medicine, 56 Dalseong-ro,   Jung-gu, Daegu 41931, Korea E-mail: mdkmk@dsmc.or.kr Excessive dietary sodium intake is a well-known risk factor of  hypertension.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
These findings suggest that high dietary sodium in -Editorial Epidemiology http://dx.doi.org/10.4093/dmj.2016.40.4.280 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:280-282,Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
"Sodium intake in diabetes mellitus 281 Diabetes Metab J 2016;40:280-282 http://e-dmj.orgtake, independent of the calorie count, is a risk factor for obe - sity.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
Available from: http://www.diabetes.,Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
Available from: http://www.who.int/nutrition/publications/ guidelines/sodium_intake/en/ (cited 2016 Jul 29).,Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
Available from: http://www.diabetes.or.kr/pro/publish/ guide (updated 2015 Mar 23).,Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
Kim MK282 Diabetes Metab J 2016;40:280-282 http://e-dmj.orgrisk factor for obesity?,Non-OADS,/arxiv_data1/oa_pdf/2c/80/dmj-40-280.PMC4995182.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/9d/dmj-40-283.PMC4995183.pdf
"Copyright © 2016 Korean Diabetes Association http://e-dmj.orgGlycemic Effects of Rebaudioside A and Erythritol in  People with Glucose Intolerance Dong Hee Shin1, Ji Hye Lee1, Myung Shin Kang1, Tae Hoon Kim1, Su Jin Jeong1, Chong Hwa Kim1, Sang Soo Kim2, In Joo Kim2 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon,  2Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea Background:  Rebaudioside A and erythritol are nonnutritive sweeteners.",Non-OADS,/arxiv_data1/oa_pdf/db/9d/dmj-40-283.PMC4995183.pdf
"Keywords:  Erythritol; Glucose intolerance; Rebaudioside A Corresponding authors: Chong Hwa Kim    http://orcid.org/0000-0002-4563-7772 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Sejong General Hospital, 28 Hohyeon-ro 489beon-gil, Sosa-gu,  Bucheon 14754, Korea E-mail: drangelkr@hanmail.net In Joo Kim    https://orcid.org/0000-0003-1307-6146 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Pusan National University School of Medicine, 179 Gudeok-ro,  Seo-gu, Busan 49241, Korea E-mail: injkim@pusan.ac.kr Received: Aug. 17, 2015; Accepted: Oct. 20, 2015INTRODUCTION Sugar-free and reduced-calorie foods and beverages are gar - nering more interest due to the increasing rates of obesity in  several countries [1].",Non-OADS,/arxiv_data1/oa_pdf/db/9d/dmj-40-283.PMC4995183.pdf
Rebaudioside A is well known for sweetness Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2016.40.4.283 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2016;40:283-289,Non-OADS,/arxiv_data1/oa_pdf/db/9d/dmj-40-283.PMC4995183.pdf
"Shin DH, et al.284 Diabetes Metab J 2016;40:283-289 http://e-dmj.org(250 to 300 times sweeter than sucrose), and is popular as a  new, non-caloric sweetener in several countries [5].",Non-OADS,/arxiv_data1/oa_pdf/db/9d/dmj-40-283.PMC4995183.pdf
